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Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered
in clinical practice, and one of the main causes of ictus and strokes. Despite the advances
in the comprehension of its mechanisms, its thorough characterization and the quantifi-
cation of its effects on the human heart are still an open issue. In particular, the choice of
the most appropriate therapy is frequently a hard task. Radiofrequency catheter ablation
(CA) is becoming one of the most popular solutions for the treatment of the disease. Yet,
very little is known about its impact on heart substrate during AF, thus leading to an
inaccurate selection of positive responders to therapy and a low success rate; hence, the
need for advanced signal processing tools able to quantify AF impact on heart substrate
and assess the effectiveness of the CA therapy in an objective and quantitative manner.
This approach would help understand which patients could effectively benefit from abla-
tion, thus avoiding unnecessary and expensive procedures, and helping in the selection of
a patient-tailored therapy.
Valuable information about AF can be provided by multilead electrocardiogram (ECG)
recordings of heart electrical activity in a noninvasive and cost-effective manner. However,
most of standard ECG processing techniques are affected by several shortcomings. First,
some CA outcome predictors are manually determined on surface ECG, thus affected by
low repetitiveness. In addition, several parameters are merely computed in one ECG lead,
therefore neglecting potential information about AF and its spatial distribution coming
from the other leads.
This doctoral thesis aims at exploiting the multi-lead character of the standard ECG
to enhance CA outcome prediction accuracy and the ability of the extracted features
to characterize CA. Application of multivariate signal decomposition techniques, such
as principal component analysis (PCA), weighted PCA (WPCA) and nonnegative matrix
factorization (NMF), allow enhancing the most discriminant components of ECG content.
Features determined in this multivariate framework will act as classifiers for distinguishing
between successful and failing CA procedures prior to their performance.
Spatial variability of the standard ECG can be exploited to highlight some properties
of the ECG signal typically observed during AF. In particular, the role of fibrillatory wave
(f-wave) amplitude as a predictor of AF termination by CA is effectively enhanced in a
multilead framework based on the PCA of the observed data matrix. Higher amplitude
values prove to be correlated with CA success, and drawbacks of traditional methods,
such as manual computation and single-lead analysis, are overcome. Variations in this
parameter measured between the beginning and the end of the procedure are also able to
quantify CA effects on AF dynamics, related to ablation outcome.
Similarly, some multivariate signal decomposition techniques are employed to assess
the predictive power of AF spatio-temporal variability (STV) on the 12-lead ECG. Pre-
vious studies have demonstrated the correlation between single-lead STV measures and
AF organization. The present study exploits the multivariate character of standard ECG
enhanced by WPCA and underlines the ability of multilead STV descriptors to predict
long-term CA outcome in persistent AF: the more irregular and dispersive the AF pattern,
the less likely AF termination by CA. To the same extent, the NMF method proves to be
an effective tool for processing STV variability content of the ECG.
The aforementioned ECG properties can be also exploited for a combined analysis of
AF content by means of the logistic regression (LR) technique. This model condenses in a
unique index the most relevant contributions provided by surface recordings by selectively
enhancing the most content-bearing ECG leads, while reducing the influence of the other
electrodes. LR measures can effectively assess AF termination by CA at several follow-up
periods.
Further contributions to AF analysis are provided by information theory, which actu-
ally helps exploring surface ECG spatial variability by assessing the degree of similarity
between AF patterns observed on different leads. These regularity measures also prove
to quantify CA effectiveness, and a link between the degree of interlead correlation and
the procedural success is demonstrated.
Another line of investigation focuses on the analysis of the ventricular response, as
changes in atrioventricular (AV) node function and its refractoriness during AF are re-
flected on the irregularity of the RR interval (RRI) distribution. Heartbeat occurrences
are modeled as a point process, and effects of sino-atrial (SA) node response to sym-
pathetic and parasympathetic inputs from the autonomous nervous system are taken
into account in this probabilistic framework. Such a method allows for the extraction of
heart rate variability (HRV) indexes which effectively highlight asymmetry and dispersion
characteristics of the RRI distribution in presence of AF.
Résumé
La fibrillation auriculaire (FA) est la trouble cardiaque la plus courante, ainsi que
une des causes principales des accidents vasculaires cérébraux. Malgré le progrès dans
la compréhension de cette pathologie, les mécanismes à la base de la FA ses effets sur
le coeur humain ne sont pas encore très clairs. D’où il vient le problème du choix de la
stratégie de traitement la plus appropriée. La thérapie d’ablation par cathéter (CA) est
de plus en plus utilisée pour traiter la FA, mais ses effets sur le substrat cardiaque ne sont
pas suffisamment compris, d’où un taux de réussite très variable et le besoin d’outils du
traitement des signaux capables de quantifier cette action. Cette approche perméttrait
de traiter par CA seulement les sujets qui peuvent béneficier de cette thérapie.
L’électrocardiogramme (ECG) à 12 voies représente un outil non invasif peu coûteux
pour caractériser la FA à partir de l’activité électrique du coeur. Cependant, les pré-
dicteurs classiques de l’issue de la CA présentent plusieurs inconvénients, notamment leur
calcul manuel sur une seule voie de l’ECG, qu’amène à négliger l’information sur la FA
présente sur les autres dérivations.
Cette thèse exploite explicitement le caractère multi-capteur de l’ECG au moyen de
techniques de décomposition multivariées, par exemple, l’analyse en composantes prin-
cipales (PCA), la PCA pondérée (WPCA), la factorisation en matrices non négatives
(NMF), démontrant qu’elles peuvent améliorer la puissance prédictive de certaines pro-
priétés de l’ECG dans le cadre de la CA.
La variabilité spatiale de l’ECG standard peut être exploitée pour souligner certaines
proprietés du signal ECG qui sont typiquement observées en présence de la FA. En parti-
culier, l’amplitude des ondes fibrillatoires est corrélée avec le résultat de la CA, et traitée
par une méthode multi-capteur basée sur la PCA. Valeurs plus élévées de ce paramètre
prédisent la réussite de l’ablation, et les inconvenients des méthodes classiques (en par-
ticulier, le calcule manuel sur une seule dérivation) sont eliminés. Les variations de ce
déscripteur mésurée entre le début et la fin de l’ablation sont également capables de
quantifier les effets de la CA sur la dynamique de la FA, en rélation avec le résultat de
l’ablation.
D’autres techniques comme la WPCA et la NMF peuvent aussi quantifier la variabilité
spatio-temporelle (STV) de la FA sur l’ECG. Des études précedents ont démontré une
corrélation entre des mésures de la STV sur une seule voie et la complexité de la FA. Cette
thèse souligne la valeur prédictive de cette mésure obténue dans un cadre multicapteur au
moyen de la WPCA. Formes d’onde plus varaibles et irrégulieres sont associées à l’échec
de la CA. Résultats similaires sont obténus en utilisant la NMF. Ces propriétés de l’ECG
peuvent aussi être combinées par la régression logistique (LR), qui mets en valeur les
contributions les plus significatives pour la caractérisation du résultat de l’ablation.
La théorie de l’information permet également d’estimer le niveau de corrélation entre
les voies de l’ECG, mis en relation avec le résultat de la CA grâce à des approches multi-
capteurs.
Enfin, une dernière ligne de recherche concerne la réponse ventriculaire manifestée sur
la variabilité cardiaque. L’approche paramétrique de processus ponctuel est capable de
quantifier les effets de la réponse vagale sur le noeud sino-atriale, et souligner certaines
propriétés de cette variabilité, améliorant ainsi la caractérisation de la FA.
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1 Introduction
1.1 Background and motivation
Atrial fibrillation (AF) is currently the most common sustained cardiac arrhythmia,
responsible for serious long-term issues, such as ictus and stroke. Unlike other cardiac
diseases, despite advances in its understanding, AF mechanisms are not clear yet, and still
need to be elucidated. Accordingly, several theories about its generation and maintenance
have been put forward. Such a variety of hypotheses have given rise to several therapeutic
approaches, mainly dependent on AF chronicity, as well as patient’s clinical background.
One of the most recurrent strategies in persistent AF treatment is represented by ra-
diofrequency catheter ablation (CA), aiming at cauterizing abnormal rhythm sources in
the atrial myocardium.
Despite its increasing employment and the higher efficacy with respect to traditional
cardioversion therapies, results obtained in clinical centers are still quite disparate and
hardly comparable, due to the multiplicity of modalities and methodologies applied for
ablation performance. Indeed, as AF causes are not known yet, it is equally hard to
establish an effective protocol, applicable under any circumstances. By contrast, in med-
ical centers CA performance is mainly guided by clinician’s considerations, related to
the pratictioner’s experience and subjectivity. One of the main AF management lines
consists in identifying potential positive responders to CA therapy, so as to exclusively
treat patients who will benefit from CA and avoid unnecessary and potentially harmful
procedures. Nevertheless, also in this case most of patient’s evaluation is frequently biased
by clinician’s subjectivity, with no assessment of AF condition by means of quantitative
and measurable parameters.
To this extent, some efforts have been made so as to search for any potential descrip-
tors of heart electrical activity during AF, which can shed some light on CA effectiveness,
thus revealing which patients can be treated by CA without risk of AF recurrence in
the follow-up. Standard electrocardiogram (ECG) is widely employed in medical centers
for recording heart electrical activity by means of some electrodes positioned on patient’s
body and monitoring his conditions. It is characterized by several advantages: it is nonin-
vasive, rapid, cost-effective, easy to acquire and provides potential diagnostic information
about a wide variety of cardiac diseases. This tool is suitable for AF analysis, whose
presence can be even visually detected on standard ECG, for instance, through the ab-
sence of P waves, replaced by irregular fibrillatory waves (f-waves), and the more irregular
RR interval (RRI) distribution. Accordingly, several attempts have been made in order
to define novel ECG-based features to be combined with patient’s clinical characteristics
and quantify CA effects on heart substrate in the presence of AF. Nevertheless, most
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of these parameters present several drawbacks. In particular, some of them are manu-
ally obtained on the standard ECG, thus affecting repeatability of the measure, which is
operator-dependent, and increasing error probability. In addition, such indices are usually
computed in only one ECG lead, thus discarding the remaining ones. However, such an
approach lacks robustness to lead selection, as spatial variability of surface ECG is not
taken into account. ECG content can considerably change with respect to the heart plane
and orientation considered, and so can the parameters measured at that specific location.
Most of the traditional techniques are not able to process ECG content from all ECG
leads at the same time, and they are therefore subject to the lead choice constraint.
1.2 Objectives
The present thesis takes a step from these preliminary considerations, and it is moti-
vated by the research for novel multilead measures extracted from the 12-lead ECG which
can predict AF termination by CA. Our investigation aims at yielding ECG-based pa-
rameters which take into account contributions from all ECG leads, and which are herein
compared with classical methods for AF analysis and CA outcome assessment. To this
end, standard ECG content is properly processed by multivariate techniques that are able
to enhance the most content-bearing components while reducing the influence of polluting
and/or redundant elements. This strategy presents the potential of examining the whole
multilead recording at once, with no need for an a priori selection of the ECG leads to be
analyzed, since the most significant contributions are automatically emphasized.
One of the main goals of this work is characterizing some classical indices determined
on the standard ECG in a multilead framework, and corroborating the correlation with
CA clinical outcome. These objectives motivate the multivariate description of f-wave
amplitude, widely regarded as a predictor of AF termination by CA. To the same extent,
information about spatio-temporal variability (STV) of AF coming from surface ECG,
which is usually exploited for rendering AF complexity, is herein applied to distinguish
between successful and failing CA procedures. Combination of these heterogeneous fea-
tures is also applied to prediction of AF recurrence after CA at several follow-ups. Another
line of research investigates the predictive accuracy of other features, based on information
theory (IT). These measures render the degree of AF regularity in terms of spatial corre-
lation between ECG leads. Finally, AF analysis and CA outcome prediction are envisaged
from another perspective, based on the analysis of the ventricular response. Changes in
RRI variability due to AF impact are characterized in a parametric probabilistic scenario,
modeling as well the dependence of RRI length on dynamic vagal inputs to the sinoatrial
(SA) node is modeled as well.
1.3 Thesis overview and summary of contributions
The remaining of this thesis consists of 8 chapters (Chapters 2 - 9) divided in 3 main
parts. In the first part, a general overview about the main themes envisaged in this
dissertation is provided. In particular, in Chapter 2 we focus on some basic clinical
concepts, which help understanding the anatomy and the electrophysiology of the heart,
with particular attention to the conduction system, responsible for heart electrical activity
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propagation. The informative content of the standard ECG and its clinical application are
then illustrated, after indicating its main characteristics, both in healthy and pathologic
conditions, and the processing modalities prior to information extraction.
Then, Chapter 3 introduces the AF problem. AF pathophysiology is herein defined,
and the main theories about its generation and maintenance are summarized, as well
as the criteria for classifying its complexity, which are crucial for therapeutic choices.
Particular attention is paid to AF chronicity effects, altering atria structure and function
through electromechanical remodeling. The most current AF therapies are then described
in our dissertation. Pharmacological and electrical cardioversion are illustrated, and their
advantages and drawbacks are reviewed. The final part of this chapter focuses on ra-
diofrequency CA, regarded as a new frontier in persistent AF treatment; its performance
modalities, as well as some of the protocols adopted, are explained. Issues derived from
this therapy prompts the search for criteria allowing the selection of the most suitable
candidates to be treated by CA. Hence, it motivates the analysis of standard ECG and
the extraction of some measures conventionally regarded as predictors of procedural AF
termination, yet affected by some critical drawbacks, such as their manual computation
in a single lead.
The central part of this thesis concerns the contributions and the methods developed
to fulfill the objectives highlighted in the previous section. The principal lines of inves-
tigation of this thesis can be graphically summarized in Fig. 1.1. The main goals of this
ECG FEATURES
F−WAVE RR VARIABILITY
AMPLITUDE STV
POINT PROCESS
PCA
SPATIAL
REGULARITY (IT)
PCAPCA WPCA NMF
LR
− LONG/SHORT−TERM CA
OUTCOME PREDICTION
− AF PATTERN RECOGNITION
− LONG/SHORT−TERM CA OUTCOME PREDICTION
− SELECTION OF CEE CANDIDATES AFTER CA
Figure 1.1: Explicative diagram of the main parts composing the thesis study. Sections
referring to ECG features are contained in solid-line boxes. The multivariate techniques
employed are included in dash-dot boxes. Clinical applications tested are marked in
dashed boxes. Meaning of acronyms: AF: atrial fibrillation; CA: catheter ablation; CEE:
electrical cardioversion; ECG: electrocardiogram; f-wave: fibrillatory wave; IT: informa-
tion theory; LR: logistic regression; NMF: nonnegative matrix factorization; PCA: prin-
cipal component analysis; STV: spatio-temporal variability; WPCA: weighted PCA.
work are the multilead assessment and enhancement of ECG features having remarkable
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predictive properties for CA outcome definition. Accordingly, we mainly focused on 2
ECG characteristics, namely, fibrillatory waves (f-wave) and RR variability. First, in
Chapter 4 the predictive role of f-wave amplitude in CA of persistent AF, traditionally as-
sessed in only one lead on surface ECG, is herein automatically computed and extended to
multiple ECG leads. This is achieved by means of reduced-rank approximations to the AA
signal determined by principal component analysis (PCA), which enhance the maximum-
variance components of the AA signal, and show to improve CA outcome prediction. This
is demonstrated at different follow-up lengths, by properly combining contributions from
all ECG leads through suitable statistical descriptors (e.g., the median amplitude).
Then, inChapter 5 we investigate another ECG feature, depicting the spatio-temporal
variability (STV) of the AF pattern. Some single-lead measures of this AF property re-
cently proposed are correlated with AF complexity, traditionally assessed on endocardial
recordings, for instance, by means of Wells’ and Konings’ criteria. In this thesis we provide
a multilead characterization of such indices, thus assessing not only the extent of temporal
repetitiveness of the atrial pattern, but also its spatial distribution over ECG leads. To
this extent, several multivariate signal processing techniques, such as PCA, weighted
PCA (WPCA), nonnegative matrix factorization (NMF), have been tested for AA signal
processing. The measures output by the algorithms developed are able to discriminate
between effective and failing CA procedures at several follow-up periods.
In Chapter 6 we combine heterogeneous ECG features for assessing AF therapy out-
come. Unlike previous chapters, we examine information about f-wave amplitude and
STV properties presented in Chapter 4 and Chapter 5 coming from all ECG leads at the
same time. Multivariate characterization of such measures is performed by the logistic
regression (LR) model, which properly weights contributions provided by the ECG leads
examined. Such selective action allows for enhancing components which are most relevant
to CA outcome prediction, which has been effectively performed at different follow-up mo-
ments.
In Chapter 7 we explore the potential predictive role of several indices typical of the
information theory (IT) domain, which quantify the level of coupling between leads, and
thus the degree of spatial correlation. This concepts have been borrowed from the theory
of telecommunication systems, whose objective is assessing the amount of information
exchanged between transmitter and receiver, and thus the percentage of data loss. To our
knowledge, they are applied for the first time to CA outcome prediction in persistent AF
and characterized in a multivariate framework. The link of AF regularity as measured by
these parameters with clinical outcome of CA therapy is emphasized on multiple ECG
leads, thanks to the compressing properties of PCA, enhancing the most relevant com-
ponents of AA signal. Regularity assessment is first carried out on 2 ECG leads, and a
multilead extension is provided as well.
In Chapter 8 we approach another perspective for AF analysis, based on the charac-
terization of the ventricular response. RRI distribution is modeled in a parametric prob-
abilistic framework, not yet applied in the framework of AF, which takes into account the
effects of the dynamic vagal inputs to the SA node on the RRI length. Features describing
the RRI variability in terms of distribution dispersion and asymmetry depend on model
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characteristics and their predictive power in CA outcome assessment is investigated. Such
indices are subsequently exploited in AF pattern recognition, and differences between AF
and SR conditions are explored.
The final part of the manuscript includes Chapter 9, which summarizes the main
results presented in this thesis and sheds some light on potential new perspectives for AF
investigation and CA outcome prediction.
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2 Electrophysiology of the heart and
electrocardiography
2.1 Introduction
The first part of this doctoral thesis aims at providing a general description of heart
anatomy, its structure and leading steps of the cardiac cycle, responsible for distribution
of oxygen to all parts of the human body. The main goal of this section is helping com-
prehension of heart activity in healthy conditions so as to better understand alterations
and complications deriving from cardiac diseases. Particular attention is paid to the
electrical conduction system, enabling the propagation of electrical potentials throughout
the cardiac tissue, and thus the blood pumping action intrinsic to the electromechanical
coupling function. Recording heart electrical activity is essential for a rapid diagnosis of
certain cardiac diseases, as well as a deeper understanding of their triggering causes. To
this goal, the 12-lead ECG represents a noninvasive and cost-effective tool increasingly
employed in clinical centers; hence, the increasing interest in developing sophisticated sig-
nal processing techniques able to extract valuable clinical information, especially under
pathological conditions. Accordingly, after introducing the clinical background around
the heart and its main functions, we give a general description of the standard ECG and
its main characteristics. More precisely, in Sec. 2.2 we provide a general overview of heart
anatomy. Subsequently, we focus on the electrical conduction system in Sec. 2.3. Stan-
dard ECG is then introduced in Sec. 2.4. Finally, an overall summary of our description
is reported in Sec. 2.5.
2.2 Anatomy of the heart
Most of this chapter refers to [55, 96, 114, 143]. The human heart is an organ that
pumps blood throughout the body via the circulatory system. It is located under the
ribcage in the center of body chest between right and left lungs. It is widely known that
the heart can be regarded as a pump propelling blood throughout the body and consisting
of 4 chambers, made entirely of muscle. The upper chambers are referred to as atria,
whereas the lower ones are named ventricles (see Fig. 2.1). These hollow compartments
are delimited by heart walls, composed of cardiac muscle, called myocardium. A wall of
muscle named the septum separates the right and the left side of the heart1.
1http://www.texasheartinstitute.org/HIC/Anatomy/anatomy2.cfm
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Figure 2.1: Anatomy of the heart 2.
Moving from the outermost heart tissue layers, a double-walled sac called the peri-
cardium encases the heart, so as to protect and anchor it inside the chest. It is formed
by 3 layers, as shown in Fig. 2.2, and between them some pericardial fluid flows so as
to lubricate the heart during contractions and movements of the lungs and diaphragm.
The innermost pericardium component is referred to as the epicardium, which represents
the external membrane enclosing the heart. Then we meet the myocardium, the thickest
layer, consisting of cardiac muscle inducing contraction. Finally, the innermost layer, or
endocardium, is the epithelial tissue lining in contact with the blood.
The heart can be regarded as an ensemble of 2 pumps connected in series. Indeed, it
pumps blood through 2 circuits: the pulmonary circuit and the systemic circuit. The first
one, the right ventricle (RV), receives blood from the right atrium (RA), after coming from
superior and inferior venous cavae (SVC and IVC, respectively), and propels deoxygenated
blood via the pulmonary artery. Blood reaches the lungs, absorbs oxygen and goes back
to the left atrium (LA) and then to the left ventricle (LV) through the pulmonary veins
(PVs). This pathway represents the pulmonary circuit. In the second pathway, the
systemic circuit, oxygenated blood leaves the body via the aortic valve to the aorta,
and from there enters the arteries and capillaries of the systemic circulation, where it
supplies the body’s tissues with oxygen. Deoxygenated blood returns via the veins to the
venae cavae (VC), re-entering the heart’s RA, so that the cycle can start again. Blood
flow through the heart is unidirectional, thanks to the cardiac valves, whose opening
and closure are enabled by proper pressure gradients. Between the RA and RV lies the
tricuspid valve (TV), and between the LA and LV there is the mitral valve (MV). The
pulmonary valve separates RV and the pulmonary artery, while the aortic valve lies in
the outflow tract of the LV, and separates the RV from the aorta. All the aforementioned
components of the heart are displayed in Fig. 2.1. A graphical representation of the blood
circuits is provided in Fig. 2.3.
2http://histologyolm.stevegallik.org/node/347
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Figure 2.2: Section of the heart wall showing the components of the outer pericardium
(heart sac), muscle layer (myocardium), and inner lining (endocardium)2.
Figure 2.3: Schematic representation of the pulmonary and the systemic circuits with
their main components [81].
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2.3 The electrical conduction system and the elec-
tromechanical coupling
The electrical conduction system of the heart, shown in Fig. 2.6, allows for the gener-
ation and propagation of impulses via a specialized conduction pathway, which stimulate
the heart to contract and pump blood. In contrast with other kinds of muscles, heart
muscle fibers are self-excitatory. It turns out that potential generation can occur without
any nerve signal triggers. The anatomy of cardiac muscle is such that the initiation of
an action potential in a fiber would result in the action potential excitation of all the
muscle fibers. Even though any part of the heart can generate impulses, the sinoatrial
(SA) node serves as a natural pacemaker, since it exhibits the highest intrinsic frequency,
thus it sets the activation frequency of the whole heart. It is located in the RA where
VC terminates, and its firing rate is usually around 70 bpm. Even though its function is
quite autonomous, we must mention that its pacing is also influenced by information sent
by the sympathetic and the parasympathetic inputs of the autonomic nervous system.
Indeed, the former increases the heart rate (HR), whereas the latter induces the opposite
effect.
The cardiac cycle is created when such impulse propagates through the conduction
system, so as to trigger the mechanical force. As a consequence, the electrical event always
precedes the mechanical action. When RA is triggered to contract, it pumps the blood
collected from all the parts of the body into the RV. When it is completely filled, blood is
forced into the lungs for oxygenation and then returned to the LA through the PVs. Blood
is finally emptied to the LV, so as to be spread throughout the body. As previously stated,
all these mechanical events are triggered by electrical stimuli. Each cardiac cycle consists
of 2 mechanical phases, contraction and relaxation, whose electrical counterparts are
referred to as depolarization and repolarization, respectively. Depolarization is induced
by a variation in the resting membrane potential of myocardial cells (from −90 to 20 mV),
which rapidly spreads throughout the myocardium. The self-depolarization of the SA
node enables a rhythmic series of action potentials, which spread throughout the RA and
LA. This induces atria contraction, and blood is pumped into ventricles (diastole). The
action potential propagates through the atria at a relatively slow velocity (0.3−0.4 m/s).
Depolarization wavefront then reaches the atrioventricular (AV) node, which provides
atria with a conductive pathway to ventricles. Since its natural frequency is lower than
SA firing rate (i.e., about 50 bpm), the AV node spontaneously follows SA frequency. The
action potentials propagates from the atrium to the AV node, thus allowing time for the
atria to pump blood into the ventricles. The AV node is a pathway of muscle fiber which
introduces a short delay of about 11 ms into the impulse propagation to the ventricles,
so that atria can effectively contract and completely empty blood into ventricles. Signal
transmission from the AV node to the ventricles is ensured by a specialized conduction
system. It consists of a bundle, i.e., the bundle of His, which then ramifies into two
bundle branches, which in turn divide into Purkinje fibers, directly connected to the
inner ventricular walls. Such components are themselves large muscle fibers whose action
potentials propagate at a velocity of 1.5 − 2 m/s. The depolarization wavefronts then
spread through the ventricular wall, from endocardium to epicardium, enabling ventricular
contraction. Once each ventricle cell has depolarized, repolarization allows for relaxation
of the myocardial muscle, and the cardiac cycle can start again. This slow process gives
17 Electrophysiology of the heart and electrocardiography
rise to a plateau in the cardiac action potential which can be observed in Fig. 2.6, in
contrast with nerve and skeletal action potentials. This plateau allows the muscle fibers
to contract in synchronism resulting in a forceful pumping action. The ECG signal,
picked up by the surface electrode on the body surface is a superposition of these action
potentials.
2.4 The standard 12-lead ECG
Due to their conductive nature, heart nerves and cells can be regarded as a source
of electrical charges in motion during depolarization and repolarization processes within
a volume conductor, i.e., the thorax. Indeed, the sum of cardiac cell potentials can
be represented by a unique heart electrical vector in a first-order approximation, whose
magnitude and direction change in time according to pulse wavefront propagation and
strength. The electrical field generated by these charges can be thus detected on its
equipotential lines on thorax surface. This electrical activity signal can be acquired by
means of electrodes positioned on the subject’s thorax and then amplified and recorded by
the electrocardiograph. Electrocardiography is a commonly used, noninvasive procedure
for recording heart electrical activity. The signal recorded, named electrocardiogram
(ECG or EKG), graphically shows the series of waves associated with electrical phenomena
of depolarization and repolarization of the heart during the cardiac cycle, and represents
the summation in space of the action potentials generated by the myocadial cells at
each time instant. The first practical ECG was invented in 1903 by Einthoven, who
was awarded with the Nobel Prize in Medicine in 1924 for it. He refined the string
galvanometer used for measuring the heart’s rhythms, and he also paid attention to wave
terminology definition and examination of some cardiac disorders on ECG [49]. ECG leads
thus report the instantaneous difference in potential between electrodes. The signals are
detected by means of metal cutaneous electrodes attached to the extremities and chest
wall, and they are then amplified and recorded by the electrocardiograph. A difference of
voltage can be measured between each pair of electrodes, named lead, whose amplitude
and direction depend on electrodes’ configuration. ECG signal values are generally quite
low, ranging from a few microvolt up to 1 V, therefore acquisition system always includes
an amplifier.
As it is a noninvasive, rapid and cost-effective test, ECG is a valuable and highly
versatile tool in clinical practice for detecting several heart dysfunctions by inspection of
alterations in ECG pattern shape or duration of wave intervals.
Electrocardiography is a starting point for detecting many cardiac problems, such as
angina pectoris, ischemic heart disease, arrhythmias, myocardial infarction. In addition,
it may reveal other findings related to life-threatening metabolic disturbances (e.g., hy-
perkalemia) or increased susceptibility to sudden cardiac death (e.g., QT prolongation
syndromes). It is routinely employed for monitoring surgeries and exercise tolerance
tests (e.g., stress tests), as well as evaluating certain symptoms (for instance, chest pain,
shortness of breath, palpitations).
As previously stated, the ECG records the complex spatial and temporal summation
of electrical potentials from multiple myocardial fibers conducted to the surface of the
body [55]. Each group of cells depolarizing at the same time can be represented as an
equivalent current dipole vector. Each vector describes the dipole’s time-varying position,
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orientation, and magnitude. The vectors related to all these groups can be summed to give
a dominant vector which describes the main direction of the electrical impulse throughout
the heart. In order to better understand the generation of the ECG signal, Fig. 2.4 displays
the sequence of the instantaneous heart wavefront vectors at each step of the cardiac cycle.
Each phase of the depolarization and repolarization processes are reflected on ECG by
the following characteristic points, also shown in Fig. 2.5:
• P wave: it describes simultaneous depolarization of left and right atria. The normal
atrial depolarization vector is oriented downward and toward the subject’s left, as it
reflects the wavefront moving from the SA to the RA and then the LA myocardium.
• QRS complex: it represents ventricular depolarization. As ventricles have larger
mass compared to the atria, the QRS complex usually has a much larger amplitude
than the P wave. The process can be divided into 2 major, sequential phases. The
first one concerns the depolarization of the interventricular septum from the left to
the right and anteriorly. The second phase includes the simultaneous depolarization
of RV and LV. The QRS pattern in the extremity leads may vary considerably from
one normal subject to another depending on the electrical axis of the QRS, whose
mean orientation is referred to the 6 frontal plane leads. In healthy conditions, the
QRS axis ranges between −30◦ and +100◦. Any deviation outside the lower (upper)
bound is referred as to left (right) axis deviation. It may occur as a normal variant
of heart condition, but sometimes it can also be symptom of more serious diseases.
• T wave: it is associated with ventricular repolarization, and its representative
vector is oriented roughly concordant with the mean QRS vector (within about 45◦
in the frontal plane). The interval from the beginning of the QRS complex to the
apex of the T wave is referred to as the absolute refractory period, whereas the
terminal part of the T wave reflects the relative refractory period.
Atrial repolarization is usually too low in amplitude to be detected, but it may become
apparent in some conditions, e.g., acute pericarditis or atrial infarction. The QRST
waveforms of the standard ECG correspond in a general way with the different phases
of simultaneously obtained ventricular action potentials, depicting the activity of single
myocardial fibers. With reference to Fig. 2.6, the rapid upstroke of the action potential
corresponds to the QRS onset. This is followed by the plateau phase, corresponding to
the isoelectric ST segment, and then completed by the active repolarization, represented
by the inscription of the T wave on ECG.
ECG baseline (the flat horizontal segments) is measured between the end of the T wave
and the beginning of the next P wave. It represents the resting potential of the myocardial
cells. Also in the PR and ST segments we encounter ECG baseline. In SR conditions, the
baseline is equivalent to the isoelectric line (0 mV). By contrast, in presence of certain
diseases there could be drifts from zero due to injury currents flowing when the ventricles
are at rest.
In clinical practice, some intervals are also studied on ECG, knowing that alterations
in their duration can be symptom of certain pathologies. In particular we mention:
• RR interval: the mean distance between two consecutive R peaks provides a HR
measure, ranging between 60 and 100 bpm at rest.
• PR interval: starting at the beginning of the P wave up to the beginning of the
QRS complex, it indicates the time of propagation of the potential action from the
SA to the AV node, thus rendering a good estimate of AV node function.
• QT interval: extending from the beginning of the QRS complex up to the end of
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Figure 2.4: Sequence of the instantaneous heart wavefront vectors at each step of the
cardiac cycle [96].
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Figure 2.5: ECG signal, its fiducial points and the corresponding phases in the cardiac
cycle [68].
Figure 2.6: The heart conduction system with its main components, their typical potential
waveforms and the corresponding points on surface ECG [96].
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the T wave. A prolonged duration is predictive of ventricular tachyarrhythmias and
sudden death.
The choice of a unique, standard system of lead position for ECG acquisition derives
from the need to compare cardiac potentials recorded in different subjects, and examine
signals acquired in the same subject, but at different times and places. In the standard
ECG 12 leads are employed. More precisely, 10 electrodes are placed at standardized
positions of the body surface. As explained later, some potentials are linearly dependent
between them. Since the voltages recorded in the leads are regarded as projections of the
heart electrical vector on the particular lead, any two of the leads may be used to plot
the instantaneous magnitude and direction of the cardiac vector in the plane they form.
The ECG leads can be subdivided into two general types, namely, bipolar leads and
unipolar leads [109]. A bipolar lead consists of two electrodes placed at two distinct sites,
so as to register the difference in potential between them. The actual absolute potential
at either electrode is not known, and only the difference between them is recorded. One
electrode is designated as the positive input; the potential at the other, or negative,
electrode is subtracted from the potential at the positive electrode to yield the bipolar
potential. Unipolar leads, in contrast, measure the absolute electrical potential at one
site, with respect to a reference potential, which is deemed to be zero. In clinical elec-
trocardiography, a specially designed electrode configuration is adopted for the 12-lead
ECG, detailed in Sec. 2.4.1-2.4.3.
2.4.1 Einthoven’s leads
The first 3 leads are defined by Einthoven’s triangle. Each lead measures the difference
in potential between electrodes at 2 of the 3 extremities (right arm; left arm; left leg), as
displayed in Fig. 2.7. Potentials are thus defined as:
I = ΦL − ΦR (2.1)
II = ΦF − ΦR (2.2)
III = ΦF − ΦL (2.3)
where I, II and III stand for potential of lead I, II and III, respectively, ΦL, ΦR and ΦF
represent the potentials at the left arm, the right arm and the left foot. As these leads
form a closed circuit, each of them can be expressed as a linear combination of the other
ones:
II = I + III (2.4)
What is more, since these 3 electrodes are positioned at the corners of a equilateral
triangle, containing the human heart at the center, such a leads’ configuration registers
heart electrical activity on the frontal plane, and each direction differs from the other one
of 60◦. Note that the right leg acts as a ground potential.
7http://www.nottingham.ac.uk/nursing/practice/resources/cardiology/function/bipolar_
leads.php
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Figure 2.7: Frontal ECG leads: Einthoven’s leads, and Goldberger’s (augmented) leads7.
2.4.2 Goldberger’s leads
In addition to the bipolar limb leads, there are 3 augmented limb leads, also known as
Goldberger’s leads. Potential of these leads is measured by assuming the central Wilson’s
terminal (or indifferent electrode) as a reference. This ground electrode is referenced
against a combination of the other limb electrodes, from which they are shifted of 30◦.
Hence, these potentials aVR, aVL and aVF, are considered unipolar and are electrically
augmented by 50% by omitting the resistance from the Wilson central terminal, which
is connected to the measurement electrode. Potentials measured are mathematically ex-
pressed as:
aVR =
I − II
2 (2.5)
aVL = I − 12II (2.6)
aVF = II − 12I (2.7)
2.4.3 Precordial leads
The limb leads take into account direction of depolarization in the frontal plane.
However, as the heart is not parallel to this plane, related leads give information about
the inferior and lateral walls but do not distinguish between other areas, in particular
septal and anterior and lateral heart walls. The precordial, unipolar leads are positioned
in specific sites on the rib cage and record potentials transmitted onto the horizontal plane
(see Fig. 2.8). In particular, leads V1 and V2 are positioned at the 4th intercostal space,
to the right and the left of the sternum, respectively. Lead V3 is placed midway between
V2 and V4, which is in turn located on the midclavicular line, at the 5th intercostal
space; lead V5 is on the anterior axillary line, at the same level as V4. Finally, lead V6 is
positioned on the midaxillary line, at the same level as V4 and V5.
2.4.4 Information content of the standard ECG
In this framework, all the aforementioned electrodes provide a three-dimensional rep-
resentation of heart electrical activity in the cardiac cycle. Most of the heart’s electric
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Figure 2.8: Precordial ECG leads [96].
Figure 2.9: The projections of the lead vectors of the standard ECG system in 3 orthogonal
planes. The volume conductor is assumed to be spherical homogeneous and the cardiac
source centrally located [96].
activity can be characterized with a dipole source model. Under this hypothesis, 3 linearly
independent leads (2 limb leads and a precordial one) are sufficient to describe heart elec-
trical activity temporal evolution. Indeed, in the 12-lead system, there is a redundancy
of 4 leads. The limb leads and the augmented leads can be expressed as a function
of 2 independent potential differences, therefore standard ECG includes 8 independent
leads. The interest in considering also the other leads can be explained by the standard
ECG ability to detect further nondipolar components, which have diagnostic significance
because of their proximity to the frontal part of the heart.
The main reason for recording also redundant leads is that it enhances pattern recogni-
tion. Indeed, it allows comparing the projections of the resultant vectors in two orthogonal
planes and at different angles. For instance, right precordial leads, V3R and V4R, are
useful in detecting evidence of acute right ventricular ischemia. In Fig. 2.9, ECG lead
projections are displayed in 3 perpendicular planes.
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Figure 2.10: Examples of IEGM. HRA: high right atrial IEGM; HIS p and HIS d: proximal
and distal HIS-bundle IEGM; CS 1− 2, CS 3− 4, CS 5− 6, CS 7− 8, CS 9− 10: distal
bipole 1− 2, bipole 3− 4, bipole 5− 6, bipole 7− 8, proximal bipole 9− 10, respectively;
RVa = RV apex IEGM; Stim 2 = stimulus channel. These signals are induced by straight
atrial pacing with a drive-cycle length of 340ms and acquired by means of a decapolar
catheter in the CS and quadripolar catheters in the high RA, His-bundle region and RV
apex, according to the protocol described in [51].
2.4.5 Other forms of heart electrical activity recording
For the sake of completeness, even though our investigation merely focuses on standard
ECG, it is worth to provide a few notions about other kinds of signals depicting heart
electrical activity, whose description can help comprehension of other sections of this
dissertation, in particular those concerning AF organization and type classification.
Intracardiac electrograms
An intracardiac electrogram (IEGM) is a record of timing or sequence of activation
of specific cardiac locations (e.g., the distal CS or the left upper PV), as measured with
electrodes directly placed within the heart via endocardiac catheters. They are generally
employed for recording electric potentials of sites that cannot be assessed by body surface
electrodes, for instance, the bundle of His, which is too small to produce sufficiently
high voltages to register on the surface ECG [162]. Furthermore, it is widely know how
difficult is to correlate heart electrical events recorded at body surface with in-depth
activity, therefore knowledge about ECG content needs to be supported by intracardiac
signals.
There are two types of IEGMs, namely, bipolar and unipolar signals. Bipolar signals
are produced when the voltages on the two recording electrodes both vary with time - as
is the case when each is positioned within the heart. By contrast, unipolar signals are
produced when one varying signal is compared with a constant (or indifferent) reference
placed outside the heart. In general, clinical practice refers to bipolar signals, as they
reduce far-field signals and they are less prone to electrical noise [162]. Examination of
unipolar signals is motivated by interest in signals from each pole of a catheter separately.
In Fig. 2.10 some examples of IEGMs are shown.
This kind of recordings allows electrophysiologists to follow the propagation of electri-
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Figure 2.11: Example of electroanatomic voltage map [116]. LIPV: left inferior PV. RIPV:
right inferior PV. RSPV right superior PV.
cal activation by noting the order of the signals in time. When an electrical impulse passes
the tissue close to an electrode, depolarization of cardiac cells takes place, as reflected by
steep deflections, named activations, in the recording. This attention to the activation
sequence represents the main difference between IEGM and ECG, which rather focuses
on signal morphology.
Such a local approach makes IEGM highly reliable, since it is barely influenced by
other biological signals, such as surrounding muscular activity or electrical activity of
other tissues and organs. On the other hand, the invasivity of this analysis increases the
risks of infections and other side-effects (e.g., thromboembolic accidents), and requires a
careful management of signal acquisition.
In AF investigation, these kind of signals are widely employed for understanding the
mechanisms of triggering and maintenance of this arrhythmia, for instance, under guided
tissue stimulation or by mapping heart electrical activity. Moreover, they are currently
used in CA for positioning the ablation catheter in combination with a visual mapping
system (e.g. CARTO system, see Fig. 2.11) and then checking whether the arrhythmia
has been terminated at the end of the procedure.
Body surface potential mapping
Despite the multiple advantages of the ECG system, the reduced number of record-
ing spots on the chest can sometimes makes it quite hard to detect small variations in
heart electrical activity and investigate certain diseases. As a consequence, body surface
potential mapping (BSPM) systems are increasingly employed so as to perform a higher
resolution analysis of heart electrical activity as seen by a higher number of sites on the
entire surface of the chest and the back of patient’s body. The number of acquisition leads
ranges between 32 and 240. This kind of system enables the generation of a torso map of
electrical activity, in which we can follow the flow of electricity related to a heartbeat. An
2.4. The standard 12-lead ECG 26
Figure 2.12: BSPM system. Left: An example of map [155]. Right: Position of BSPM
leads [93].
example of BSPM map is displayed in Fig. 2.12, besides the a schematic representation
of leads’ location.
AF comprehension has considerably taken benefit from BSPM analysis. In [57] dif-
ferent patterns of atrial activation have been observed in surface in several subjects by
means of this system. In [58], noninvasive localization of AF trigger sites is accomplished
by the BSPM system. The study led in [18] demonstrates that it is possible to assess AF
spatio-temporal organization on BSPM maps by means of PCA.
Despite its valuable clinical content, BSPM has not been adopted yet as a routine
tool for cardiac diagnosis. This can be explained by several factors, such as the longer
time of signal acquisition, the more difficult equipment installation and the unsuitability
to be used during surgery. Accordingly, standard ECG represent a proper trade-off be-
tween invasive recordings and high-resolution surface potential mapping and it is generally
preferred for daily clinical practice.
2.4.6 ECG processing
ECG acquisition can be hampered by different types of noise and artifacts which can
profoundly alter and/or hide useful information about heart electrical activity. Hence,
the importance of an adequate ECG signal processing prior to information extraction
and further computational steps. In general, some preprocessing actions are required for
noise filtering. Understanding the causes of noise can help choosing the proper filter,
and keeping signal properties as most unaltered as possible, since any changes in voltage
amplitude, phase, frequency, morphology can notably influence ECG interpretation and
alter final diagnosis about the presence/absence of a disease.
Some sources of noise are technical. For instance, potential interference can come from
power line interference (50− 60 Hz), owed to improper grounding of the ECG equipment
and interference from other equipment close to the ECG acquisition system. Other types
of noise can have a physiological origin. For instance, we mention baseline wander, with
spectral content below 1 Hz, which can be caused by respiration or body movements.
Another source of interference is the electromyographic noise, due to the electrical activity
of skeletal muscles during contraction. Unlike baseline wander, the range of its frequency
components is comparable with that of the QRS complex. It turns out that suppressing
this kind of noise is not a trivial task, as there is the risk of introducing signal distortion.
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Similar issues are encountered when electrodes are not correctly positioned or they get
disconnected, as contact impedance of the skin around the electrode is altered.
Another preprocessing task which is particularly useful in cardiac disease diagnosis
is the automatic detection of ECG fiducial points and intervals. Such inspection can
also help isolating certain components on the ECG (for example, distinguishing ventric-
ular and atrial activity, VA and AA). The interest in developing automatic tools makes
ECG processing operator-independent and provides rapid and objective measures of ECG
properties.
Preprocessing operations strongly depend on signal properties, as well as the goal of
the investigation on ECG. The preprocessing tools employed in this doctoral thesis will
be presented in more detail later for AF characterization in the Contributions’ part of the
manuscript.
2.5 Summary and conclusions
This introductory chapter renders a general overview of cardiac electrophysiology.
Basic anatomy and physiology concepts and definitions are provided so as to facilitate
comprehension of the main problems around AF, its treatment and the technical tools
developed in the Contributions’ section. Special attention is paid to the heart conduction
system, since the knowledge about its activity and any alterations are fundamental for
understanding and tackling the AF problem. We focused on non invasive tools for AF
diagnosis and treatment as provided by the ECG analysis, a cost-effective and rapid
approach, which is increasingly employed in clinical centers for recording heart electrical
signal evolution. All these concepts will help understanding AF pathology and envisaging
potential diagnostic and therapeutic strategies.
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3 Atrial fibrillation
3.1 Introduction
In Chapter 2 we have described some concepts about heart anatomy and functions,
and we have illustrated the role of standard ECG for examining heart electrical activity.
In this chapter we introduce the AF problem and we provide some elements which help
understanding this arrhythmia. First, in Sec. 3.2 we provide a general definition of atrial
arrhythmia, then we move to AF description in Sec. 3.3. Several AF treatment strategies
are discussed in Sec. 3.4, with particular attention to the CA therapy in Sec. 3.5, whose
outcome prediction techniques are dealt with in Sec. 3.6. Main conclusions are finally
summarized in Sec. 3.7.
3.2 Definition of atrial arrhythmias
Arrhythmias are defined as dysfunctions in the normal beating action of the heart, and
are generally divided into two categories: ventricular and supraventricular. The irregular
beats can either be too slow (bradycardia) or too fast (tachycardia). Ventricular arrhyth-
mias occur in the lower chambers of the heart, namely, the ventricles. Supraventricular
arrhythmias (SVA) are heart rhythm disorders affecting the upper part of the heart, i.e.,
the atria or the atrial conduction pathways [16]. In particular, they generally involve
the atria, the AV junction, or vessels directly communicating with the atria, such as the
vena cava or PVs. All cardiac arrhythmias are produced by several mechanisms, including
disorders of initiation and propagation of potential impulses, respectively defined as auto-
matic and re-entrant. Cardiac cells affected by abnormal automaticity exhibit an increase
in firing rate, and they can overdrive the SA node, the natural heart pacemaker, if the rate
of the ectopic focus is higher. The most current types of supraventricular arrhythmias
include:
• Premature atrial contractions (PACs): occurring when the atria contract too
soon, causing the heart to beat out of sequence.
• Paroxysmal supraventricular tachycardia (PSVT): a rapid but regular heart
rhythm which originates in the atria and speeds up the heart rate up to 150− 250
bpm. The word “paroxysmal” refers to a non-permanent condition, and it means
occasional or occurring from time to time.
• Accessory pathway tachycardias (e.g., Wolff-Parkinson-White, WPW,
syndrome): a group of abnormalities caused by extra, abnormal muscle pathways
between the atria and the ventricles. The pathways cause the electrical signals to
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arrive at the ventricles too soon, and the signals are sent back to the atria. The
result is a very fast heartbeat. People with WPW may also be more likely to have
PSVT episodes.
• AV nodal re-entrant tachycardia (AVNRT): a rapid rhythm caused by mul-
tiple pathways passing through the AV node.
• Atrial tachycardia (AT): a rapid heart rhythm coming from the atria.
• Atrial fibrillation (AF): consisting in the chaotic generation of electrical impulses
in the atria which propagate through the AV node in a irregular and rapid manner.
Further details are provided in the following sections.
• Atrial flutter (AFL): similarly to AF, AFL is induced by one or more rapid
circuits in the atria, but it is generally characterized by the presence of a more
organized electrical circuit. The activation usually originates within the RA and
produces characteristic saw-toothed waves on the ECG.
3.3 Atrial fibrillation
3.3.1 Definition and pathophysiology
It is estimated that 2.2 million adults in the United States have intermittent or chronic
AF, making it the most common sustained arrhythmia [133]. It increases in prevalence
with age, and affects up to 5% of the population older than 69 years, and 8% of the pop-
ulation older than 80 years. AF is associated with a 5-fold increase in risk of stroke [132].
AF is a supraventricular tachyarrhythmia inducing a disorganized generation of elec-
trical signals in the atria and consequent deterioration of mechanical function [53]. More
precisely, the atria beat in a chaotic and irregular manner, out of coordination with the
ventricles (see Fig. 3.1). Consequently, the atria risk to empty blood into the ventricles
during their contraction in an incomplete manner, thus increasing the probability of pool-
ing or clotting. These clots can break off and travel downstream, and if they lodge in an
artery in the brain, this can cause a stroke. In general, AF is associated with increased
rates of death, stroke and other thrombo-embolic events, heart failure and hospitalizations,
degraded quality of life, reduced exercise capacity, and LV dysfunction [53].
AF is thought to be caused by atrial fibrosis, and lost of atrial muscle mass, due to
several factors, such as aging, chamber dilatation, inflammatory processes, and genetic
causes. Dilatation of the atria can derive from any structural abnormalities of the heart
that cause a rise in the intra-cardiac pressures. This includes valvular heart disease
(such as mitral stenosis, mitral and tricuspid regurgitation), hypertension, and congestive
heart failure. Atria dilatation activates several molecular pathways, which induce atrial
remodeling and fibrosis, with loss of atrial muscle mass, and may also involve the SA node
and the AV node, with changes in electrical refractoriness [53].
3.3.2 ECG aspects of AF
Standard ECG is more and more exploited for AF understanding and treatment,
for its noninvasivity, cost-effective acquisition and all the other advantages presented in
3http://www.saintvincenthealth.com/services/heart/heart-resource-library/
atrial-fibrillation/default.aspx
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Figure 3.1: Heart electrical wavefront propagation during SR (left) and AF (right) and
their effects on ECG pattern 3.
Chapter 2. Indeed, AF impact on heart electrical activity can be even visually detected
on ECG recording, as shown in Fig. 3.1. During AF, no regular P waves are identifiable,
but thy are replaced by multiple, irregular f-waves firing at rate of 150-300 bpm on the un-
dulating baseline, rendering alterations in the atrial depolarization. Ventricular response
variability is also affected by higher dispersion compared with SR, and it is reflected in
RR interval distribution on ECG, though the QRS contour is usually normal [96].
3.3.3 Mechanisms of AF triggering and maintenance
Despite advances in the understanding of this disease, very little is known about the
mechanisms responsible for AF triggering and maintenance. To this end, several theories
about AF initiation and perpetuation have been put forward as to help its monitoring and
guide treatment strategies. Indeed, AF triggers may be focal targets for ablative therapy.
AF induction is now thought to involve an interaction between initiating triggers and
an abnormal atrial tissue substrate capable of maintaining the arrhythmia. Such triggers
are often in the form of rapidly firing ectopic foci located in muscular sleeves extending
from the LA into the proximal parts of PVs and overriding the normal impulses generated
by the SA node. Although structural heart disease underlies many cases of AF, the
pathogenesis of AF in apparently normal hearts is less well understood [97]. According
to [54], two major theories have been put forward to explain AF genesis and maintenance
(see Fig. 3.2), namely:
1) single or multiple rapidly firing atrial ectopic foci;
2) circuit re-entry and multiple wavelets.
Ectopic foci hypothesis
The ectopic foci hypothesis deals with a single or small number of reentrant source(s)
giving rise to fibrillatory conduction. Ectopic foci arise when electrical impulses rapidly
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Figure 3.2: Models of AF mechanisms.
Models of AF mechanisms. a. Ectopic foci. b. Single reentry circuit. c. Multiple reentry
circuits [119].
discharge in areas outside the SA node, widely known to be the heart natural “pace-
maker”, as explained in Sec. 2.3. This can come from a steepening of the diastolic phase
of the action potential in cells that normally show automaticity, causing them to reach
their threshold potential earlier and generate ectopic firing [119]. Alternatively, ectopic
foci can sometimes arise just after the main action potential, due to alterations in ionic
exchange current flows, which can activate cells again, and induce ectopic firing. More
recently, however, in [62, 69] it has been shown that some ectopic foci sources triggering
and sustaining AF can be identified around the PVs. This discover opened new ther-
apeutic possibilities aiming at interfering with the ability of the re-entering circuits to
perpetuate themselves, for instance the maze operation developed in [38]. Because of
shorter refractory periods and the abrupt changes in fiber orientation, PVs are widely
known to be potentially responsible for AF uncoordinated activity. Targeted destruction
of ectopic foci is usually accomplished by surgery or catheter-based techniques.
Circuit re-entry and multiple wavelet theory
Re-entries occur when a signal loops back and activates cells that has already triggered.
Under these circumstances, different areas can continuously reactivate each other, thus
giving rise to one or more circuits. One of the first model is referred to as “leading-circle
model” in [8] and encompasses re-entry propagation around an anatomical obstacle, such
as a vein orifice. One of the basic ideas of this theory is the concept of “wavelength of
re-entry”. This wavelength represents the distance covered by the electrical impulse in
one refractory period, and it is equal to the product of the refractory period and the
conduction velocity. According to this theory, if the pathway of the potential circuit
is shorter than this characteristic wavelength, the impulse will traverse the circuit and
return to its starting point in a time shorter than the refractory period, thus it will
encounter refractory cells and will be extinguished. Therefore, the wavelength is the
shortest electrical pathway able to sustain re-entry. The other impulses will have longer
revolution times, and will therefore be dominated by the faster activity of the “leading
circle”. As a result, this model assumes that the number of circuits that can be main-
tained depends on atrial size and the refractory wavelength. The lower the conduction
wavelength, the lower the minimum circuit size, the higher the number of circuits that
can be accommodated for perpetuating AF. The number of wavelets depends on the
refractory period, conduction velocity, and mass of atrial tissue. Increased atrial mass,
shortened atrial refractory period, and delayed intra-atrial conduction increase the number
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of wavelets and promote sustained AF [53, 97]. Re-entry within the atrial myocardium is
facilitated by conduction slowing and shortening of the refractory period, with increased
dispersion of refractoriness further contributing to arrhythmogenesis. The role of other
functional regions, for instance, the LA posterior free wall, superior and inferior vena
cava, coronary sinus (CS), and interatrial septum, has also been taken into account in AF
pathogenesis. Even though the distinction described is not strict, it is hypothesized that
PV sources may play a dominant role in younger patients with short paroxysms of AF,
whereas an abnormal atrial tissue substrate may play a more important role in patients
with structural heart disease and persistent or permanent AF. The so-called “multiple
wavelet hypothesis”, assessed for the first time in [110], can also be ascribed to this group
of theory concerning AF maintenance and generation. This recent model rather involves
multiple randomly propagating wavelets instead of closed loop re-entry. This process is
thought to maintain AF regardless of its triggering source, as perpetuated by continuous
conduction of several independent wavelets of excitation [30], varying in size and velocity,
irregularly wandering through atria, which collide, mutually annihilate, coalesce, or give
rise to new wavelets in a self-sustaining turbulent process [159].
Before concluding this section, it is worth noting some more recent hypotheses, which
represent a basis for some of the most employed AF therapeutic strategies, in particular
in relation with ablation. The study led in [116] points to the role of complex fractionated
atrial electrograms (CFAE) as the substrate responsible for AF maintenance. In [147] the
potential application of CFAE analysis to AF ablation is investigated. In [118] it is stated
that AF may be sustained by localized electrical rotors and focal impulses. Wavelets and
multiple re-entry circuits can be suppressed by drugs that prolong the refractory period
and inhibit re-entry, and by ablating areas of the re-entrant pathway.
3.3.4 Atrial electrical remodeling
AF can produce changes in atrial function and structure, which explain the gradual
worsening with time of this arrhythmia [7]. Atrial remodeling consists in any persistent
change in atrial structure or function, increasing the tendency to triggering or sustaining
AF [120], either through rapid ectopic firing or reentry mechanisms. It has been shown
that long-term rapid atrial pacing or maintenance of AF led to a progressive increase
in the susceptibility to AF: “AF begets AF" [119]). This phenomenon was explained
by a shortening in atrial impulse wavelength. When the wavelength is short, small ar-
eas of intra-atria conduction block may already serve as a site for initiation of reentry,
thus increasing the vulnerability to AF. This condition is also expected to increase the
tendency to AF maintenance, since it allows more reentering wavelets to coexist in the
available atrial surface. Clinical evidence shows that patients with more prolonged AF
may develop increasing problems with time and are less likely to experience SR restoration
and maintenance [7]. Several mechanisms and effects are implied in the atrial remodeling.
First, ionic exchanges are profoundly altered by this phenomenon, in particular a gradual
inactivation of the calcium current subsequent to intracellular overload [120]. In turn,
this action reduces the action potential duration and atrial refractory period, responsible
for sustaining AF. Such phenomena cause atrial contractility loss, since calcium current
abnormalities induce atrial dilation, which further promotes reentry, and facilitates atrial
fibrosis occurrence. Assessment of remodeling effects has a fundamental clinical value for
AF treatment and its successful outcome [7]. Hence, the importance of a deep under-
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standing of AF mechanisms.
3.3.5 AF classification
Several criteria are adopted for AF study and management. Clinical guidelines illus-
trated in [28] ascribes AF cases to 5 categories according to the presentation and duration
of the arrhythmia:
• First-diagnosed AF: it concerns every subject presenting an AF episode for the
first time, regardless of its duration or the presence and severity of other symptoms.
• Paroxysmal: it is a self-terminating AF form, usually within a 48 hour temporal
window. Below this limit, spontaneous AF termination is more likely. In this type
of AF, triggered activity seems to be the dominant factor, therefore suppressing the
firing source should terminate the arrhythmia.
• Persistent: it is either characterized by recurrent AF episodes or longer than 7
days, and must be treated by cardioversion, either pharmacological or electrical.
Such advanced forms of AF exhibit a certain degree of electrical remodeling, pro-
portional to arrhythmia progress.
• Long-standing persistent: AF episodes last longer than 1 year, and a rhythm
control strategy is required.
• Permanent: patients are affected by ongoing long-term episodes, with failed or no
attempt at cardioversion.
An alternative criterion leading AF classification takes into account the degree of its
organization, traditionally assessed on invasive cardiac signal recording, dependent on the
number of fibrillating wavelets and the chronification of the disease. This concept will be
explained in detail in Sec. 5.2. In the literature, we can find two reference systems for AF
classification from invasive recordings. The Wells’ system put forward in [161] takes into
account the morphology of single bipolar atrial electrograms. Four distinct AF types are
encompassed by this criterion:
• Type I, AF1: characterized by discrete beat-to-beat atrial electrogram complexes
of variable morphology and cycle-length, alternating to isoelectric baseline segments
free from perturbation.
• Type II, AF2: beat-to-beat complexes are similar to those typical of Type I. By
contrast, the baseline is not isoelectric and it is affected by multiple perturbations.
• Type III, AF3: AF pattern presents a higher degree of disorganization, with no
clear isoelectric intervals.
• Type IV, AF4: resulting from the alternation between the Type II and Type III
patterns.
For the sake of clarity, some representative pattern examples are displayed in Fig. 3.3 for
the first three types.
The second paradigm is the Konings’ system [78], aiming at classifying patterns of hu-
man RA activation during electrically induced AF. According to the number of wavelets
activating the atrial wall and mapped by high-density epicardial recordings, we can en-
counter three different types of AF.
• Type I: single broad wave fronts propagate uniformly across the RA.
• Type II: presenting 1-2 nonuniformly conducting wavelets
• Type III: RA activation is highly fragmented and exhibits 3 or more wavelets with
variable direction of propagation.
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Figure 3.3: Classification of bipolar atrial recordings during AF according to Wells’ cri-
terion: Type I (AF1), Type II (AF2) and Type III (AF3) [10].
In general, Wells’ classification is more frequently adopted, since it can be acquired
more easily during clinical electrophysiological studies.
3.4 Overview of the main AF therapies
AF management strategies aim at relief of symptoms and prevention of severe com-
plications associated with AF at the same time [28]. For this purpose, antithrombotic
therapy, control of ventricular rate, and treatment of concomitant cardiac pathologies are
generally performed.
In patients with short paroxysms of AF, curative strategies should generally concen-
trate on providing control of the arrhythmia itself. By contrast, in patients with persistent
AF, it is not trivial to decide whether to try to restore and then maintain SR (rhythm
control), or to accept the arrhythmia and control the ventricular rate (rate control) [97].
In rate control strategies, the arrhythmia is allowed to continue. Even though the control
of ventricular rate allows for improving symptoms, the risk of thromboembolism per-
sists and ventricles are passively filled, without any active atrial contraction, since atria
are still in fibrillation. On the other hand, rhythm control aims at SR restoration and
AF suppression, but the pharmacological treatment adopted is prone to provoke serious
thromboembolic complications. Therefore, regardless of the arrhythmia pattern, and in
the absence of contraindications, such a therapy should be combined with anticoagulation.
The choice of one of these approaches strongly depends on several factors, such as AF
history and severity of additional disturbances.
3.4.1 Cardioversion of persistent AF
In the rhythm control therapies’ scenario, cardioversion procedure refers to the process
of SR restoration in the presence of an abnormal rhythm. Indeed, the objective of this
kind of therapies is “resetting” AF irregular fibrillatory rate and restore the physiological
SR, either by pharmacological or electrical means. Cardioversion is used most frequently
for those who are symptomatic or newly diagnosed. Broadly speaking, cardioversion is
generally applied to two patients’ categories: those who are affected by AF symptoms and
those who present with AF for the first time [138]. Symptoms can be quite different in
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terms of severity, such as hypotension, uncontrolled ischemia, or angina, or palpitations,
fatigue. However, any AF symptoms caused by atrial fibrillation warrant consideration of
cardioversion as a management option. Also patients exhibiting AF for the first time are
generally treated by cardioversion, so as to slow disease progression. Another group of
patients who may benefit from cardioversion are those who have postoperative AF. Indeed,
it can occur in the first days after surgery, when anticoagulation may be undesirable.
Many episodes of postoperative AF resolve spontaneously. Patients who do not experience
spontaneous AF termination may undergo cardioversion before an AF duration of 48 hours
in order to avoid coagulation. It is important to remember that all types of cardioversion
can present some side-effects related to embolic risks. Thromboembolism (blood clot
traveling through the bloodstream) can occur after cardioversion if a thrombus (blood
clot) becomes dislodged from the atria as the heart begins to beat normally. Blood clots
can form within the atria during AF since blood flow is slowed. Accordingly, patients
are usually given an anticoagulant and their monitoring during and after the procedure
is strongly recommended.
3.4.2 Pharmacological treatment
Several pharmacological agents may be used for acute cardioversion in AF patients
with AF, including oral and intravenous medications [42]. Pharmacological cardiover-
sion is generally employed in subjects affected by short AF episodes with little or no
structural heart disease. Indeed, it can be suitable for the treatment of AF of recent
onset, but efficacy is dramatically reduced in patients with AF persisting for more than
48 hours [97]. It also serves as a complementary therapy in combination with electrical
cardioversion either after the procedure (to stabilize SR restoration effects) or prior to
its performance (in order to increase its success probability). Several drug categories are
generally administered to AF patients, including oral and intravenous medications.
SR conversion rate of chemical cardioversion is generally lower than with electrical
cardioversion, but it does not require conscious sedation or anasthesia, and may facilitate
the selection of proper antiarrhythmic drug therapies to prevent AF recurrence [53].
3.4.3 Electrical cardioversion
Because of the relative simplicity and high efficacy, electrical cardioversion (CEE)
is more frequently performed than its chemical counterpart [42]. This therapy consists
in applying a synchronized, low-voltage electric current to convert AF rhythm back to
normal SR [138]. The electric current enters the body through metal paddles or patches
applied to the skin of the chest, either in anteroposterior or anterolateral configuration,
as in Fig. 3.4. A cable connects the pads to an external defibrillator, which allows for
monitoring patient’s heart rhythm and applying the necessary energy to restore SR. CEE
is usually accompanied by sedation or total anesthesia, as the shock may be uncomfort-
able. The delivered shock causes all the heart cells to contract simultaneously, thereby
interrupting and terminating the abnormal electrical rhythm. If initial shocks do not
succeed in restoring SR, cardioversion is repeated after changing paddle position, and/or
delivering higher energy. Then, according to the protocol adopted, procedure can be
repeated until AF termination or is interrupted. It is important to avoid rupture of blood
clots which may become dislodged from the heart and cause a stroke. Therefore, during
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Figure 3.4: CEE procedure for conversion of AF to normal SR [148].
the procedure, anticoagulants are usually given to the patient prior to its performance.
It is generally preferred to chemical cardioversion not only for the higher success rate,
but also for the shorter duration of the procedure and the reduced risk of causing other
arrhythmia. Success probability is inversely related to the AF duration and LA size [89].
Furthermore, since adequate current delivery determines its successful accomplishment,
it is essential to ensure an effective contact of paddles to patient’s body, so as to reduce
electrical impedance and facilitate energy delivering.
3.4.4 Some considerations about cardioversion limitations
Even though more than 90% of cardioversion interventions prove to be effective, they
can be affected by several drawbacks occurring in the postoperative phase. Success prob-
ability increases if electrical and pharmacological cardioversion are combined, which pre-
vents reverting back to AF. Indeed, cardioversion can sometimes be responsible for other
arrhythmias or problems of impulse conduction.
As stated above, since quivering atria do not contract vigorously in AF patients,
blood clots can form and can be dislodged from the heart when applying CEE, thus
increasing the risk of a heart attack or a stroke [138]. Fortunately, most blood clots
can be prevented by previous anticoagulation therapy, thus thinning the blood before
cardioversion. Furthermore, concerning CEE, some precautions must be adopted when
setting energy of electrical shocks and the number of their attempts so as to avoid tissue
damage.
In general, cardioversion effectiveness depends on several factors, such as patient’s
AF history, episode duration, presence and severity of additional symptoms. If disease
chronification is quite advanced, both types of cardioversion can fail restoring SR. As a
consequence, persistent and chronic forms of AF are more likely to be successfully cured
by other kinds of strategies, in particular ablative therapies.
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Figure 3.5: An example of a Maze lesion in the atria from a posterior perspective. The
4 PVs are visible on the LA. The black hatched lines are incisions and the white lines
ablation lesions [45].
3.5 Ablation therapy for AF treatment
3.5.1 Introduction
In AF treatment framework, ablation is an invasive technique aiming at destroying
the sources of abnormal rhythm and modifying atrial conduction properties so that AF
cannot be maintained even when triggered. First ablation attempts were made by James
Cox in 1987, who introduced a surgical intervention (the Maze procedure) aiming at
preventing AF propagation by means of strategic incisions in the atria [39]. Hereinafter,
procedure noninvasivity became one of the main clinical goals, thus incisions were not
performed anymore during an open-heart surgery, but catheters delivering energy were
introduces so as to burn fibrillatory targets. The key to the success of any catheter or
surgical ablation of AF is the correct choice of lesions and the production of adequate
transmural lesions, which can even yield more effective results than those obtained with
electrical and/or pharmacological cardioversion. A 5-year study has demonstrated that
after a single procedure more than half of patients experience SR restoration [125].
3.5.2 Maze ablation
Maze ablation is a procedure accomplished during an open-heart surgery in which
several incisions are performed in several atria critical locations by means of a scalpel,
such that a maze is created and AF wavefronts cannot propagate [26]. This surgical
strategy assumed that reentry mechanisms illustrated in Sec. 3.3.3 are the main cause of
AF triggering and maintenance. The atrial incisions, shown in Fig. 3.5, act as anatomic
barriers which prevent atrial reentry and allow sinus impulses to activate the entire atrial
myocardium, thereby preserving atrial transport function postoperatively [39]. Irrigated
radiofrequency ablation can be sent through a bipolar clamp or endocardially using a
monopolar pen. Since its introduction, the procedure has gone through three iterations
(Maze I, II, and III) based on cut-and-sew techniques that ensure transmural lesions
to isolate the PVs, connect these dividing lines to the mitral valve annulus, and create
electrical barriers in the RA that prevent macroentrant rhythms.
In order to reduce intervention invasivity, as well as its duration, a tendency to de-
crease the number of lesions has been pursued, by keeping the same mechanistic goals
aforementioned. In some studies it was remarked that LA is usually the source of AF
wavefronts, whereas RA acts as a bystander. Accordingly, Cox introduced the so-called
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Minimaze procedure. Indeed, he discovered that in most subjects AF conduction can be
prevented by a lesion set isolating all PVs, a line between the isolated PV line to the
mitral valve annulus (which ideally encircles the CS at that point) and a right atrial line
across the TV-IVC.
Secondly, new energy sources for ablation have been developed so as to replace cut-and-
sew techniques. Cryoablation and radiofrequency ablation are the most common methods,
which use hand-held probes applied endocardially by direct vision. Alternatively, clamp
devices hold the atrial wall between 2 jaws, and send radiofrequency energy to produce
a complete lesion. Newer energy sources (e.g., laser, microwave, and ultrasound) have
the advantage of generating transmural lesions even when applied epicardially. A further
development of this technique is the use of a limited thoracic incision and thorascopically
guided procedure.
Despite the quite high long-term success rate, Maze ablation is not considered as a
first-line strategy in AF treatment, since it requires a cardiopulmonary bypass in a open-
heart surgery. Several severe side-effects can occur in the postoperative phase, including
stroke, pneumonia, myocardial infarction or other arrhythmias. Accordingly, it is usually
performed subsequently to other therapies’ failure (both cardioversion and/or catheter-
ablation treatment) or during other urgent heart surgery, for instance, coronary artery
bypass surgery or heart valve repair. Some people could need a pacemaker implanted
after the procedure.
3.5.3 Radiofrequency catheter ablation
In this paragraph, most of the description of CA procedure refers to [92]. Radiofre-
quency CA is a nonsurgical procedure for treating AF aiming at the electrical isolation
of abnormal AF sources so as to avoid irregular rhythm conduction throughout heart
tissue [44]. Nowadays, CA is regarded as a first-line therapy, as it can directly eliminate
the abnormal sources responsible for AF and offers the possibility of a lasting cure [157].
Early radiofrequency CA techniques take a step from the Maze procedure by performing
linear lesions in the atrial endocardium. In this procedure thin, flexible catheters are
inserted into the femoral vein in the groin and threaded up through the vena cava (VC)
and into the heart. An electrode at the tip of the wires delivers radiofrequency energy
to the fibrillating heart tissue. Once the catheter is positioned, some small electrodes are
inserted in different areas of the heart. They allow for the detection of heart areas altering
physiological electrical activity. Once the source of the problem has been found, one of
the catheter lines is used to send electrical energy to the selected area. Subsequently, a
small scar is created, thus electrically “disconnecting” fibrillating sources from healthy
heart regions and stopping abnormal rhythm conduction. Catheter positioning, as well
as the anatomy of the PVs and LA, are confirmed by fluoroscopy, pulmonary venography,
3-dimensional electroanatomical mapping, intracardiac echocardiography, computed to-
mography, remote guidance using magnetic resonance imaging, or combinations of these
techniques. An injury is likely to be induced to the myocardium by the application of
thermal energy - most commonly by radiofrequency or cryothermy.
Some initial successful attempts to stop AF have been obtained by creating linear
incisions in the atria, as in the surgical Cox-Maze procedure, and replicating these lesions
with radiofrequency CA. Electrical isolation of PVs from the rest of the atrium, performed
around the origin of the veins, is the cornerstone of most CA procedures [69], based on
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the ectopic foci hypothesis explained in Sec. 3.3.3. Furthermore, vagal inputs may also
influence mechanisms of AF triggering and maintenance, and many of them are located
close to the PV-LA junction [27]. The study in [116] introduces the concept of CFAEs,
which are signals with rapid deflections and short cycle lengths corresponding to areas of
wavebreak, vagal innervation, slow conduction, or re-entry. They were originally defined
as either atrial electrograms that have fractionated electrograms composed of two or more
deflections, and/or perturbation of the baseline with continuous deflection of a prolonged
activation complex, or atrial electrograms with a very short cycle length (< 120 ms).
In [99] CFAEs in RA and LA have been regarded as an ablation target, hence the interest
in their role in AF management. According to [117], ablation of such sources could restore
SR definitively with no risk of AF recurrence. By ablating these areas the propagating
random wavefronts are progressively restricted until the atria can no longer support AF.
In [115] freedom from AF following a single has been reported in 70% of permanent AF
patients.
By contrast, more recent studies claim that other sites can trigger the arrhythmia,
such as LA posterior wall, SVC, CS. Moreover, further modifications of the procedures
have incorporated linear LA ablation, or mitral isthmus ablation, or both for certain
patients. Accordingly, initial approaches aiming at eliminating isolated foci in the PVs
has progressively evolved to circumferential electrical isolation of the entire PVs’ tissue.
CA seems to be more effective in restoring SR than conventional anti-arrhythmic
drugs, by reporting a success rate of 85% of cases at 1 year and 52% at 5 years [50].
Unlike other therapies, if the patient proves to be a positive responder to CA therapy,
procedural SR restoration is durable and the subject can be considered completely free
from the arrhythmia.
3.5.4 Objectives and protocols
Due to uncertainty about its outcome, criteria defining the main CA steps as well as
its endpoint are not strictly systematic, thus leading to different medical protocols. The
ideal approach depends on individual patient characteristics and AF chronicity, and may
require a combination of strategies.
The limited available studies suggest that catheter-based ablation offers benefit to
selected patients with AF, but these studies do not provide convincing evidence of ab-
solute rates of therapy effectiveness. Heterogeneity in the methods of published trials
limits the ability to compare different techniques. Outcomes may have been influenced
by the different patient populations studied, ablative techniques and end points utilized,
and number of repeat ablations. Other confounding factors are prevalence of structural
heart disease, the length of follow up, the use of antiarrhythmic drugs, SR restoration
modalities [45]. More specifically, one of the main issues in CA characterization is the
definition of procedural success itself, varying among groups practicing this therapy.
All therapeutic strategies generally aim at either SR restoration or AF conversion to
an intermediate arrhythmia, such as AFL. While conversion to SR during ablation of
persistent AF has been often associated with excellent outcomes, it is not clear whether
this endpoint is a sufficient condition for long-term freedom from AF recurrence [46,
85], since acute AF termination does not necessarily imply durable therapeutic success.
Using similar stepwise ablation protocols, results have varied for termination of persistent
AF during ablation from 48% to 85% despite similar long-term outcomes. This implies
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either that AF termination is not necessary for good long-term outcomes or that, if all
drivers/sources were not terminated at the first session, they can be addressed during
another session. In other words, the cumulative effect of multiple ablation procedures
may be equivalent to AF termination during the first session. At a follow-up of 1-2 years,
approximately 85% of patients undergoing one or more CA procedures were reported to
be arrhythmia-free without antiarrhythmic medications.
Different contrasting theories about therapy combination have been put forward. In
some centers ablation target is SR restoration immediately after the procedure as well as in
the follow-up. Other groups do not necessarily aim at arrhythmia termination within the
procedure, but they also exploit complementary therapies (i.e., cardioversion) to achieve
long-term AF freedom and stabilize CA effects. The study carried out in [61] shows that
most patients undergoing CEE after CA experience AF recurrences. Conversely, in [46]
it is stated that acute AF termination by CA has no influence over the long-term out-
come, thus justifying the use of complementary curative strategies. The main procedural
endpoints may depend on the type of AF and include completion of a predetermined
lesion set, depending on technical choices. Some groups aim at AF termination during
ablation [63], while other rather address noninducibility of AF after CA [70]. In any
case, there is still debate surrounding the predictive value of such endpoints, and various
approaches are currently adopted in medical practice.
In addition, follow-up length is highly variable as well, as AF can be observed in
several moments of the postoperative phase, especially when treating a persistent form.
At follow-up visits, a 12-lead ECG should be recorded to document the rhythm and
rate, and to investigate disease progression. The assessment of clinical intermediate and
long-term outcome after CA is still a subject of discussion. Symptom-based follow-up
may be sufficient, as symptom relief is the main aim of AF ablation [28]. The most
recent HRS Expert Consensus Statement guidelines for CA trials in [27] recommend that,
immediately after CA performance, there be a 3-month “blanking period” during which
any fibrillatory episodes are seen as a physiological reaction during recovery from CA,
and not as AF recurrence episodes. After this blanking period, if the patient remains
free of arrhythmia recurrences, CA can be considered effectively accomplished. Expert
consensus recommends an initial follow-up visit at 3 months, with 6 monthly intervals
thereafter for at least 2 years.
3.5.5 Introduction to the clinical protocols and the ECG databases em-
ployed in the study experimental setup
As evinced in previous sections, multiple paradigms can be used for assessing CA
procedural success. According to the procedural success criterion examined, ECG param-
eters proposed in this doctoral thesis have been examined and validated on different ECG
databases. In each chapter, we examine one-minute 12-lead surface ECG signals recorded
at a sampling rate of 1 kHz. Standard ECG is acquired in each patient undergoing CA
at the beginning of the procedure. We generally refer to such signals when dealing with
prediction tasks. In other experimental parts, for instance, in Sec. 4.6, we will examine
the same kind of recordings acquired in other moments of the procedure, in particular
close to the end of ablation.
One on the main difficulties encountered throughout our work has been the manage-
ment of a database whose size has changed in time, as patients involved in our study did
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Figure 3.6: Schematic diagram of the ECG databases employed for the experimental vali-
dation of our methods. Each dataset refers to a different clinical criterion for CA outcome
assessment and its size is also reported. Meaning of acronyms: AF: atrial fibrillation; CA:
catheter ablation; CEE: electrical cardioversion; SR: sinus rhythm; SVA: supraventricular
arrhythmia.
not undergo CA all at the same time. As a consequence, clinical conditions of some sub-
jects have been evaluated later in time. This explains the employment of different datasets
throughout the dissertation; they are graphically represented in the diagram in Fig. 3.6.
The subjects involved in our study undergo stepwise CA [25], starting with circumferential
PV ablation with LASSO-guided disconnection, followed by fragmented potentials, non-
PV triggers, roof line and mitral isthmus line right atrial ablation. Some patients received
a pharmacological treatment subsequent to CA procedure, mainly amiodarone (for some
patients, solatol and flecaine). Some of them underwent a second ablation. In this case,
only ECG signals related to the first procedure are taken into account in our study.
We globally deal with two main criteria for CA outcome prediction, which differ for the
length of the follow-up length, when postoperative AF screening is carried out. Indeed,
looking at the short-term outcome means evaluating CA procedure effectiveness, whereas
in longer follow-ups clinicians more generally focus on patient’s conditions and take AF
history into account. As a result, the short-term ECG dataset is related to a certain
number of CA procedures, whereas the long-term database concern a group of distinct
AF patients. If we look at the diagram in Fig. 3.6 from left to right, we can summarize
such datasets according to the clinical task of interest as follows:
1) Acute AF termination by CA: The dataset includes 28 patients, whose procedural
outcome is considered in a very short-term temporal window within the blanking pe-
riod. During this period, no clinical evaluation about definitive freedom from AF can
be put forward, since any kind of fibrillatory activity within this temporal window is
generally part of the postoperative reaction, in combination with other phenomena,
such as edemas and inflammations. As a consequence, examining ablation outcome
in this time interval exclusively provides a preliminary perspective of immediate
CA effectiveness right after the procedure. Acute AF procedural termination was
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defined as the conversion either directly to SR or intermediate SVAs, either directly
by ablation or by CA followed by CEE. Three patients who did not experience AF
termination after a first procedure underwent a second ablation, making a total of
nP = 31 procedures. Accordingly, nS = 26 procedures are considered successful,
whereas nF = 5 procedures failed.
2) Selection of CEE candidates: In line the CA procedural protocol adopted in this
study, cardiologists perform a certain number of steps during the procedure aiming
at AF termination. However, if they are not able to effectively stop fibrillatory
activity at the end of the intervention, they usually perform CEE so as to restore
SR and stabilize ablation effects. In the light of these considerations, cardioversion
performance in the short-term postoperative phase can be regarded as a criterion
of ablation procedural failure, hence the importance of properly choose positive
responders to CEE. Accordingly, 54 ECG recordings have been included in our
analysis (3 subjects out of 51 experienced a double procedure). In 37 procedures, AF
was not terminated by CA only, and CEE was applied immediately after ablation.
In the remaining cases, AF was terminated either by CA exclusively or accompanied
by pharmacological treatment in the follow-up.
3) AF vs SR and other SVAs: We move now to a longer follow-up interval, be-
ginning after the aforementioned blanking period, whose duration must be at least
about 6 months. As we said before, this retrospective analysis of patient’s clinical
conditions must take into account a multiplicity of factors which can influence the
final procedural outcome, with particular attention to complementary CEE thera-
pies or additional ablations. If multiple procedures are performed, signals acquired
during the first intervention are examined. The main endpoint is AF termination
in the long-term follow-up; the arrhythmia can be converted either directly to SR
or to intermediate arrhythmias. In this framework, supraventricular arrhythmias
(SVAs) are considered as an evolution of AF uncoordinated electrical activity to
more organized and regular waveforms, which are likely to be more easily treated
by other therapies. Twenty patients (19 males, 60± 11 years) with a median persis-
tent AF episode duration of 4.5 months (2 to 84) form this ECG dataset. After a
median follow-up of 9.5 months, CA was successfully accomplished in nS = 13 out
of nP = 20 patients (65%), whereas nF = 7 procedures were not effective.
4) SR vs AF and other SVAs: The ECG recordings forming this set have been ac-
quired in 36 patients. More precisely, nS = 29 subjects experienced AF termination
by CA and durable SR restoration in the long-term follow-up (8±4 months), whereas
the remaining ones (nF = 7) did not. In case of repeat ablations, ECG recordings
related to the first CA procedure are included into the analysis. Unlike the previous
therapy success definition, despite the same temporal follow-up window, a stricter
criterion for assessing AF termination is imposed. Indeed, long-term CA success is
defined as freedom from ECG/Holter-documented sustained AF recurrence (> 30 s)
at follow-up after at least 6 months subsequent to the blanking period. Therefore,
at a certain moment of the long-term follow-up clinicians verify whether durable SR
restoration has been achieved. Accordingly, any SVA form is regarded as a procedu-
ral failure. As opposed to previous studies [17, 121], termination of AF during CA
was generally not achieved in all patients. Nevertheless, this is not detrimental to
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our study, since AF termination by CA is not predictive of long-term outcome [46],
which is the event with clinical interest.
Assessment of CA procedural outcome has been carried out according to criteria 1 and 4
throughout the Contributions’ parts (Chapters 4-6). ECG features’ ability to generalize
prediction results at each follow-up is attempted, and significant results are commented
and explained. Despite the clinical interest of criterion 3, the gold standard [25] seems
to privilege definitive freedom from every kind of arrhythmia as a clinical endpoint (as in
Criterion 4), so as to guarantee durable SR and healthier conditions to the patient and
make him free from AF therapy. Concerning the selection of CEE candidates according
to criterion 2, its performance has not only a therapeutic value, but it also represents an
important technical contribution of this thesis, since in Chapter 6 we will merge some of
the ECG features of interest and test such combined measures for this therapeutic task.
However, as we deal with persistent form of AF, CEE is not generally able to restore SR
permanently, and usually plays the role as a complementary therapy.
3.5.6 Risks and limitations
It is important to remember that treating AF by ablation implies some potential risks.
The main clinical goals are abolishing or reducing symptoms, improving LV function by
restoring both electrical and mechanical atrial systole, and finally reducing the risk of
stroke [45].
CA risks in persistent AF are somewhat higher than with ablation for other cardiac
arrhythmias [50]. This is due to several factors, such as the longer duration of the pro-
cedure, the greater extent of the scars, as well as their location (e.g., near the PVs).
Post-procedural stroke can occur in up to 2% of the treated patients. PV damage (which
can produce lung problems leading to severe shortness of breath, cough, and recurrent
pneumonia) occurs in up to 3%. Damage to other blood vessels (in particular, those
through which the catheters are inserted) affect 1−2% of ablated patients. Also bleeding
from the cauterized sites must be taken into account. In general, both the success of the
procedure and the risk of complications improve when the ablation is conducted by an
electrophysiologist with extensive experience in ablating AF.
Recently, new and very advanced 3-D mapping systems have been developed for use
in ablation procedures, and allow cardiologists to create ablation scars with a high level of
precision. In spite of these advances, CA is still a lengthy (4 or more hours) and difficult
procedure, and its success rate is quite uncertain. Even with modern mapping systems,
ablation procedures work best in patients who have relatively brief AF episodes, which
is the case of paroxysmal AF. Success rate is lower in patients affected by chronic or
persistent AF forms, or by critical underlying cardiac disease, such as heart failure, or
heart valve disease. Initial reports described success rates between 22% and 85%, with
better results observed for patients with paroxysmal rather than persistent or permanent
AF. Long term results are limited by follow-up of generally no more than 1 year in most
trials [92]. The arrhythmia recurs in at least 15 − 20% within 1 year, and in 25 − 50%
within 3 to 5 years. Furthermore, it is important to continue with anticoagulant therapy
to prevent strokes, whose risk remains elevated even after CA.
As pointed out in Sec. 3.5.4, the lack of a unique technical protocol and differences
in procedural endpoints makes it hard results’ comparison. The existence of such a wide
variety of techniques is due to the inability to generalize procedure results: the same
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method can lead to different procedural outcomes in more patients. Since very little is
known about AF generation, it is equally difficult to clearly assess CA mechanisms and
quantify its effects on heart substrate. CA effectiveness still strongly relies on operator’s
experience, and evaluation of patient’s conditions before and during CA. Since not all
subjects seem to positively respond to ablation therapy, one of the main current tendencies
is attempting to select patients who are more likely to experience AF termination by CA,
thus allowing an improved patient-tailored management of AF. In such a manner, the
success rate of the therapy would increase, and the number of failing CA procedures
minimized. This strategy would help avoiding unnecessary procedures, and reducing
hospitalization costs and duration, and potential complications to patients who would
not actually benefit from this therapy.
3.6 Predicting CA outcome from ECG analysis
Remarks made in Sec. 3.3.2 about the important role played by the ECG in AF man-
agement justify the attempt of identifying any potential ECG-based descriptors, whose
value can discriminate between successful and failing CA procedures, thus helping selec-
tion of patients who can be effectively treated by cardioversion or CA and experience
durable SR restoration.
Recent research led in [52] demonstrates that some clinical factors, such as right atrial
dimension, AF duration and patient’s weight, can predict AF recurrence after CEE. Some
attempts have also been made in [2, 3], based on sample entropy measures determined on
surface ECG, whose tuning parameter values have been attentively set. The study carried
out in [154] reveals that tracking AA frequency and its harmonics on certain precordial
ECG leads can help prediction of CEE procedural failure in persistent AF.
In [124] the predictive power of some clinical features is corroborated. More precisely,
AF termination by CA is more easily achieved in patients with a shorter history of AF,
a smaller LA dimension, and a longer baseline AF cycle length (AFCL), measured in
the left atrial appendage (LAA). Similar findings are confirmed by [98]. The same study
also confirmed that AFCL measured on surface ECG is not only correlated with the
endocardial measure, but it is also predictive of CA success. In [165] the decrease in
AF dominant frequency between the baseline and instant of procedural AF termination is
proved to be predictive of SR maintenance after CA in the follow-up. Even though no links
with procedural success are proved, the study in [19] demonstrates that the impact of CA
on heart substrate can be assessed in terms on AF spatio-temporal complexity, regardless
of the outcome reported. The concept of AF organization and its characterization in a
multivariate framework represents one of the main contributions of this doctoral thesis,
and it will be developed in detail in Sec. 5.2. In [121], the value of the peak-to-peak
f-wave amplitude measured in leads II and V1 seems to predict CA outcome: the higher
its value, the more likely AF termination by CA. Furthermore, the amplitude measured
in lead II and V1 was correlated with younger age and shorter AF history, and in lead II
only it was correlated with a smaller LA.
Despite this evidence, all these features are affected by several shortcomings. First,
some parameters, such as f-wave amplitude and AFCL [98, 121], are manually acquired,
therefore their measure is quite subjective and is operator-dependent, thus more prone
to errors. This could significantly affect prediction performance, due to the low values
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of the parameters cited (the order of mV for amplitude, ms for AFCL). Secondly, all
these parameters are merely computed in one ECG lead, while neglecting other leads.
Even though it is widely known that lead V1 exhibits the highest atrial-to-ventricular
activity ratio [129], lead selection is not driven by any systematic criteria, and clinicians
generally choose leads in which it is easier to inspect wave properties. However, standard
ECG is characterized by a high degree of spatial variability, i.e., AA signal features may
vary considerably from a lead to another, thus affecting prediction performance derived
thereof. Furthermore, due to its location, lead V1 may represent RA activity predom-
inantly, therefore lacking sufficient information to describe LA activity. Accordingly, a
parameter value could sensitively vary from one electrode to another one. Finally, this
kind of approach lacks robustness, since the measure obtained could not be reliable, e.g.,
if an ECG lead gets loose or disconnected.
Such background motivates our research, which intends to avoid the shortcomings
linked to the intrinsic spatial variability of the atrial signal on surface recordings. To this
end, we aim at determining multivariate measures which combine contributions from all
leads and exploit ECG spatial diversity to predict CA outcome.
3.7 Summary and conclusions
This chapter has provided a global description of AF. In particular, we defined this
arrhythmia and its main causes. Several theories about its generation and maintenance
mechanisms have been proposed in the literature, and they have been summarized herein.
The long-term effects and the electromechanical remodeling performed by AF have been
discussed as well. Subsequently, the therapeutic scenario has been characterized. We first
focused on cardioversion, both pharmacological and electrical, whose long-term effective-
ness rate is quite low in persistent and permanent AF. Particular attention has been paid
to CA, whose performance has yielded more promising results, but whose effect assessment
is currently an open challenge, due to the disparate protocols and techniques, as well as
the difficulty in giving a procedural success definition. With the intent to achieve a trade-
off between invasivity and risks on the one hand, and therapeutic efficiency on the other
hand, clinical centers are increasingly involved in exploring the predictive power of surface
ECG. This would allow for an a priori selection of positive responders to CA, and the
reduction in the number of failing procedures. Since most of the measures obtained on the
standard ECG are either manually computed or determined in only one ECG lead, our
research aims at determining novel parameters which are able to condense contributions
from all ECG leads and discriminate between successful and failing CAs at each follow-up
moment. The next chapter begins to summarize the main contributions of this thesis.
Part II
Contributions
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4 F-wave amplitude as a predictor of CA
outcome in a multi-lead framework
4.1 Introduction
It is widely known that AF effects on the cardiac cycle are reflected on ECG pattern.
As explained in Sec. 3.3.2, one of the main alterations is represented by the absence
of the physiological P wave, which is replaced by small, irregular, rapid deflections in
the ECG waveform, varying in amplitude, shape, and timing. Such oscillations from
ECG baseline are referred to as fibrillatory waves (f-waves) and they are displayed in
Fig. 4.1. This visual evidence serves as a powerful clinical tool for straightforward AF
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Figure 4.1: Example of ECG recording during AF and its characteristic waves. Boxes highlight
TQ intervals where f-waves can be observed.
detection. In addition, its content has been so far exploited in the framework of CA
description. Indeed, several works have demonstrated its correlation with procedural
outcome. However, f-wave amplitude measure assessment is still operator-dependent and
lacks a unique, standard definition. As a consequence, multilead ECG content is not
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adequately exploited. Moreover, standard signal processing approaches for f-wave am-
plitude characterization do not entirely exploit ECG content, in particular components
expressing its interlead spatial variability [121]. Our work aims at extracting information
about f-wave amplitude in an automatic and quantitative framework taking into account
all ECG leads. Spatial variability of standard ECG is properly exploited to enhance f-
wave predictive power in the noninvasive assessment of CA outcome in persistent AF.
The main results of this chapter have been published in [102–104, 106] and investigated
in more detail in this doctoral thesis. The chapter is structured as follows. In Sec. 4.2
the concept of f-wave peak-to-peak amplitude and its role in AF analysis is illustrated.
Multivariate characterization of this feature is then explained in Sec. 4.3. The method
proposed is based on an interpolation algorithm which is able to automatically compute
mean f-wave amplitude on a certain lead. Such algorithm represents the starting point for
a multilead extension based on principal component analysis (PCA), as it can be applied
to each lead of the AA signal low-rank approximation, detailed in the next sections. At the
final step, contributions to f-wave amplitude description from all ECG leads are properly
combined in a single parameter and applied in different contexts. Such an index can act
as a binary classifier of CA outcome prediction, thus distinguishing between successful
and failing CA procedures immediately before their performance at different follow-ups.
The techniques developed are first applied to prediction of acute AF termination by CA
in Sec. 4.4. Variations of this parameter are also able to quantify CA impact over AF
activity within the ablation procedure, which is highly correlated with the procedural
outcome; details are provided in Sec. 4.6. The main conclusions of this chapter are finally
summarized in Sec. 4.7.
4.2 Clinical assessment of f-wave amplitude
4.2.1 Etiology and clinical interpretation
As stated in Sec. 3.3.2, the P wave observed on ECG under SR conditions reflects
atrial depolarization. The depolarization wavefront propagates in a regular and organized
fashion from the SA node toward the AV node, thus resulting in a coordinated atrial
contraction and pumping of blood into the ventricles.
By contrast, during AF atrial contraction is irregular and chaotic, due to the multi-
ple fibrillatory impulses propagating and colliding throughout the heart. These random
phenomena of wavefront sum and cancellation result in the generation of f-waves, whose
amplitude, repetition rate and shape vary according to the degree of evolution of the
disease and other patient’s conditions. More specifically, f-wave amplitude on ECG is
function of the magnitude of the underlying cell voltage, which in turn renders the de-
gree of conduction viability of the atrial myocardial tissue mass. In addition, it is also
influenced by impedance between the electrode and the atria, as well as the directionality
and cancellation of wavefronts. Typically in early stages of the disease (e.g., paroxysmal
forms), the AF pattern can resemble atrial flutter (AFL), when it exhibits regular f-waves
with high amplitude, while in other cases, especially more chronic forms of AF (e.g., long-
standing persistent AF), the opposite characteristics can be observed. Both patterns can
be also found in the same subject at different moments.
AF is generally referred to as coarse if f-waves peak-to-peak amplitude in lead V1 is
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higher than 0.1 mV, fine otherwise [129]. This distinction is usually not strict, as both
patterns can be found in the same patient and multiple factors influence this parameter.
Yet, most of the medical community agrees with the correlation between AF coarseness
and LA function, especially when dealing with certain forms of AF (e.g., rheumatic,
arteriosclerotic). More specifically, AF coarseness could derive from the progressive LA
enlargement caused by atrial remodeling, and the consequent decrease in tissue compliance
induces atrial contractile dysfunction [128].
Richness of f-wave amplitude content has spurred the development of different analysis
approaches in the context of AF treatment, which take a step from the analysis of single-
lead atrial amplitude led in [121].
4.2.2 Standard methods of f-wave analysis and their limitations
Valuable information can be extracted from the f-wave amplitude feature to explain
CA effects on heart substrate and differentiate patients according to procedural outcome.
Medical community widely recognizes the predictive power of f-wave amplitude, which
is shown to be correlated with AF termination by CA. Indeed, high amplitude values
result from multiple atrial cells depolarizing at the same instant, thus rendering a more
organized and coordinated AF activity, which is easier to be treated by CA. This empirical
observation is confirmed by several studies. In [31] the correlation between f-wave size
and procedural success is demonstrated in lead V1 and aVF. Similar conclusions can be
drawn in [121], where maximal and mean f-wave amplitude measured in leads V1 and II
are examined.
Different methods have been proposed to compute f-wave peak-to-peak amplitude.
In [163] it is computed as the mean value of the 4 maximum-amplitude f-waves over the
whole ECG recording. In [121] it is defined as the mean value over 10 (or 30) consecutive
f-waves. In all these studies f-wave amplitude is manually determined on the surface ECG.
Therefore, index accuracy is highly affected by operator’s subjectivity and more prone to
errors, due to the lower measure repeatability.
Moreover, these results seem to demonstrate f-wave size predictive value only in certain
leads examined separately, thus disregarding potentially useful information from other
leads. It has been demonstrated that lead V1 exhibits the maximum atrial-to-ventricular
amplitude ratio [129]. Yet, due to its proximity to the right atrial wall, valuable in-
formation about other areas responsible for AF triggering and maintenance (e.g., LA,
PVs) may not be taken into account [62]. Therefore, not only these approaches do not
consider contributions coming from multiple ECG leads, but selection of single electrodes
is not driven by further systematic criteria. As we will see, our multilead approach not
only avoids the drawbacks associated with the spatial variability of the atrial signal in
surface recordings, but is able to effectively exploit this variability to improve prediction
performance and robustness to electrode selection.
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4.3 Multilead characterization of f-wave ampli-
tude by means of principal component analysis
4.3.1 ECG preprocessing and atrial activity extraction
Before introducing some multivariate processing techniques of the AA signal, let us first
illustrate how this signal is actually defined and extracted. Unless differently specified,
this preprocessing stage will be accomplished throughout this work prior to ECG feature
extraction.
ECG recordings are first processed by a fourth-order zero-phase type II Chebyshev
bandpass filter with −3 dB attenuation at 0.5 Hz and 30 Hz cut-off frequencies. The
filter selected is able to accurately reduce the influence of noisy components typically
encountered in ECG analysis without deforming signal shape [143, 153]. The choice of
this pass-band is consistent with the typical range of AF dominant frequency, between
3 and 12 Hz, and suppresses baseline wander and high frequency noise (e.g., myoelectric
artifacts), besides 50 Hz power line interference.
In order to exclusively extract AA, removal of QRS complexes and segmentation of
TQ intervals are carried out after automatically detecting ECG fiducial points. R waves
are located on lead V1 by means of the Pan-Tompkins’ algorithm [127], whereas Q wave
onset and T wave offset are detected with an improved version of Woody’s method [24].
TQ intervals, which actually contain f-waves, are then mean-corrected and concatenated
on each lead ` = 1, . . . , L, thereby representing AA in an (L×N) matrix YAA:
YAA = [yAA(1) · · ·yAA(N)] ∈ RL×N (4.1)
where vector yAA(n) = [y1(n), . . . , yL(n)]T stands for the multilead AA signal at sample
index n, L is the number of leads used, andN the number of samples of the AA signal y`(n)
for each lead ` = 1, 2, . . . , L. All residual artifacts and spurious peaks due to concatenation
have been automatically removed by means of signal first-derivative thresholding.
Depending on the application and the type of feature extracted, we chose either to
process the full standard ECG, thus setting L = 12, or examine a subset of ECG leads.
Indeed, as explained in Sec. 2.4.4, Einthoven’s standard leads (or limb leads, I, II, III) and
Golbderger’s augmented leads (aVR, aVL, aVF ) are derived from the same 3 measurement
points, and are thus redundant (linearly related, see Eq. (2.4)- (2.7)). Accordingly, lead
III, aVR, aVL and aVF can be discarded by our analysis, as I and II are sufficient to
characterize heart electrical activity on the frontal plane. Finally, all precordial leads
have been introduced too, in order to record the cardiac electric potential in a cross
sectional plane, for a total of L=8 leads, that is, I, II, V1-V6. The number of ECG leads
retained in our analysis will be clearly indicated in each section.
4.3.2 Automatic f-wave amplitude computation
According to previous studies, successful CA procedures can be predicted by higher
values of f-wave peak-to-peak amplitude on the surface ECG [121]. Nevertheless, pre-
diction accuracy is so far affected by amplitude manual computation, leading to higher
error probability, especially in the presence of irregular and complex patterns. Similar
shortcomings can occur when dealing with different operators performing the acquisition
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Figure 4.2: Single-lead atrial waveform interpolation algorithm. Upper and lower en-
velopes eMAX and eMIN pass through the local extrema of the input signal y`; their sub-
traction yields eDIFF.
of such a parameter, so its measure is not uniquely defined. In this framework, we de-
velop an automatic procedure for computing the mean amplitude value of the AA signal
y`(n) on a specific lead ` = 1, 2, . . . , L. More precisely, its local maxima of y`(n) are
detected so that an upper envelope eMAX(n) passing through them can be determined
by the shape-preserving piecewise cubic Hermite interpolating polynomial (PCHIP) [74].
Similarly, a lower envelope eMIN(n) is computed as well, once detected the local minima
of the signal. PCHIP interpolation reduces the negative effect of local spurious peaks
and signal artifacts, and the global trend of the curve is exclusively taken into account.
Peaks located near the edge between two consecutive TQ intervals are discarded from
the computation. The difference eDIFF(n) = |eMAX(n)− eMIN(n)| between the two curves
outlines the general trend of the main oscillations of f-waves, and its temporal mean over
the AA signal length N :
D(y) = 1
N
N∑
n=1
eDIFF(n) (4.2)
represents the final output of our algorithm. An example is shown in Fig. 4.2. The
operator D(·) is characterized by an offset-invariance property:
D(ky + α) = |k|D(y), ∀k, α ∈ R. (4.3)
Index D condenses the information about f-wave over the whole recording and its peak-
to-peak amplitude pattern in a single objective parameter computed in a fully automated
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manner.
4.3.3 Principal component analysis: definition and derivation of princi-
pal components
The rationale of our approach is the intrinsic variability of the surface ECG across
leads, as they are all measured from different points of the patient’s body. Assuming
that the AA signal extracted from the standard ECG YAA can be considered as a surface
mixture of a certain number of unknown sources supports the application of PCA. This
decomposition can express multivariate data as a linear combination of these uncorrelated,
orthogonal, most descriptive sources, the so-called principal components (PCs) [29], with
the highest percentage of input data information as explained by their energy. Other
techniques are also employed in blind source separation for orthogonal component ex-
traction. For instance, independent component analysis (ICA) allows the computation
of such sources by taking into account their statistical independence constraint, and it
has been widely employed for several biomedical applications, such as fetal ECG sepa-
ration [41, 167, 169] and electro-magnetic brain signal analysis [71]. ICA requires that
the components are not only orthogonal, but also statistically independent. This stronger
assumption weakens the orthogonality constraint of mixing matrix columns. However, we
aim at searching for any signal components which are not only common to all observations,
but exhibit also the highest energy content. This goal motivates PCA application, since
linear filtering highlights information shared by all the AA observations. Owing to the
relation between energy and amplitude, we aim at investigating whether dominant PCs
can retain the information necessary for an accurate characterization of f-wave on surface
ECG. Most of the PCA theoretical description that follows is inspired by [168].
Observation model
The key idea of PCA is to reduce the dimensionality of input multivariate data in a
few components, while retaining most of the information as measured by variance [73].
It is worth introducing the general concept of spatial filtering, as an optimal tool for
recovering a certain signal of interest from the ensemble of observations [152]. Indeed,
a multivariate set of observations YAA with L components can be represented at each
time instant by applying a generic linear transformation M, formed by projection column
vectors mk:
X = MTYAA (4.4)
yielding a set of transformed variables X. According to PCA rationale, large variances
have important structure, therefore PCs with larger associated variances represent inter-
esting structure, while those with lower variances are typically associated with noise [139].
Computational model
The core of PCA is searching for a linear combination of the observations, whose
variance is maximized. Let us consider a generic one-dimensional signal or component
x ∈ < derived as a linear combination of the observations yAA ∈ <L [168]:
x = mTyAA (4.5)
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According to the PCA rationale, the first principal direction m1 is the unit-norm vector
maximizing the variance of Eq. (4.5) as measured by the function:
E[x2] = mTE[yyT ]m = mTRym (4.6)
where {·}T represents the transpose operator and Ry = E[yAAyTAA] stands for the co-
variance matrix of input data. In order to determine the first dominant direction m1,
maximization of Eq. (4.6) can be accomplished by means of the Lagrange’s multipliers’
technique, consisting in working on the criterion:
J = mT1Rym1 − λ(mT1m1 − 1) (4.7)
where λ represents the Lagrangian multiplier and the constraint m1mT1 = 1 is introduced
to guarantee a unique solution. J is the Lagrange’s function; its gradient is zero at the
optimal solution, corresponding with local stationary points. To this end, we derive J
with respect to m1 and we impose it is equal to zero.
∇m1J = 2Rym1 − 2λm1 = 2(Ry − λIL)m1 = 0 (4.8)
where IL is the identity matrix of order L. Eq. (4.8) highlights that λ is actually an
eigenvalue of Ry and m1 the corresponding eigenvector:
Rym1 = λm1 (4.9)
By multiplying both sides of Eq. (4.9) by mT1 we obtain:
mT1Rym1 = λmT1m1 = λ (4.10)
sincemT1m1 = 1. Substituting Eq. (4.10) into Eq. (4.7) yields J = λ. It turns out that the
selection of the eigenvector maximizing variance must be performed by taking λ as large
as possible. This condition is fulfilled when m1 is the normalized dominant eigenvector of
Ry, and λ the corresponding eigenvalue. The second principal direction m2 is the unit-
norm maximizer of criterion in Eq. (4.6), lying orthogonal to the first principal direction
m1, i.e., mT2m1 = 0. At the generic kth step, the kth principal direction mk is the unit-
norm maximizer of Eq. (4.6) lying orthogonal to the previous principal directions {mi}k−1i=1 ,
i.e., mTkmi = 0, for i < k. The principal components {x1, x2, . . . , xk}, are obtained by
replacing m with the corresponding principal directions in Eq. (4.5).
4.3.4 Algorithms for computing PCA
PCA performance requires an eigenvalue decomposition (EVD) of the data covariance
matrix Ry, which yields:
Ry = ΓΛΓT (4.11)
where Γ is a (L×L) orthonormal matrix containing the eigenvectors of Ry, whereas Λ is
a diagonal matrix containing the corresponding eigenvalues. With reference to the PCA
definition introduced in Eq. (4.4), knowing that ΓΓT = ΓTΓ = IL for the orthonormality
property, we can compute the PCA factors as:
M = Γ (4.12)
4.3. Multilead characterization of f-wave amplitude by means of
principal component analysis 56
Uniqueness of the solution is guaranteed only if additional constraints are introduced,
as orthonormality of the columns of M in PCA. Sources’ variance is normalized to 1 by
means of the factor Λ− 12 .
The main issues of this algorithm is that processing Ry can induce a loss of precision
and lead to numerical instability. As a consequence, it is generally preferred avoiding the
explicit computation of this matrix and running the singular value decomposition (SVD)
of the input matrix Y, which yields:
Y = USVT (4.13)
where U is an (L × L) orthonormal matrix whose columns represent the left singular
values of Y, V is a (N×L) matrix containing the right singular values, and S is a L-sized
diagonal matrix whose elements represent the corresponding rank-ordered, nonnegative
singular values. By plugging these factors into Ry expression, we obtain:
Ry ≈ 1
T
YYT = 1
T
USVTVSTUT = 1
T
US2UT (4.14)
By keeping in mind the EVD of Ry given in Eq.(4.11), we can verify the following iden-
tities:
U = Γ (4.15)
1
T
S2 = Λ (4.16)
It turns out that the PCA factors can also be directly determined from the SVD of the
data matrix Y as:
M = U (4.17)
The last equation in (4.16) clarifies the relation between eigenvalues of the covariance
matrix Ry and the singular values of input data Y.
4.3.5 Reduced-rank PCA for AA approximation
Knowing that the first source retains most of the AA signal variance, we investigate
whether it is possible to exploit this property to characterize f-wave spatial distribution.
Consequently, we search for a linear function of the maximum-variance elements of y =
yAA. The PCA algorithm yields the dominant source as:
x1 = mT1 yAA, (4.18)
thus isolating the contribution of x1 to yAA from that coming from other sources. As ex-
plained in Sec. 4.3.3, the first principal directionm1 maximizes the variance of x1, achieved
whenm1 is the normalized dominant eigenvector (related to the highest eigenvalue) ofRy.
We find m1 such that x1 is the most descriptive source, i.e., each lead yi is represented by
the term mi1x1 with the minimal global error, where mi1 = [M]i1. The output function
in Eq. (4.18) can clearly be seen as a weighted average of the observed variables. As a
result, contributions from all leads are taken into account in the computation of x1.
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Figure 4.3: The multilead AA signal YAA (continuous line) and its rank-1 estimation by
PCA (dashed line). Top: lead II. Middle: lead V1. Bottom: lead V3.
More generally, the truncation of the model YAA = MX yields the rank-R approxi-
mation:
ŷAA(n) =
R∑
k=1
mkxk(n) (4.19)
with R < L. Note that ŷAA has the same size as yAA. In Fig. 4.3 an example of AA
signal reconstruction through PCA iss reported in some ECG leads.
4.3.6 Multilead f-wave amplitude descriptor
Once AA signal approximation is carried out, f-wave amplitude in each ECG lead is
computed as explained in Sec. 4.3.2. This results in an L-component vector DL, whose
entries represent the temporal mean of the f-wave amplitude envelope values on every
electrode:
DL = [d1, d2, . . . , dL]T. (4.20)
Generally speaking, in a rank-R approximation ŶAA, we compute amplitude entries as
d`,r = D(m`rxr) =|m`r|D(xr), r = 1, . . . , R, according to the property in Eq. (4.3). The
entries of DL are then sorted in increasing order, so as to determine their median value
D˜L in the final step. The choice of the median is justified by its ability to describe overall
data distribution without loss of generality, with a higher degree of robustness to outliers,
compared to other statistical descriptors such as the mean value. The sequence of the
algorithm steps is justified by the need for capturing as most of input signal energy as pos-
sible and effectively rendering f-wave amplitude properties. Experimental evidence shows
that reversing signal interpolation and PCA decomposition does not provide comparable
results in multi-lead f-wave characterization. Indeed, interpolation induces a consider-
able loss of energy, which can not be effectively captured by PCA, thus disregarding
information essential to atrial amplitude description. Parameter D˜L can be considered
as a descriptor of the global spatial distribution of f-wave amplitudes over the observed
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leads. Its clinical significance in the context of CA outcome prediction is assessed in the
remaining of this chapter.
4.4 Prediction of acute AF termination by CA
4.4.1 ECG data and CA success criterion
AA signal YAA is processed by our algorithm once selected a reduced subset of 8
leads of the standard ECG, consisting of the precordial ECG leads and the Einthoven’s
leads I and II. This choice has been previously justified in Sec. 2.4.4. In order to describe
the most representative components of AA signal for f-wave amplitude representation,
input data are approximated by the dominant PC exclusively, that is to say, by setting
R = 1 in Eq. (4.19). In the experimental section benefits from this technical choice
are detailed. With reference to Sec. 4.3.6, it is worth noting that when R = 1, m`1 =
[m1]` is the `th component of the dominant direction m1. We examine the 31-procedure
database employed for predicting acute AF termination by CA and previously presented
in Sec. 3.5.5. It is worth to mention that the reduced number of failing CA procedures
(nF = 5) can limit the generalization power of experimental results. This issue mainly
affects several parts of this thesis, especially the early stages, when the number of patients
involved in the study is still quite limited and CA outcome sometimes is not known yet.
The impact of such factor has been verified throughout this thesis by testing our predictors
on new patients enrolled in the study.
4.4.2 Statistical Analysis
According to this protocol, categories under examination are referred to as “AF termi-
nation” and “non AF termination” by CA. All the ECG parameters defined in the sequel
are expressed as mean ± standard deviation in Table 4.1. Data normal distribution is
Table 4.1: Interclass statistical analysis for AF procedural acute termination assessment.
AF Non AF
p valuetermination termination
D˜8 0.038± 0.019 0.015± 0.007 9.56 · 10−4
D˜12 0.030± 0.012 0.015± 0.006 8 · 10−3
D8 0.042± 0.023 0.022± 0.01 6.4 · 10−2
D12 0.049± 0.070 0.022± 0.01 5.0 · 10−2
D(V1) 0.068± 0.022 0.054± 0.017 1.85 · 10−1
RMS(V1) 0.075± 0.110 0.027± 0.017 1.55 · 10−1
SampEn(Ls, r(1)s ) 0.299± 0.063 0.218± 0.107 2.67 · 10−1
SampEn(Ls, r(2)s ) 0.143± 0.029 0.106± 0.052 3.25 · 10−1
R˜MS8 0.016± 0.009 0.009± 0.006 1.40 · 10−1
R˜MS12 0.024± 0.015 0.016± 0.008 1.40 · 10−1
RMS8 0.021± 0.016 0.021± 0.021 3.76 · 10−1
RMS12 0.037± 0.048 0.026± 0.024 2.48 · 10−1
first verified through the Lilliefors’ test. Interclass differences are then evaluated through
an unpaired Student’s t-test if data follow a normal distribution, a two-sample Wilcoxon
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rank sum test otherwise, under a confidence level α=0.05; p values associated with each
unpaired test are reported in Table 4.1 as well. The predictive power of our model is
measured by the area under curve (AUC) of its receiver operating characteristic (ROC)
curve, based on the maximization of sensitivity and specificity, i.e., the rate of true pos-
itives and true negatives, respectively. The generalization ability of our analysis to an
independent dataset is assessed by a leave-one-out cross-validation (LOOCV) technique.
More specifically, AUC values are computed several times by keeping a sample of 30 pro-
cedures out of 31 and thus discarding one case at each iteration, so as to compute their
average value at the final step. AUC values of each descriptor are displayed in Table 4.2;
in addition, we report the corresponding average of optimal cut-off values determined by
LOOCV, associated with the maximization of the sum of true positive and true negative
cases determined over the 31-procedure database.
Table 4.2: CA outcome prediction performance for AF procedural acute termination
assessment.
AUC Best cut-off
D˜8 0.98 0.023
D˜12 0.91 0.022
D8 0.77 0.027
D12 0.78 0.027
D(V1) 0.68 0.060
RMS(V1) 0.71 0.013
SampEn(Ls, r(1)s ) 0.75 0.289
SampEn(Ls, r(2)s ) 0.72 0.139
R˜MS8 0.72 0.005
R˜MS12 0.72 0.011
RMS8 0.63 0.012
RMS12 0.67 0.014
4.4.3 Results
Our multilead method is first compared with a classical single-lead descriptor of f-wave
amplitude, namely, its mean value in lead V1 output by the algorithm previous proposed,
denoted D(V1). Another classical single-lead method focusing on AA signal magnitude
has been considered, namely, the root mean square value (RMS) on the lead V1, i.e.,
RMS(V1). Finally, a non-linear complexity index, the sample entropy SampEn [130], is
also examined on the same electrode. This feature depends on two parameters: Ls and
rs. Parameter Ls represents the length of the sequences the ECG recording is split in.
Such sequences are then compared, and the tolerance for accepting matches is denoted
by the parameter rs. This threshold is chosen as a fraction of the AA input signal
standard deviation in V1, denoted σV1 , so as to assure the translation and scale invariance
of SampEn. Both parameters have been set according to the guidelines given in [80],
yielding Ls = 2 besides two values of rs, namely, r(1)s = 0.1σV1 and r(2)s = 0.2σV1 .
In the multilead framework, the discriminative power of our descriptor D˜L has been
assessed both on the ensemble of 8 linearly independent ECG leads (L = 8), as defined
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in Sec. 4.4.1, and on the full standard ECG (L = 12), yielding indices D˜8 and D˜12,
respectively. The same comparison is carried out by replacing the median with the mean
value when combining the entries of vector DL in Eq. (4.20), thus giving D8 and D12 as
output. More precisely, the indexD12 has been already proposed in [102], but in this study
PCHIP is applied instead of cubic spline interpolation. Accordingly, the ability of PCHIP
interpolation to effectively render f-wave peak-to-peak amplitude is also examined and
compared with the spline interpolation technique. For the sake of comparison with our
algorithm, after PCA application and rank-1 approximation, the RMS value is computed
on every row of the data matrix ŶAA resulting from Eq. (4.19). This feature is computed
both on 8 and 12 ECG leads, so as to compute the median (R˜MS8, R˜MS12) and mean
values (RMS8, RMS12).
Robustness of our multilead predictor D˜L to ECG lead selection has also been tested.
For each value of lead-subset size L ranging from 1 up to 8, the proposed multilead
predictor has been run on all 8!/((8 − L)!L!) possible lead combinations. CA outcome
prediction performance has then been assessed for each combination of ECG leads from
the corresponding values of D˜L, using the LOOCV technique. In this manner, the min-
imum, maximum and mean AUC values over all L-lead subset combinations have been
obtained as a function of the subset dimension L; their corresponding intervals are dis-
played in Fig. 4.4. The lead combinations providing the best prediction performance for
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Figure 4.4: D˜L prediction performance as a function of the size L of the subset of the
8 independent ECG leads. Vertical lines represent the range of AUC values between
the minimum and the maximum obtained for each L; mean values are highlighted with
markers. AA: measuring D˜L directly from the observed AA signal. PCA: measuring D˜L
from approximation in Eq. (4.19) with R = 1.
each subset dimension are shown in Table 4.3. In order to demonstrate PCA effectiveness
in filtering and enhancing content-bearing information from the AA signal, the same
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Table 4.3: ECG lead subsets with optimal prediction performance based on parameter
D˜L
Number of leads (L) Leads
1 V3
2 II, V4
3 I, V3, V4
4 II, V3, V4, V5
5 II, V1, V3, V5, V6
6
[I, II, V1, V3, V5, V6]
[I, II, V2, V4, V5, V6]
[II, V1, V2, V4, V5, V6]
7 [I, II, V1, V2, V4, V5, V6][II, V1, V2, V3, V4, V5, V6]
analysis is repeated by combining all amplitude contributions from each of the leads of a
L-sized subset directly computed on the AA signal, without previous PCA approximation.
Benefits from PCA compression into the most descriptive PCs are demonstrated by results
in Fig. 4.5, showing the AUC values assessing our algorithm performance for each value
of the approximation rank R, ranging from 1 (the value adopted in our algorithm) to 8
(full-rank reconstruction of the input data). Each analysis based on AUC evaluation is
further validated by the LOOCV technique.
4.4.4 Discussion
Benefits from automatic computation of f-wave amplitude
The predictive value of f-wave amplitude for CA of persistent AF has been scrutinized
in previous studies [121]. However, not only it has been manually obtained, but only
one ECG lead has been considered in its computation. By contrast, a method aiming at
automatically computing f-wave peak-to-peak amplitude on a single lead is proposed in
our study (Sec. 4.3.2). As in the study led in [121], the higher f-wave amplitude, the more
likely AF termination by CA. Values of these parameters are very close to those obtained
in [121] (0.08± 0.03 mV for successful CA procedures, 0.05± 0.03 mV for the failing ones,
p < 0.01, AUC = 0.77) However, no significant interclass differences can be highlighted
by D(V1), as reported in Table 4.1.
Comparison with other atrial signal parameters
Single-lead methods for computing f-wave amplitude do not prove to be adequate for
CA outcome prediction. For instance, like D(V1), no significant differences are highlighted
by the RMS value, whose prediction performance is rather inaccurate. Non-linear analysis
is neither capable of distinguishing between successful and failing CA procedures. Indeed,
not only sample entropy SampEn in V1 does not prove to be an effective predictor of
CA outcome, but our results show that this index exhibits lower values when dealing
with failing CA procedures. By contrast, lower values of this index were associated with
higher probability of CEE success in [5]. Indeed, these results contradict our hypothesis
about a positive correlation between the sample entropy and AA signal spatio-temporal
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Figure 4.5: Classification performance for the 8 linearly independent ECG leads. AUC of
D˜8 as a function of R, the number of PCs retained in approximation (4.19).
complexity. One would actually expect that more organized AA waveforms as measured
by lower SampEn values render a less critical disease profile, easier to be treated by CA.
Yet, this hypothesis is not verified in our study, regardless of the threshold rs chosen.
Finally, not only the computational load demanded by SampEn is notably higher than
that of other predictors, but its parameters must be also tuned, which requires further
assumptions on the AF model.
Multilead atrial signal amplitude measurement
The method presented is able to exploit spatial variability as a tool for f-wave am-
plitude characterization in CA outcome prediction framework. Regarding this multilead
perspective, features based on RMS values computed on several leads do not seem to be
able to quantify f-wave amplitude content. Indeed, no significant interclass differences
are underlined by these descriptors, and AUC values in Table 4.2 are quite weak too,
especially those related to the prediction performance of RMS8 and RMS12. By contrast,
descriptors defined in our PCA-based multilead framework are more robust and reliable
than their single-lead counterparts and than classical multilead approaches. The novel
predictor D˜8 effectively discriminates between successful and failing CA procedures, as
shown in Table 4.1, and its values are directly correlated with CA success, in conformity
with results of previous studies [121]. We also confirmed the advantages derived from
multilead analysis, as we can see in Fig. 4.4 that the mean AUC increases as the number
of ECG leads do.
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Benefits of PCA-based ECG signal approximation
A further advantage of our multilead approach over the direct examination of AA signal
amplitude is proved in Fig. 4.4. Indeed, AUC mean values associated with our method are
generally higher than those obtained without PCA preprocessing. In addition, the higher
the number of leads, the larger the difference between the two methods, as AUC intervals
partially or completely overlap only when L is sufficiently low. Moreover, additional
benefits derive from PCA compression. As shown in Fig. 4.5, displaying the AUC index
as a function of the PCA approximation rank R, the fewer PCs are retained, the higher
the discriminative power of the predictor. Indeed, PCA ascribes noisy and/or spurious
signal components to the least significant PCs, which seems to enable the extraction of the
information about f-wave amplitude shared by observations when retaining the dominant
PC of the atrial ECG data.
ECG-lead preselection
The use of all 12 leads of the ECG in standard clinical practice is justified by clinicians’
necessity to compare the projections of heart electrical vectors in two orthogonal planes
and at different angles, so as to increase pattern recognition accuracy [96]. However,
as stated in the Introduction of the present thesis, linear relations between limb and
augmented leads do not add further information which can be effectively exploited for
CA outcome prediction. Conversely, it seems that selecting the 8 independent leads
boosts PCA filtering action, as redundant elements are already partially removed before
the decomposition, and the relevant components are put into evidence more easily. This
may explain why D˜8 outperforms its 12-lead counterpart.
Table 4.3 shows leads helping discrimination between successful and failing CA proce-
dures for a certain subset size L chosen. Note that some ECG lead combinations recur in
each subset. In particular, the optimal L-lead subset typically includes leads of smaller
optimal subsets, together with a new electrode. The presence of leads representing heart
electrical activity on multiple planes confirms again the hypothesis that clinical informa-
tion coming from multiple electrode locations can improve ablation outcome prediction.It
is also worth noting that lead V1 starts giving effective contribution when more than 4
leads are considered, in contrast with standard medical practice for AF analysis focusing
on feature extraction in this electrode for single-lead analysis [129]. This result can be
probably explained by the fact that this lead is not close enough to the PVs and the LA,
therefore it is not able to sufficiently characterize information from these sites.
Combining contributions from multiple ECG leads
In this section further attention is paid to the computation modalities of the multilead
descriptor of f-wave amplitude, i.e., how single-lead contributions coming are combined
with each other. Such feature should provide a measure of central tendency of the dataset,
namely, the value which is roughly equidistant from all the elements of the set considered.
Experimental evidence reveals that the median value statistic (˜·) performs better than
the mean (·) on our signal database, since it is less sensitive to outliers. Furthermore,
the median is more suitable for skewed data distributions, this being often the case of
f-wave amplitude, whose visibility and magnitude can depend on lead location as well
as on AF characteristics in the patient examined. Hence, the low accuracy affecting CA
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outcome predictorsD12 andD8. These results do not seem to generalize evidence reported
in [102]. This phenomenon can be probably explained by the fact that the mean value DL
indistinctly takes contributions from all leads into account. On the contrary, the median
D˜L exclusively highlights the role played by the middlemost elements in the sequence of
contributions. In this manner, the global trend of f-wave amplitude is effectively depicted,
while neglecting the extrema of DL, which are generally not representative enough to
summarize the main characteristics of this spatial distribution.
Conclusions
The method put forth in this section is able to predict CA outcome in persistent AF
by exploiting information about spatial distribution of f-wave amplitude. Such knowledge
is effectively characterized on standard ECG by means of reduced-rank approximation to
AA signal determined by PCA, which filters out the least significant components of the
signal while enhancing the most discriminative contributions. An algorithm for f-wave
amplitude computation based on PCHIP interpolation is also presented. This automatic
approach yields results comparable with those reported in [121] and helps overcoming
the shortcomings of manual measures. Combination of interpolation operations and PCA
approximation, followed by the averaging of lead contributions, effectively improves CA
outcome prediction quality. The proposed method overcomes traditional classification
approaches and proves to be more robust to lead selection, which can be an advantage in
practical settings where, e.g., electrodes may become loose or get disconnected from the
patient’s skin.
4.5 Measures of central tendency for long-term
CA outcome prediction
The predictive power of the proposed descriptor of f-wave amplitude is now investi-
gated so as to verify whether it can be extended to long-term CA outcome prediction.
As explained in Sec. 3.5.5, changes in classification criterion do not only concern the
duration of the follow-up, but also the evaluation of procedural success, merely defined as
AF conversion to SR in the long-term follow-up, namely after 6 months [25]. In addition,
we do not aim at evaluating the specific ablation intervention, but the patient’s condi-
tion in a more general framework, which takes into account every factor of AF history
and evolution after ablation. Accordingly, complementary cardioversion therapies (either
electrical or pharmacological) and/or additional CA procedures can also contribute to the
final outcome of ablation.
4.5.1 Methods and results
In this experimental section, we are going to test our method on the ECG database of
nP = 36 patients presented in Sec. 3.5.5. Freedom from AF recurrence is investigated in
a long-term follow-up period of at least 6 months. As in the short-term analysis, also in
this case we have to deal with unbalanced categories, since the database is characterized
by a low number of failing CA procedures (nF = 7). The influence of this factor on pre-
diction performance needs to be more clearly elucidated. Accordingly, unpaired statistical
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analysis is led as explained in Sec. 4.4.2; results are displayed in Table 4.4. Table 4.5 also
Table 4.4: Interclass statistical analysis: extension of amplitude measures to the long-term
follow-up.
AF Non AF
p valuetermination termination
D˜8 0.033± 0.020 0.034± 0.016 9.5 · 10−1
D˜12 0.030± 0.013 0.031± 0.015 7.8 · 10−1
D8 0.035± 0.022 0.048± 0.026 1.9 · 10−1
D12 0.032± 0.017 0.042± 0.021 2.0 · 10−1
reports classification performance results.
Table 4.5: CA outcome prediction performance: extension of amplitude measures to the
long-term assessment of AF termination by CA.
AUC Sensitivity Specificity Best cut-off
D˜8 0.49 0.59 0.57 0.033
D˜12 0.51 0.62 0.57 0.030
D8 0.63 0.21 0.86 0.045
D12 0.65 0.21 0.86 0.036
4.5.2 Discussion and conclusions
Our investigation demonstrates that each of the amplitude features previously pro-
posed can not accurately discriminate the categories of interest and generalize our results
to long-term prediction of CA outcome. This can be probably explained by the mul-
tiplicity of confounding factors (e.g. cardioversion, additional ablations), whose impact
may be not adequately reflected on the atrial amplitude index. Owing to the risk of
arrhythmic episodes and the application of complementary therapies after CA over the
long-term follow up (namely, chemical or electrical cardioversion), these two criteria can
return different results for the same patient.
By contrast, multivariate RMS-based parameters now seem to be able to effectively
predict AF termination by CA in the long-term followup, in contrast with evidence related
to prediction of acute procedural success. This can be probably explained by the impos-
sibility for these parameters to capture certain effects immediately after CA performance,
which may be hidden by inflammations and other postoperative reactions. The impact of
such factors probably decreases after several months, whereas the role of other elements,
such as atrial remodeling and auxiliary therapies, becomes more important.
As explained in Sec. 4.4.4, each ECG lead yields its own contribution to the character-
ization of the heart electrical vector in terms of magnitude and orientation, thus providing
a different perspective of AF activity. As a consequence, such a specificity may be lost
when simply averaging single-lead terms into a unique f-wave descriptor. This observation
led us to explore other techniques which can selectively enhance the most content-bearing
ECG leads so as to improve long-term CA outcome prediction. This line of investigation
will be illustrated later in Chapter 6.
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4.6 Assessment of therapy effects on AF dynamics
during CA
4.6.1 Introduction
In this section we examine the ability of the f-wave amplitude index proposed in Sec. 4.4
to describe changes in AF pathophysiology during CA. We now investigate whether f-
wave amplitude information can be used to quantify CA impact on AF by considering
the evolution of heart electrical activity throughout the intervention. More precisely, we
aim at assessing ablation effects by looking for a relation between the initial and the final
part of the procedure and observing how f-wave amplitude varies within this temporal
window.
This parameter highlights variations in f-wave amplitude for each patients’ category,
and allows the quantification of the ablation effects at different follow-up lengths. More
specifically, we will demonstrate that a decline in f-wave amplitude between the beginning
and the end of the procedure can be remarked in patients experiencing AF termination
by CA, for the two follow-up windows considered in this study.
4.6.2 ECG data and CA outcome criteria assessment
According to the guidelines provided by HRS Expert Consensus Statement guidelines
for CA trials [25] and introduced in Sec. 4.4.1, for each AF patient we can examine pro-
cedural success according to multiple criteria, which differ from each other, for instance,
for the observation time and the endpoint of the procedure.
Following these guidelines, two different criteria of procedural success have been in-
troduced into our study. Short-term CA outcome is verified on the dataset of 31 CA
procedures defined in Sec. 3.5.5 . Long-term CA success is assessed on the 20-subject
dataset described in the same section. Under this hypothesis, AF termination has been
observed in 13 patients out of 20. The smaller size of the second dataset is due to the fact
that some ablations were accomplished not long before this study, so long-term outcome is
still unknown. For each sample of both datasets, one-minute surface 12-lead ECG signals
acquired at the beginning and at the end of the CA procedure are examined.
4.6.3 Multilead descriptor of f-wave amplitude
The single-lead contributions to f-wave amplitude spatial distribution characterization
are computed on the rank-1 AA signal PCA-approximation as explained in Sec. 4.3.6 by
Eq. (4.20), and they are finally averaged so as to yield the index:
DL =
L∑
`=1
d`
L
=
L∑
`=1
|m`1|D(x1)
L
= ‖m1‖1
L
D(x1) (4.21)
In [102], the role of DL as a CA outcome predictor has been evidenced in a multivariate
framework, as explained in Sec. 4.3.6: the higher its value, the more likely procedural AF
termination. In this section, a further role is herein ascribed to DL as a descriptor of AF
evolution during CA, reflected on f-wave amplitude temporal variations which are negative
for successful procedures, positive otherwise, regardless of the observation period during
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Figure 4.6: Example of a scatter plot of random data, the regression line y = Sx+ I and
discrepancies di between estimated and real data
follow-up. Such variations are quantified by means of the linear regression analysis [14].
Generally speaking, given an observation i, this approach models the interaction between
an independent (or control, or predictor) variable xi and the effect (or response) variable
yi by means of the linear law:
yi = Sxi + I + ei (4.22)
where S stands for the slope of the straight-line relationship and I the intercept with
the y axis, computed by the least squares (LS) method, which takes into account the
discrepancies di between real observations yi and their estimation Sxi + I, as shown in
Fig. 4.6. Mathematical demonstration is provided in Appendix A.1. The additional term
e represents the unknown error component superimposed on the true linear relation, due
to the measurement system or random disturbances. With reference to our application,
we aim at modeling CA therapeutic impact as rendered by changes in f-wave amplitude
measured between the beginning of CA (START) and its completion (END). Accordingly,
in our application the index DLSTART represents the regression independent variable, and
we investigate whether any linear law can describe its relation with the dependent variable
DLEND.
4.6.4 Statistical analysis and results
Values of all parameters are expressed as mean ± standard deviation for each category
in Table 4.6. Subscripts SUCC and FAIL refer to successful and failing CA procedures,
respectively, according to the protocols above presented, whereas subscripts ST and LT
are related to the length of the observation followup (short-term and long-term period,
respectively); headings START and END are associated with the moment of the acqui-
sition of the ECG recordings during the procedure. In this experimental session, in line
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Table 4.6: Regression analysis of the parameters DL, D(V1), D˜L (mV) and NMSE (n.u.:
normalized units).
START END RP S PS PI
(DL)SUCC,ST 0.049± 0.070 0.046± 0.060 0.982 0.836 1.52 · 10−18 3.90 · 10−11(DL)FAIL,ST 0.022± 0.010 0.033± 0.027 0.900 2.422
(DL)SUCC,LT 0.055± 0.100 0.051± 0.085 0.998 0.849 8.52 · 10−5 4.76 · 10−5(DL)FAIL,LT 0.039± 0.020 0.036± 0.023 0.894 1.008
(D˜L)SUCC,ST 0.030± 0.012 0.029± 0.014 0.448 0.527 1.88 · 10−1 2.93 · 10−1
(D˜L)FAIL,ST 0.015± 0.006 0.016± 0.010 0.788 1.381
(D˜L)SUCC,LT 0.026± 0.009 0.027± 0.010 0.725 0.791 7.00 · 10−1 5.95 · 10−1
(D˜L)FAIL,LT 0.035± 0.013 0.031± 0.021 0.561 0.878
D(V1)SUCC,ST 0.068± 0.022 0.067± 0.022 0.789 0.802 1.68 · 10−2 4.01 · 10−1
D(V1)FAIL,ST 0.054± 0.018 0.048± 0.012 0.665 0.446
D(V1)SUCC,LT 0.076± 0.024 0.070± 0.023 0.883 0.834 1.12 · 10−4 1.46 · 10−1
D(V1)FAIL,LT 0.054± 0.012 0.062± 0.020 0.840 1.392
(NMSE3)SUCC,ST 15.4± 15.9 14.0± 14.1 0.092 0.082 2.40 · 10−3 6.72 · 10−1(NMSE3)FAIL,ST 18.7± 16.9 35.5± 29.7 0.813 1.428
(NMSE3)SUCC,LT 9.80± 9.65 8.50± 7.80 0.476 0.384 8.49 · 10−1 7.54 · 10−2(NMSE3)FAIL,LT 25.1± 24.7 26.5± 28.9 0.251 0.294
with [103], we set L = 12 so as to take into account all lead contributions in regres-
sion analysis. For each patients’ group (SUCC, FAIL) and follow-up window (ST, LT),
the relation between DL values computed at the beginning of the ablation (independent
variable X) and those obtained at its completion (dependent variable Y ) is assessed by
the linear regression analysis. The value of Pearson’s correlation coefficient RP , defined
in Appendix A.1, is computed so as to assess the validity of linearity hypothesis. We
assume that the value of the slope S of each regression law Y = SX + I can quantify
CA effects over patients’ heart substrate and their temporal dynamics, knowing that the
intercept I has small values. In addition, statistical differences between slope values have
been assessed through a parallelism test [156] for each couple of regression lines (SUCC,
FAIL); p values output by such test are computed as explained in [156] and are referred to
as PS and PI in Table 4.6. In first approximation, we assume that intercept value is close
to zero and can be neglected. Then, in order to confirm the validity of our hypothesis,
we perform a further test to assess statistical differences between the intercepts of each
linear law, quantified by the p value PI . If the slopes are significantly different, there is no
point comparing intercepts. If the slopes are indistinguishable, the lines could be either
parallel with distinct intercepts, or identical (i.e., same slopes and intercepts) [166].
The scatter plots in Fig. 4.7 display the distribution of DL values acquired after the
completion of the ablation ((DL)END) as a function of those describing the beginning of
the procedure ((DL)START) for each criterion of procedural success (short-term success
and long-term success, respectively); the regression laws related to each category are also
represented. Statistical analysis has been carried out under a confidence level α equal to
0.05.
A comparison with previous works has been drawn as well. F-wave peak-to-peak
amplitude D(V1) has been studied on lead V1 [102, 121]. In addition, the NMSE3 index
defined in [19] as the NMSE between the AA signal and its rank-3 PCA-approximations
on V1 is examined as well. This index will be further studied in Chapter 5. It has also
been computed for each CA step and analyzed according to the aforementioned protocol.
Finally, in order to assess the ability of the mean value to properly condense ECG leads’
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Figure 4.7: Scatter plot of (DL)END as a function of (DL)START and data regression lines
associated with each category (successful CA: ’O’, continuous line; failing CA: ’×’, dotted
line.). (Left) Short-term follow-up; (Right) Long-term follow-up.
contributions in a unique measure, the proposed index DL has been compared with the
median f-wave amplitude as rendered by D˜L and defined in [106].
4.6.5 Discussion and conclusions
Results of our analysis in Table 4.6 show highly linear correlation between DL values
acquired at the beginning of the procedure and those determined at the end. This result
can be generalized for each class of subjects and CA outcome observation time. Ex-
perimental evidence also confirms our assumptions about reduction in f-wave amplitude
within the observation temporal window chosen. Indeed, a significant reduction in f-wave
amplitude is found to be associated with CA success, quantified by a value of the slope S
lower than unity. By contrast, when CA procedures are ineffective, the index DL increases
or remains unchanged, which can be a clue of disease presence even after the ablation.
Moreover, statistically significant differences can be observed for S values between the
groups under examination (SUCC, FAIL) at each time of follow-up. Such results con-
firm the robustness of the ECG-based feature proposed even in presence of outliers. For
example, even when we remove the point (DL)FAIL,ST = (0.036, 0.079) in the regression
analysis, values obtained do not invalidate conclusions drawn by previous experiments
(R = 0.99, S = 1.34, PS = 0.037). This evidence shows the ability of our descriptor to
evaluate CA impact over AF evolution, which are specific for each group of subjects. Mean
f-wave amplitude on V1 (D(V1)) provides statistically significant inter-class differences,
but its short-term value decreases after CA whether the procedure is effective or not.
This outcome is not consistent with our initial assumption, as we expect a reduction
in f-wave amplitude only when CA is successful. Moreover, the linearity assumption is
not as reliable as for our descriptor. Single-lead amplitude seems to distinguish between
the categories considered (SUCC, FAIL) more accurately in the long-term than in the
short-term follow-up. However, its discrimination ability is clearly outperformed by that
of our multilead descriptor, since interclass differences are quantified by lower PS values.
Regarding NMSE3, even though significant differences are reported for the short-term CA
outcome examination, the linearity hypothesis proves to be quite weak, especially when
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dealing with successful procedures, as proved by the low R values in regression analysis.
Similarly, analysis over longer periods shows no significant differences between regres-
sion line slopes. Moreover, our investigation merely focuses on V1, the lead classically
employed in clinical practice for AF analysis in surface ECG. Even if it is well known
that this is the lead with the largest atrial-to-ventricular signal amplitude ration [129],
contributions from other leads are not analyzed at all by this classical approach. Some
pertinent information is neglected, thus leading to a partial comprehension of the disease.
Concerning the median operator D˜L, despite the capability of effectively predicting of
acute AF termination by CA [106], it seems not be able to differentiate successful and
failing CA procedures when looking at f-wave amplitude dynamics, since the regression
laws are not significantly different between each other. Moreover, data distribution is not
accurately described by a linear law, as proved by the low regression coefficients values.
This result could be explained by the fact that averaging single-lead atrial amplitude con-
tributions better preserves information about CA dynamics. Indeed, it is more sensitive
to amplitude variations, in particular those of extrema values (i.e., very low and/or very
high amplitude values). By contrast, the median operator rejects outliers more easily, and
this probably leads to discarding contributions describing amplitude dynamics.
To summarize, we corroborated the ability of the index DL to quantitatively evaluate
CA impact on AF dynamics during its performance through a multilead characteriza-
tion of f-wave amplitude variations. A linear correlation between the beginning and the
end of the procedure has been demonstrated. In particular, a reduction in DL values
can be associated with successful procedures, thus showing CA efficacy in progressively
suppressing f-waves, regardless of the length of the postoperative followup. Experimental
evidence proves that AF pathophysiology is deeply influenced by CA performance, and
its modifications can be noninvasively quantified by f-wave amplitude variations in the
standard ECG.
4.6.6 Further developments
In this section, we investigate whether these results can be extended over a larger
database in a longer follow-up. Therefore, we repeat AF dynamics analysis on the 36-
patient database introduced in Sec. 4.5.1 in the framework of long-term CA outcome
prediction. Furthermore, we compare the measures of central tendency presented in this
chapter, namely, mean value of the f-wave amplitude descriptor DL and the median D˜L.
Both the 8-lead subsets and the full standard ECG are examined. Finally, we examine
the AA signal interpolation techniques presented in [103] and [106], i.e., the cubic spline
method and the PCHIP algorithm, respectively.
In Table 4.7 we can generally remark that it is hard to generalize our initial assump-
tions over the database considered.
For instance, as in the previous analysis, despite the significant differences between
the related linear laws, Table 4.7 underlines that mean amplitude D(V1) always decreases
within CA performance time regardless of the procedural outcome. The NMSE index
is also affected by several drawbacks, including the lack of linearity of the relation hy-
pothesized. Generalization of previous results obtained on the parameter D12 cannot be
effectively accomplished on this database. When applying the spline technique, not only
linearity assumption seems not to be correct, but the hypothesis that f-wave amplitude
decreases only when CA is effective is not verified anymore. Similar conclusions can be
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Table 4.7: Linear regression of f-wave amplitude: statistical analysis and results over the
36-patient ECG database.
START END RP S PS PI
(D12)SUCC,SPLINE 0.039± 0.028 0.0546± 0.071 0.676 1.726 1.63 · 10−2 1.51 · 10−1(D12)FAIL,SPLINE 0.053± 0.029 0.060± 0.038 0.642 0.845
(D8)SUCC,SPLINE 0.044± 0.039 0.049± 0.046 0.500 0.591 1.47 · 10−2 4.01 · 10−1(D8)FAIL,SPLINE 0.061± 0.039 0.086± 0.055 0.882 1.241
(D˜12)SUCC,SPLINE 0.036± 0.020 0.039± 0.026 0.735 0.913 6.22 · 10−1 7.12 · 10−1
(D˜12)FAIL,SPLINE 0.038± 0.018 0.042± 0.036 0.535 1.026
(D˜8)SUCC,SPLINE 0.041± 0.030 0.046± 0.045 0.283 0.422 1.24 · 10−2 1.08 · 10−1
(D˜8)FAIL,SPLINE 0.040± 0.019 0.066± 0.056 0.759 2.295
(D12)SUCC,PCHIP 0.032± 0.017 0.045± 0.062 0.538 1.971 6.30 · 10−2 2.45 · 10−1(D12)FAIL,PCHIP 0.042± 0.021 0.048± 0.026 0.629 0.782
(D8)SUCC,PCHIP 0.035± 0.022 0.034± 0.018 0.635 0.524 1.25 · 10−2 7.28 · 10−1(D8)FAIL,PCHIP 0.048± 0.026 0.061± 0.036 0.663 0.907
(D˜12)SUCC,PCHIP 0.029± 0.013 0.033± 0.030 0.330 0.740 9.51 · 10−1 9.25 · 10−1
(D˜12)FAIL,PCHIP 0.031± 0.015 0.033± 0.024 0.500 0.776
(D˜8)SUCC,PCHIP 0.033± 0.019 0.032± 0.017 0.359 0.306 2.30 · 10−4 2.16 · 10−2
(D˜8)FAIL,PCHIP 0.034± 0.016 0.045± 0.034 0.726 1.502
D(V1)SUCC 0.065± 0.028 0.064± 0.028 0.860 0.839 9.04 · 10−2 5.50 · 10−3
D(V1)FAIL 0.075± 0.040 0.078± 0.033 0.920 0.758
(NMSE3)SUCC 10.2± 10.0 9.6± 10.6 0.362 0.382 8.61 · 10−1 6.23 · 10−2(NMSE3)FAIL 21.2± 25.4 21.5± 30.7 0.274 0.332 S
drawn when the PCHIP interpolation is introduced into the atrial amplitude algorithm.
However, we can interestingly remark that the parameter D˜8PCHIP presented in [106] and
herein discussed in Sec. 4.3, is able to effectively quantify CA impact over AF dynamics
as assessed in Sec. 4.6.4, since median f-wave amplitude descriptor decreases if CA is
effective, otherwise it rises. The linear relationships computed are statistically different
from each other, despite the lack of linearity of these features, which can be due to the
limited number of sample (especially in the group of failing CA procedures) and the
influence of certain outliers (among patients experiencing procedural AF termination), as
shown in Fig. 4.8. For the sake of completeness, regression analysis of D˜8PCHIP has been
also performed in the short-term follow-up context. Indeed, in Fig. 4.8 we can remark
that also in shorter follow-up windows actual amplitude data are not accurately fitted
by a linear law. In addition, slope values are lower than 1 both when dealing with suc-
cessful CA procedures (CA beginning: (D˜8)START,PCHIP = 0.038 ± 0.019; CA conclusion:
(D˜8)END,PCHIP = 0.032±0.09) and failing interventions ((D˜8)START,PCHIP = 0.015±0.007,
(D˜8)END,PCHIP = 0.019 ± 0.009), thus contradicting our hypothesis about the link be-
tween f-wave amplitude variations and procedural outcome. This experimental session
also highlights how difficult it is to generalize AF dynamics during CA due to the wide
variety of factors differentiating the short-term follow-up period (such as postoperative
inflammations, edemas, anesthesia) from the long-term phase (complementary cardiover-
sions therapies, atrial remodeling). In addition, similarly to classification tasks, regression
analysis is hampered by the examination of unbalanced categories, thus the need to vali-
date these results on larger databases, in particular with more data related to failing CA
procedures.
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Figure 4.8: Scatter plot of (D˜8)START,PCHIP as a function of (D˜8)END,PCHIP and data
regression lines associated with each category (successful CA: ’O’, continuous line; failing
CA: ’×’, dotted line). (Left) Short-term follow-up; (Right) Long-term follow-up.
4.7 Summary and conclusions
In this chapter, the role of f-wave amplitude as a predictor of CA outcome in per-
sistent AF has been investigated. In particular, its spatial distribution has been as-
sessed on standard ECG, thus exploiting its multilead properties and overcoming the
limited perspective of traditional single-lead methods. In addition, amplitude measures
are uniquely determined and objective, since the algorithms proposed are fully automatic.
Indeed, the introduction of signal interpolation techniques considerably improves ampli-
tude computation accuracy, and f-wave global trend is effectively rendered. In addition,
we demonstrated that reduced-rank approximations determined by PCA are able to cap-
ture the most descriptive components of the AA signal, which are relevant to f-wave
amplitude characterization. Statistical measures of this ECG feature are found to be
able to discriminate between successful and failing CA procedures, thus predicting acute
AF termination, as illustrated in Sec. 4.3. The extension of such results to long-term
CA outcome prediction is then carried out in Sec. 4.5. Finally, spatial diversity of f-wave
peak-to-peak amplitude has been probed on standard ECG in combination with temporal
dynamics within CA procedural time. Linear regression analysis allows for quantification
of CA effects on heart substrate, which are found to be correlated with CA outcome, as
demonstrated in Sec. 4.6.
Despite the effectiveness of our methods for f-wave amplitude characterization a CA
outcome prediction, they merely extract an average information about f-wave amplitude
without taking signal variability into account. To this goal, an attempt in this direction
has been made in Sec. 4.6 by characterizing AF evolution between two distinct procedural
moments. However, combining spatial information with knowledge about temporal AF
variability could be of interest for our application, as we could expect a relation between
signal variability and ablation results. In the next chapter, we investigate whether it is
possible to assess AF temporal variability also within a specific moment of ablation (in
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particular, the early beginning) and attempt to exploit such information to perform CA
outcome prediction.
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5 Multilead decompositions of ECG signal for
STV feature definition in CA outcome prediction
5.1 Introduction
As we recalled in Sec. 3.3.3, the mechanisms underlying AF are not yet fully under-
stood. Indeed, AF has a complex pathophysiology, with various substrates and mecha-
nisms interacting in a complex fashion. This arrhythmia has long been described as a
disorganized or “random” phenomenon [78, 111]. However, more recent works have high-
lighted the existence of an underlying structure behind the apparent chaos [22], depending
on myocardium anatomy, electrophysiological properties, and autonomic innervation [94].
Several factors influence this activity, including age, simultaneous occurrence of other
pathologies and effects of atrial remodeling due to disease chronification. Knowledge
about AF organization has a crucial clinical value, as it can help clinicians determining the
mechanisms triggering AF and choosing the most suitable therapy [47, 53]. Furthermore,
spatiotemporal mapping of AF organization could enhance recognition of wave patterns
and evaluate their correlation with atrial functional and structural properties [94].
Several attempts at quantifying AF organization have been made in previous studies.
However, most of them focus on endocardial recordings, which are invasively acquired
and mainly provide quite a local perspective of heart electrical activity [21, 48]. Other
works [4, 18, 150] have rather explored surface recording properties so as to assess AF
complexity noninvasively. Nevertheless, analysis is usually led in only one ECG lead,
therefore potential clinical information from other leads could not be taken into account.
Yet in [19] it has been demonstrated that atrial spatial variability manifests itself, and
thus can be measured, on surface recordings. AF variability has been explained not only
according to its temporal evolution, namely, in terms of the temporal repetitiveness of
its pattern, but also by taking into account its spatial distribution over heart substrate,
which can be easily observed on surface ECG signals, due to the different locations of
recording electrodes.
So far, information about AF organization and its intrinsic variability has not been
directly exploited for assessing AF therapy effects, in particular CA outcome. In fact, we
could expect that CA treatment could influence the degree of pattern complexity when
converting AF to SR or other more organized arrhythmia (for instance, AFL). Conversely,
we could also suppose that more variable and irregular atrial waveforms hint more complex
in-depth phenomena, which are more difficult to be treated by CA, whose effectiveness
strongly depends on the correct detection of AF sources.
In the light of these considerations, this chapter tries to shed some light on spatio-
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temporal variability (STV) of AF as assessed on the 12-lead ECG and investigate its links
with AF therapy outcome. Henceforth, after an overview about classical methods for STV
characterization in Sec. 5.2, we develop our multilead framework and their application
to CA outcome prediction in persistent AF. Several multivariate techniques have been
investigated for characterizing AF STV content in CA outcome prediction, with particular
attention to PCA, weighted PCA (WPCA) and nonnegative matrix factorization (NMF)
in Sec. 5.3, Sec. 5.4 and Sec. 5.5, respectively. Some general conclusions about AF STV
investigation are drawn in Sec. 5.7.
5.2 Motivation and links with AF organization
Since a unified definition of AF organization has not been given yet, this concept has
been widely employed to characterize different but complementary properties of heart
electrical activity during AF, such as the repetition rate of atrial activations, correlation
among atrial electrograms, and the level of morphology similarity of waveforms recorded
at several atrial sites [94].
Measures of STV content have been mainly applied to classification of AF organi-
zation into different categories after visual inspection of waveform size, shape, polarity,
amplitude, and beat-to-beat intervals, first observed on atrial electrograms (AEG). The
degree of organization of AF wavefronts propagating inside the atria has been tradition-
ally examined on intracardiac recordings. In [161] bipolar atrial electrogram signals have
been classified on the basis of the AEG morphology and the nature of its baseline into 4
types, presented in Sec. 3.3.5. The same section also recalled another classification system
widely employed in clinical centers and put forward in [78], based on the evaluation of
AF frequency and irregularity by means of high resolution epicardial mapping of the RA
free wall, as well as the incidence of continuous electrical activity and reentry.
As stated in Sec. 3.3.3, other models also tried to explain AF activity as the result
of interactions between multiple wandering atrial wavelets [111]. Further studies have
then confirmed the potential role of pulmonary veins (PVs) as an important source of
spontaneous electrical activity initiating AF [62, 69].
The need for a systematic and quantitative evaluation of AF organization has prompted
the development of several mathematical tools. As a consequence, different criteria and
measures have so far been proposed for assessing this characteristic of AF pathology. The
rationale is to investigate evidence of some underlying structure in atrial activity during
AF. The wide variety of methods proposed in the literature makes it difficult to compare
and interpret such indices.
In [21] the level of spatial correlation between multiple activation sequences is cor-
related with AF presence, and enables selection of antiarrhythmic drug therapy for SR
maintenance. In [48], AF morphology characterization based on PCA and automatic
clustering provides a quantitative tool for AF classification. The study described in [123]
also proposes more advanced techniques for feature extraction and SVM-classification to
perform the same task. Other approaches focus on temporal regularity of atrial acti-
vations and assess AF complexity according to the level of beat-to-beat variability [95].
More recently, time-frequency analysis has been applied to intracardiac recordings for
paroxysmal AF analysis in [126]. Despite their effectiveness, such approaches are all inva-
sive. Furthermore, even though information provided by endocardial recordings is local,
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thus very accurate, in certain cases AF analysis could benefit from a wider perspective of
heart electrical activity, accounting for multiple sites and their interaction. Noninvasive
recordings can render a global vision of AF dynamics and noninvasively provide measures
of heart electrical activity. Some nonlinear measures based on sample entropy [130] com-
puted on surface ECG have also been exploited to predict spontaneous paroxysmal AF
termination [4]. This study also claims that more organized AF patterns as quantified by
this index predict AF termination by CEE. The main drawback of these indices is that
they are computed in only one ECG lead, thus potential information about AF complexity
provided by the remaining leads is not exploited.
Recent attempts to exploit ECG spatial properties have been made in [150] by com-
bining frequency and complexity measures, in order to discriminate between persistent
and long-standing AF. Also, in [57] wavefront propagation maps extracted on BSPM
recordings have been used for visual classification of AF complexity types according to
Konings’ criteria [78]. This research prompted a quantitative multilead analysis in [18],
and underlines that AA spatio-temporal organization can be effectively represented by the
first few PCs determined by PCA, retaining most of the total variance, thus quantifying
the similarity between the principal subspaces of the AA signal along consecutive time
segments.
An attempt of assessment of AF therapy effects by means of complexity measures has
been subsequently performed in [19], which demonstrated that AF complexity estimated
in lead V1 decreases after CA performance. Nevertheless, analysis is still limited by the
single-lead perspective and therefore most of multilead ECG spatial content is not entirely
exploited. Furthermore, no correlation with procedural outcome has been demonstrated.
In this chapter we take a step from past works focusing on AF complexity in order
to outline this property in a multilead framework, thus stressing the descriptive power of
spatial diversity typical of standard ECG. Indeed, it is widely known that measures of
AF organization depict its level of chronification, which profoundly influences the choice
of the therapy. On the other hand, the therapy itself modifies the heart substrate, and
thus the degree of complexity of the arrhythmia, as confirmed by [60]. In this thesis
we show that therapy-induced changes are reflected on STV content as measured by our
noninvasive multilead indices. We also demonstrate that such indices, measured before
CA, can predict its outcome, hence they can be a useful tool for an improved patient-
tailored management of AF.
As stated in the previous section, PCA decomposition has already been applied both
to endocardial [48] and surface recordings for AF analysis [19, 57]. In Sec. 4.3 PCA
has been performed on standard ECG in order to describe f-wave amplitude spatial
distribution. Similarly, PCA could help estimating how AF organization is distributed
over heart substrate thanks to different lead locations. Such complexity can be ren-
dered by its temporal evolution along ECG recording, namely, by evaluating the de-
gree of temporal repetitiveness of signal patterns. To this end, we split the multi-
lead AA signal YAA in Eq. (4.1) in a fixed number S of equal-length segments (see
Fig. 5.1), each containing NS = [N/S] samples, so that YAA = [Y(1),Y(2), . . . ,Y(S)],
with Y(s) = [y((s − 1)NS + 1),y((s − 1)NS + 2), . . . ,y(sNS)], s = 1, . . . , S. We can
thus fix a reference segment r 6= s, so as to assess the persistence or repetitiveness of the
components of the AA signal Y(r) over the length of the whole recording.
In the next sections, some multivariate approaches for extracting STV content from
the AA signal are illustrated. We explain how such information can be mathematically
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Figure 5.1: Repartition of the multilead AA signal in segments for STV content extraction.
assessed on the 12-lead ECG, and results of their application to CA outcome prediction
in persistent AF are also provided and discussed.
5.3 Multilead STV predictors in the PCA frame-
work
Taking a step from [18], we assume that components of the reference segment r in the
ECG signal can be extracted by applying a linear transformation:
Y(r) = M(r)X(r) (5.1)
Subsequently, a fixed number n of columns M(r)n is extracted from the mixing matrices
M(r) computed by PCA in this reference interval. Such columns, the so-called principal
directions, weight the relative spatial contribution of the PCs to the ECG leads. After
these steps, AA signal is estimated in all other segments s 6= r by projecting Y(s) on the
subspace spanned by the columns of M(r)n computed in r, thus yielding:
Ŷ(s,r)n = M(r)n [M(r)n
TM(r)n ]
−1
M(r)n
TY(s) (5.2)
that is, the orthogonal projection of Y(s) on the span of M(r)n . In the light of these
considerations, we expect that the closer the estimation as defined in Eq. (5.2) to the
reference signal, the more persistent this atrial component throughout the recording, thus
suggesting a sort of repetitiveness of the pattern, hence a higher level of organization.
Therefore, the approximation quality can be generally evaluated by means of the normal-
ized mean square error NMSE(s,r)` between the actual signal y
(s)
` (t) on the `th lead and its
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estimation ŷ(s,r)`,n (t):
NMSE(s,r)`,n =
sNS∑
t=(s−1)NS+1
[y`(s)(t)− ŷ(s,r)`,n (t)]2
sNS∑
t=(s−1)NS+1
[y(s)` (t)]2
(5.3)
with ` = 1, · · · , L. In [18] it was shown that more organized AA waveforms needed fewer
PCs to be approximated with an adequate level of accuracy. Consequently, for sufficiently
low values of n, an inverse relationship between NMSE and AF organization was remarked,
since the higher the NMSE value, the more disorganized AA. That study investigated the
recurrence of the components related to the first segment, therefore the mean NMSE
is computed by setting r = 1, and averaging Eq. (5.3) over the remaining segments
(s = 2, . . . , S). Nevertheless, this index has been computed in only one fixed ECG
lead, V1, which exhibits the largest atrial-to-ventricular amplitude ratio, as previously
stated [129]. Yet its proximity to the right atrial free wall may neglect useful information
about other sites, in particular the left atrium and the PVs, which play a crucial role in
AF initiation and maintenance [62]. This observation prompts us to consider other leads
in order to yield a global view of AA evolution.
5.3.1 Combination of NMSE indices in a multilead framework
After PCA performance, we investigate how to properly combine NMSE values com-
puted on each ECG lead so as to extract predictive information about AF therapy out-
come. To overcome issues affecting previous studies, we propose computing the mean
value µ`,n and the standard deviation σ`,n of NMSE(s,r)`,n values over all possible combina-
tions of estimated and reference segments (s, r), for each lead ` [101]. Index µ`,n offers a
global perspective of segment estimation performance, whereas σ`,n gives a measure of AF
inter-segment variability along the recording. Contributions from the L leads analyzed
are thereby combined into the interlead NMSE weighted sum:
µ˜PCAL =
L∑
`=1
µ`,n
σ2`,n
/ L∑
`=1
1
σ2`,n
(5.4)
whose weights are represented by NMSE inverse variance values 1
σ2
`,n
per lead; contribu-
tions coming from ECG leads rendering more regular and less dispersive patterns are thus
considered to be more relevant. A further interpretation of σ`,n can be given in terms of
uncertainty: low standard deviation values render a more stable reconstruction across time
segments, whereas high values denote higher projection error uncertainty. Accordingly,
leads guaranteeing a more robust AA content characterization have a stronger influence
in the computation of the output descriptor. The choice of such weights can be further
justified if we assume that the complexity information is reflected on the ensemble of
ECG leads as a set of independent random variables. The best linear minimum-variance
unbiased estimator of the complexity descriptor will thus be given by the weighted mean
of Eq. (5.4) [75]. As a result, greater weight is given to values coming from lower-variance
distributions. The flow chart in Fig. 5.2 summarizes the main processing stages of our
method.
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Figure 5.2: Diagram flow chart of the algorithm returning the inverse-variance weighted
mean µ˜PCA8 as a CA outcome predictor.
5.3.2 Setting the NMSE tuning parameters
Some parameters of the NMSE index need to be set prior to its computation, namely,
the number S of AA segments which need to be processed, and the number of spatial
topographies n retained for AA signal estimation. In particular, the choice of the adequate
number of segments S must be accomplished by keeping their length NS sufficiently high
for AF pattern analysis. Accordingly, we investigated how the proposed NMSE index
µ˜PCAL varies when changing S value. The number of samples per segment NS is kept
constant and equal to a specific value from the set NS = [1000200030004000]. The
corresponding evolution is displayed in Fig. 5.3. The feature keeps quite a constant value
when S increases, thus proving its robustness to the choice of this parameter. In Fig. 5.3
we also examine how this measure varies as a function of NS instead, once set the number
S of segments. Also in this case the NMSE-based predictor proves its robustness to tuning
parameters, since its variations are quite limited (below 10%) when S varies, regardless
of the number of segments examined. In the light of this experimental evidence, a unique
number of segments S has been set for all patients so as to generalize algorithm tuning.
Findings illustrated in Sec. 4.4.3 show that not only that the dominant PCA source
retains the most of the AA global variance, but that it is also able to explain the most
relevant components to CA outcome prediction as proved by the decreasing trend of the
AUC index as a function of the truncation rank n shown in Fig. 4.5 in Sec. 4.4.3. Further
experimental results are presented later in the chapter and support the choice of setting
n = 1, so the corresponding subscript will be omitted in the sequel for convenience. Only
the subscript PCA is kept as a reference to the type of decomposition applied (for further
comparisons with other techniques in the following sections), as well as the one indicating
the number of leads L employed (either L = 8 or L = 12).
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Figure 5.3: Evolution of the inverse-variance weighted mean µ˜PCAL as a function of NMSE
tuning parameters. (Left): the number of segments S, for a fixed number NS of samples
per segment. (Right): the number NS of samples per segment, for a fixed number S of
segments. The index is determined on the rank-1 (n = 1) approximation to the 8-lead
AA signal (L = 8).
Table 5.1: PCA characterization of STV content: interpatient statistical analysis and CA
outcome prediction performance (n.u.: normalized units).
AF termination Non AF termination p value AUC Sensitivity Specificity Best cutoff
µ˜PCA8 [n.u.] 65.68± 19.27 37.59± 21.88 0.0082 0.84 0.77 0.86 45.57
µ˜PCA12 [n.u.] 65.85± 28.41 44.09± 27.49 0.12 0.76 0.85 0.71 45.57
NMSEPCA8 [n.u.] 45.56± 26.93 30.35± 26.93 0.19 0.64 0.77 0.71 49.03
NMSEPCA12 [n.u.] 67.80± 22.11 80.73± 14.48 0.18 0.69 0.69 0.57 69.00
D(V1) [mV] 0.08± 0.03 0.06± 0.01 0.03 0.80 0.62 0.86 0.05
SampEn(Ls, r(A)s ) [n.u.] 2.82± 0.39 3.06± 0.43 0.21 0.70 0.62 0.86 3.12
SampEn(Ls, r(B)s ) [n.u.] 2.42± 0.38 2.66± 0.43 0.20 0.70 0.62 0.86 2.73
SampEn(Ls, r(C)s ) [n.u.] 2.14± 0.37 2.39± 0.42 0.20 0.70 0.62 0.86 2.44
AFCLV1 [ms] 139.63± 19.66 121.75± 23.83 0.09 0.71 0.62 0.71 129.87
5.3.3 Methods and results
The 20-patient dataset described in Sec. 3.5.5 has been employed for assessing the
prediction significance of our method. In our experimental framework, AF was successfully
converted to SR or other arrhythmia in nS = 13 out of nP = 20 patients, whereas nF = 7
procedures were not effective. As shown in Fig. 5.4, the spatial distribution of the single-
lead mean error NMSE, averaged over all patients on every ECG lead, underlines how
irregular CA outcome prediction is and how strongly it depends on electrode selection.
Hence, we demonstrate that a more robust and reliable prediction performance can be
provided by a multi-lead approach. In Fig. 5.4 single-lead prediction performance is
assessed by the AUC index as well. For the sake of comparison, the same setting parameter
values as for µ˜PCA8 are adopted. We also verified how CA outcome performance is affected
by variations in the value of the PCA approximation rank n; results are displayed in
Fig. 5.5.
As displayed in Table 5.1, categories under examination are referred to as “AF termi-
nation” and “Non AF termination”. All parameters are expressed as mean ± standard
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deviation. Once verified the kind of data distribution, differences between successful and
failing CA procedures were statistically determined by a suitable unpaired test. The p
values output by each unpaired test are obtained under a confidence level α = 0.05,
and are also reported in the same table. Binary classification accuracy of each feature is
quantified by the AUC index. Furthermore, the optimal cutoff discriminating between the
two groups of patients and the related values of sensitivity and specificity are indicated.
The proposed predictor µ˜PCA8 is compared with its 12-lead counterpart µ˜PCA12 . With
reference to Eq. (5.3), some single-lead NMSE measures are also determined in V1 for
both groups of ECG leads, namely, NMSEPCA8 and NMSEPCA12 , as explained in [18].
The non-linear index of AF complexity based on sample entropy presented in [5] is also
computed in the same ECG leads. The length Ls of the signal sequences to be compared
is set to 2, whereas the threshold of sequence similarity is equal to a fraction of AA signal
standard deviation in V1, σV1 (r(A)s = 0.1σV1 ; r(B)s = 0.15σV1 ; r(C)s = 0.2σV1).
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Figure 5.4: Single-lead mean NMSE as a predictor of CA outcome. (Left) Mean and
standard deviation of the NMSE value µ`, ` = 1, . . . , L (averaged over the whole AF
database) as a function of the ECG lead selected. (Right) AUC index describing the AA
single-lead NMSE CA outcome prediction performance as a function of the ECG lead
selected.
5.3.4 Results and discussion
The discriminative power of the NMSE-dependent parameters presented in the pre-
vious section is corroborated by experimental results. The most relevant contribution
is to demonstrate the superiority of multilead strategy over standard single-lead NMSE:
the inspection of NMSE spatial distribution can provide a more complete outlook of AF
evolution on the heart substrate. Fig. 5.4 shows how the single-lead mean NMSE is
strongly affected by the lead chosen. This variability is also confirmed by the spatial
distribution of its variance, displayed in the same figure. Accordingly, CA outcome pre-
diction performance is also affected by this choice, as highlighted by the AUC index trend
in the same figure. This result supports the idea of combining all these contributions in a
unique parameter offering a more global perspective of AF activity. In the weighted mean
µ˜PCA8 every single-lead contribution is weighed in terms of spatio-temporal dispersion.
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Figure 5.5: AUC values describing µ˜PCA8 prediction performance as a function of the rank
n of the WPCA decomposition.
Indeed, NMSE variance can be exploited as a lead selector: it detects the ECG lead
providing the most stable and accurate signal reconstruction. It is worth noting that
NMSE inter-segment variance can quantify the spatio-temporal degree of repetitiveness
of the AA wavefront pattern: the higher NMSE dispersion among segments, the more
complex and unpredictable AF pattern evolution.
PCA capability of representing AA by compressing its content into very few PCs is
also confirmed by experimental evidence in Fig. 5.5, which supports our technical choice
of n value. µ˜PCA8 have been computed by varying the number of PCs n, which ranges
from 1 (the value set for our algorithm) to 8 (full-rank decomposition, i.e., the original
AA data without approximation). The quality of CA outcome prediction considerably
worsens when increasing the truncation rank n. The fewer PCs employed in the decom-
position, the better the classification performance, as if the dominant PCs preserved the
discriminative power of the complexity index. Indeed, noisy and/or redundant elements
are typically ascribed to the very last PCs, while preserving the most representative
features of the AA signal. It it worth noting that this experiment has returned a similar
result in Fig. 4.5 in Sec. 4.4 when characterizing f-wave amplitude, thus demonstrating
once more that reduced-rank PCA approximations to AA signal can effectively retain the
most discriminant components for CA outcome prediction.
Classification performance of multilead CA predictors proves to be more accurate when
reduced-rank approximations are computed on the subset of 8 independent leads rather
than the whole standard ECG. This is in line with results reported in Sec. 4.4. Hence,
the higher predictive power of the index µ˜PCA8 , which outperforms its 12-lead counterpart
µ˜PCA12 .
CA outcome prediction quality of our multilead descriptor of AF STV content is char-
acterized by a higher degree of accuracy compared with traditional single-lead measures
of AF complexity. Concerning single-lead AF complexity measures determined by PCA
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on different sets of ECG leads, i.e., NMSEPCA8 and NMSEPCA12 , not only statistically
significant interpatient differences cannot be remarked, but AUC values related to their
discrimination capability are also extremely low. These results could be explained by the
limited outlook of single-lead complexity measures, which ignore interlead relationships.
Relevant information from other electrodes is neglected, thus reducing discrimination
capabilities. Furthermore, as lead V1 is close to the right atrial free wall, there is the risk
of ignoring useful information about other important anatomical areas, such as the left
atrium and the PVs, which play a crucial role in AF initiation and maintenance [62], but
do not reflect in V1 with the same degree of significance as RA does. Also, concerning
nonlinear AF complexity indices such as sample entropy, no statistically significant inter-
class differences can be remarked, regardless of the values of tuning parameters. Not only
sample entropy index is affected by the same shortcomings typical of the other single-lead
features, but its parameters need to be fine-tuned prior to its computation.
Analysis of the AA amplitude as rendered by D(V1) arouses different remarks. Ac-
tually, we can notice the satisfactory ability to distinguish between successful and failing
ablations, as well as the effective reproduction of results manually reported in previous
works using a different persistent AF database [121]. Even though this descriptor can ef-
fectively capture AA signal amplitude characteristics if the pattern is sufficiently regular
and f-waves are easily detectable, interpolation operations can be hampered by residual
spurious peaks or very irregular patterns. What is more, no information about AF STV
is provided by this feature. The study led in [98] assesses the predictive role of AFCL
measured on surface ECG for CA of persistent AF. However, its measure is affected by a
lack of reproducibility and prediction reliability of its measure, as it is usually manually
acquired. Moreover, no significant differences are pointed out by this predictor in V1,
denoted AFCLV1 . Finally, correlation between ECG-based parameters and intracardial
measures of AFCL has not been confirmed in some studies [67].
One of the main shortcomings of our research is the impossibility to demonstrate
the correlation between the NMSE-based predictor proposed and AF spatio-temporal
organization, due to the lack of simultaneous invasive recordings. Such a connection can
only be hinted at by the results presented in [18], which demonstrated such correlation
in V1. Accordingly, the potential connection with CA outcome and AF organization by
means of our multilead characterization of the NMSE index should be further investigated.
5.4 Moving to the weighting perspective in the
WPCA framework: weighted principal compo-
nent analysis for STV quantification
As mentioned in the previous section, a possible strategy for processing multivariate
standard ECG consists in searching for a reduced set of uncorrelated components retain-
ing as much of its spatial variability as possible. To this goal, PCA has been widely
applied to the ECG, due to its non-parametric nature, simplicity for implementation
and versatility [29, 72, 131, 142]. Nevertheless, PCA is not always recommended in ECG
processing. As it gives the same relevance to all observations, the low-rank approximation
can be sensitive to outliers and become unstable. This issue affects every decomposition
method based on the minimization of a criterion function in the ordinary least squares
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(OLS) sense. Accordingly, in this section we explore another multivariate decomposition
technique, referred to as weighted principal component analysis (WPCA), in order to
improve the robustness of reduced-rank data representation and exploit its properties for
CA outcome prediction [105].
5.4.1 WPCA decomposition
The AA signal is processed as described in Sec. 5.2. Accordingly, we split the AA signal
in S segments so as to quantify STV properties. Instead of classical PCA, the WPCA
technique is thus applied to each reference segment Y(r) by minimizing a weighted least
squares (WLS) loss function [66] as described next. Hence, each entry of the input matrix
Y(r) is separately weighted with a fixed, nonnegative quantity. These leveraging factors
can be collected in a matrix W(r) having the same dimensions as Y(r). The WLS loss
function can be expressed as:
h(Ŷ(r)|Y(r),W(r)) = ‖(Y(r) − Ŷ(r)) ∗W(r)‖2F =
L∑
`=1
N∑
t=1
[w`(t)(r)(y`(t)(r) − ŷ`(t)(r))]2 (5.5)
where ∗ stands for the Hadamard (or elementwise) product, whereas the operator ‖·‖F
represents the Frobenius norm. As in classical PCA, some orthogonality constraints are
applied to M(r) and X(r) defined in Eq. (5.1) in order to reduce model ambiguities.
5.4.2 Definition of the weight matrix
Special attention must be paid to the assignment of the weights collected in matrix
W(r). Indeed, an accurate choice of these values can give rise to a kind of filtering action
which enhances not only the leads, but also the time samples giving the most meaningful
contributions, while neglecting those that do not yield significant information or can
pollute atrial observations. In the context of our application, temporal samples in each
segment on the same lead are all equally treated, as we merely focus on intersegment and
interlead variability. On the other hand, we aim to emphasize leads exhibiting a more
stable and regular waveform while reducing the influence of those characterized by higher
temporal dispersion, quantified in terms of energy. We assume that the input signal Y(r)
can be modeled as:
Y(r) = Y(r)S +Y
(r)
N (5.6)
namely, as the sum of a content-bearing component Y(r)S (describing AF activity in our
application) and a noisy component Y(r)N , due not only to data acquisition noise, but
also to elements discarded by the low-rank WPCA-approximation. We assume that the
high dispersion level affecting the term Y(r)N = (Y(r)−Y(r)S ) can alter or hide informative
elements coming from YS in each lead. This term can be regarded as the argument
Y(r) − Ŷ(r) of the WLS criterion defined in Eq. (5.5) to be minimized according to the
algorithm described afterward. To this end, each lead is weighted by the inverse of AA
signal variance, thus reducing the influence of high-energy electrodes. More precisely,
each row of W(r) is weighed by the inverse of the standard deviation σ(r)` associated with
the corresponding lead ` = 1, . . . , L in Y(r) and computed on each segment r = 1, . . . , S:
W(r) = [(σ(r)1 )
−1
(σ(r)2 )
−1
. . . (σ(r)L )
−1
]T1 (5.7)
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Figure 5.6: Evolution of µ˜WPCA8 as a function of the number of segments S.
where 1 is a row vector with N unit entries. According to this definition, standard PCA
is a special case of WPCA, where W(r) is the unity matrix, i.e., a uniform weighting
scheme. Once a weight matrix has been chosen, WPCA can be carried out by following
the algorithm steps summarized in the Appendix A.2. Each reference segment r is thus
processed in keeping with the WPCA model from Eq. (5.1). Then, STV feature extraction
is accomplished as explained in Sec. 5.3, thus yielding the predictor µ˜WPCA8 defined in
Eq. (5.4) at the final step. It is worth noting that AA signal reconstruction is influenced
by the choice of the weight matrixW(r), thus the output value of the predictor will change
in turn according to the weights selected. The predictive value of different forms of W(r)
will be tested in Sec. 5.4.5.
5.4.3 Choice of NMSE characteristic parameters
As in Sec. 5.3.2, NMSE requires an a priori tuning of algorithm parameters. In line with
conclusions drawn for STV characterization through PCA in Sec. 4.4.1, an approximation
of rank n = 1 has been applied to the AA signal, divided in S = 4 time intervals. This
setting is motivated by results describing how the STV descriptor µ˜WPCA8 is influenced
by the values of S and Ns as for PCA, displayed in Fig. 5.6 and Fig. 5.7, respectively.
Variations in this feature as a function of these parameters are quite limited, thus justifying
application of our setting to the whole AF database.
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Figure 5.7: Evolution of µ˜WPCA8 as a function of the number of samples per segment NS.
5.4.4 WPCA computational load
As WPCA is an iterative algorithm (described in Appendix A.2), a stopping criterion
has been introduced, that is to say, the converge tolerance  = 10−5. In order to assess
WPCA computational load, the number of iterations for convergence and the final value
of WLS convergence criterion C∗ (defined in Eq. (7) in Appendix A.2) are determined for
a fixed NS value. These values are first computed on each segment s = 1, . . . , 4 and then
averaged over the 20-patient database presented in Sec. 3.5.5. Test results are reported in
Table 5.2. We can remark that both parameters do not significantly vary when changing
the segment to be processed, and that computational burden is relatively low in terms
of iterations. A similar result is obtained when considering variations in the number of
samples per segment NS. This further evidence supports the robustness of our method
to the choice of tuning parameters, and guarantees its convergence to solution.
5.4.5 Analysis of CA outcome prediction through WPCA and results
The predictive power of the STV features determined by means of WPCA are tested
on the 20-patient database aforementioned. Our 8-lead descriptor µ˜WPCA8 is compared
with its 12-lead counterpart µ˜WPCA12 . Results of the unpaired statistical test are reported
in Table 5.3. AUC analysis results are validated by means of the LOOCV technique
and are also herein indicated. Fig. 5.8 plots the AUC values describing the classification
performance of µ˜WPCAL as a function of the number L of leads retained in the analysis.
For each value of L ranging from 2 up to 8, µ˜PCAL value has been computed for all
8!/((8 − L)!L!) possible ensembles of leads. CA outcome prediction performance has
5.4. Moving to the weighting perspective in the WPCA framework:
weighted principal component analysis for STV quantification 88
Table 5.2: Assessment of WPCA convergence characteristics. (Top) Average number of
iterations for convergence, with the stop threshold  = 10−5. (Bottom) Average final
value of WLS convergence criterion C∗ (Eq. (7) after convergence, with  = 10−5, [n.u.]).
Criterion values normalized by a scaling factor equal to 10−6.
HHHHHHNS
s 1 2 3 4
Average number of iterations
1000 96 84 114 93
2000 92 100 92 96
3000 84 90 92 103
4000 85 98 101 112
C∗
1000 9.0 8.8 9.1 8.9
2000 8.8 9.0 8.6 9.2
3000 8.6 9.1 9.1 8.7
4000 9.0 8.9 8.9 9.0
Table 5.3: Long-term CA outcome prediction through the WPCA decomposition: inter-
patient statistical analysis and ROC assessment (n.u.: normalized units).
AF termination Non AF termination p value AUC Sensitivity Specificity Best cutoff
µ˜WPCA8 [n.u.] 70.76± 17.74 37.54± 20.01 0.0013 0.91 0.85 0.71 40.64
µ˜WPCA12 [n.u.] 63.03± 18.12 61.64± 20.87 0.88 0.47 0.62 0.43 53.76
then been assessed for each lead combination from the corresponding values of µ˜WPCAL ,
and validated by the LOOCV technique. As already done in Sec. 4.4.3, for each size L,
the minimum, maximum and mean AUC values over all L-lead subsets are obtained as
a function of the subset dimension L, and their related ranges of values are displayed
in Fig. 5.8. The lead combinations with the best prediction performance for each subset
dimension are shown in Table 5.4. The same type of analysis is performed on the descriptor
µ˜PCAL obtained after PCA data approximation for sake of comparison. The case L = 1
has been excluded from this test, since in this case the method is equivalent to single-lead
analysis.
In our application, we deal with multivariate decomposition techniques based on the
maximization of the variance of the AA signal, conveying information about AF spatio-
temporal distribution. Consequently, another crucial point of our investigation is under-
standing how these techniques act on AA signal energy content. More precisely, the input
Table 5.4: ECG lead subsets with optimal prediction performance of µ˜PCA8 and µ˜WPCA8 .
Number of leads (L) Leads (PCA) Leads (WPCA)
2 I, V1 I, V1
3 V3, V4, V6 I, II, V2
4 V1, V3, V4, V6 I, V2, V3, V5
5 [II, V2, V3, V4, V5] [I, II, V2, V4, V5][V2, V3, V4, V5, V6] [I, II, V1, V3, V6]
6 I, V2, V3, V4, V5, V6 I, II, V2, V3, V4, V6
7 [I, II, V1, V2, V3, V4, V6] I, II, V1, V2, V3, V4, V5[I, II, V1, V2, V3, V5, V6]
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Figure 5.8: AUC values characterizing µ˜WPCAL prediction performance as a function of
the size L of the subset of the 8 independent ECG leads (S = 4, n = 1). WPCA: rank-1
decomposition of the atrial signal in the ECG lead subsets according to the WPCA model;
PCA: rank-1 decomposition of the atrial signal in the ECG lead subsets according to the
PCA model.
AA signal variance has been computed on each ECG lead, thus obtaining the components
of atrial power distribution forming the vector σ2AA = [σAA21, σAA22, . . . , σAA2L]T , with L = 8.
Effects of the multilead weighting scheme on the decompositions of AA observations are
also compared to those obtained by standard PCA. The rank-1 approximations Ŷ are
computed by WPCA and PCA and averaged over all patients. The resulting power
distribution vectors σ2WPCA and σ2PCA are plotted in Fig. 5.9. Following this line, this
evaluation has been accomplished in the framework of CA outcome prediction as well.
In particular, we tested whether AA signal energy σ2AA associated with each lead can
effectively perform as a predictor of the ablation result; hence, the quantification of their
classification accuracy on each ECG lead by means of the AUC criterion, whose values
are displayed in Fig. 5.10. The same analysis is led on the energy values computed on
the rank-1 approximations output by PCA and WPCA, σ2PCA and σ2WPCA, respectively,
resulting in the AUC values also plotted in Fig. 5.10. Effects of WPCA truncation on CA
outcome prediction are also assessed by the AUC criterion, whose evolution as a function
of the decomposition rank n is plotted in 5.11. Finally, further tests confirm the validity
of the model introduced in Eq. (5.6) by assessing CA outcome prediction performance on
the basis of different definitions of the weight matrix W(r) and comparing analysis results
in Sec. 5.4.6.
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Figure 5.9: Effects of the multilead weighting scheme on AA reconstruction. σ2AA: vari-
ance of the input AA signal per lead; σ2PCA: variance per lead of the rank-1 AA signal
approximation by PCA; σ2WPCA: variance per lead of the rank-1 AA signal approximation
by WPCA.
5.4.6 Discussion
As for PCA, CA outcome prediction quality improves when the subset of 8 independent
ECG leads is processed, in agreement with results in Table 5.3. The proposed index
µ˜WPCA8 is able to discriminate between the groups of interest and outperform its PCA
counterpart, thus proving the benefits of our a priori knowledge about atrial observations
in the form of the weights used in WPCA. For both decomposition techniques, Table 5.4
displays the ensemble of leads which best help discriminating between successful and
failing CA procedures based on the maximization of the AUC criterion. Except for the
case L = 2, we can note that for a fixed subset size L the leads involved in the prediction
change with respect to the method applied. As far as WPCA is concerned, lead V1 does
not generally provide the main contribution to CA outcome prediction. In fact, other
leads, such as I, II, V2, recur more frequently. This evidence is in contrast with standard
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Figure 5.10: Assessment of CA outcome prediction performance of single-lead energy
descriptors. σ2AA: energy per lead of the original AA signal; σ2PCA: energy per lead of
the rank-1 AA signal approximation by PCA; σ2WPCA: energy per lead of the rank-1 AA
signal approximation by WPCA.
medical practice, and it can be probably explained by the placement of lead V1, not close
enough to critical sites responsible for AF genesis and maintenance, such as the PVs and
LA, commonly acknowledged as potential AF sources. This seems to be confirmed by the
recurrence of at least one lead close to the left side of the heart in each L-size subset, for
instance, V5 and V6. Moreover, we can note the simultaneous presence of at least one
limb lead and one horizontal lead in each L-sized subset, in contrast with PCA, since some
groups contain Wilson’s leads exclusively. It turns out that the use of leads representing
heart electrical activity on multiple planes improves prediction accuracy, which is further
enhanced by the selective action of the WPCA weighting scheme.
On further analysis, AA standard deviation measured on each ECG electrode proves
to be a reliable index, since it does not only weights AF temporal dispersion, but it is
also a statistical measure of uncertainty. Indeed, if AA patterns on certain leads are
excessively irregular and/or variable, the corresponding inverse standard deviation values
automatically reduce their influence. This selective action seems to boost the compression
power of the decomposition. More specifically, the effect of possible redundancies is
already reduced before computing the iterative minimization algorithm by selecting the
8 linearly independent ECG leads, so that the most discriminant AA components are
put into evidence more easily. In Fig. 5.8 the AUC criterion quantifies the classification
performance of µ˜WPCAL and µ˜PCAL as a function of the number of ECG leads L exploited
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Figure 5.11: AUC values describing µ˜WPCA8 prediction performance as a function of the
rank n of the WPCA decomposition.
for the prediction selected among the 8 independent leads. Classification results obtained
using WPCA in terms of mean AUC outperform those by PCA, especially as size L
increases. This figure also confirms the benefits derived from the spatial variability of the
standard ECG. The higher the number of leads employed, the more accurate CA result
prediction, assessed by higher mean AUC values.
Further advantages derived from the weighting framework are displayed in Fig. 5.9.
First of all, it can be noticed that the trend of σ2WPCA values is very similar to that of σ2AA.
In addition, σ2WPCA values are closer to σ2AA than those obtained when performing classical
PCA (σ2PCA), thereby quantifying a lower error of reconstruction of the original data for the
same approximation rank. Energy values obtained after AA signal approximation, either
by PCA or WPCA, are lower than those computed directly on input data because of the
low-rank representation effect. It can be inferred that WPCA can better preserve energy
content of the AA signal and condense it more efficiently in a single, maximum-variance
PC than conventional PCA. Differences between these decompositions in terms of the
amount of information retained by the rank-1 approximation are particularly evident in
V1 and V2, which represent the reference leads for AF analysis in medical practice, owing
to their proximity to the RA. Note how WPCA significantly enhances, in an automated
fashion, the relevance of these leads in the AA signal decomposition. The use of these
energy-descriptors in single-lead prediction does not provide satisfactory results, as shown
in Fig. 5.10. Indeed, their prediction performance is poor, and also highly dependent on
the lead considered. In general, these results confirm the need for an adequate combina-
tion of atrial signal contributions from different ECG leads in a more robust multilead
framework, capable of filtering out uninformative AA signal features and exploiting ECG
spatial variability. However, the importance of their contribution is significantly reduced
when applying PCA, thus losing relevant information about AF energy content in the as-
sociated heart sites. By contrast, the WPCA scheme can effectively improve CA outcome
prediction by reinforcing the most discriminative features of input data thanks to the a
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priori knowledge about AA signal energy distribution.
In line with results presented in Sec. 5.3.3, Fig. 5.11 proves that ablation outcome
prediction considerably benefits from low-rank representation of AA data. As for PCA,
AUC values related to the index µ˜WPCA8 have been computed by varying the number
of PCs n retained in the WPCA truncation in Eq. (5.2) from 1 (the value set for our
algorithm) to 8 (full-rank decomposition, i.e. original data). The lower n, the more
accurate prediction performance, especially when retaining less than 5 PCs prior to WPCA
application. The first dominant source seems to contain the most meaningful components
of the AA signal, whereas the effect of noisy and/or redundant elements ascribed to the
very last PCs is negligible. Also this evidence is consistent with results obtained on f-wave
amplitude in Sec. 4.4.3.
Experimental results corroborate the validity of the weighting model adopted, as-
suming the inverse-standard deviation values as W(r) weights as explained in Sec. 5.4.2.
Conversely, other weighting schemes are not able to give comparable classification re-
sults. For instance, the weight matrix depending on AA standard deviation values per
lead W(r) = [σ(r)1 , σ
(r)
2 , . . . , σ
(r)
L ]T1 does not manage to properly emphasize ECG lead
contributions, thus showing a weak predictive power (AUC= 0.53, p value= 0.98). These
results corroborate our AF model, as AA maximum-power components seem to selectively
enhance the most informative contributions by means of the weighting structure. Another
strategy consists in giving more weight to leads better explained by a reduced-rank PCA
approximation, thus defining W(r) elements as a function of the inverse value of standard
deviation of the error between original data and rank-1 PCA approximation per lead
(W(r) = [(σ1(r)N )−1, (σ2
(r)
N )−1, . . . , (σL
(r)
N )−1]T1). However, no significant differences be-
tween effective and failing CA procedures have been found (AUC= 0.67, p value= 0.69).
In other tests, we hypothesize that W(r) components depend on the value of the standard
deviation itself (W(r) = [σ1(r)N , σ2
(r)
N , . . . , σL
(r)
N ]T1), although, similar results are obtained
(AUC= 0.63, p value= 0.37). This leads us to conclude that focusing on noisy components
that may be present in the AA signal does not actually improve the selective action of the
weighting scheme, whereas considering variance of the whole signal gives more emphasis
to its most informative components, thus improving prediction accuracy.
5.4.7 Conclusions
Similarly to the PCA-based method, STV characterization in the presence of AF by
means of the WPCA technique is affected by the lack of knowledge about AF spatio-
temporal organization as claimed by standard clinical criteria, for instance those defined
by Wells’ and Konings [78, 161]. As a consequence, in this dissertation STV discrim-
inative power in CA outcome prediction can be effectively assessed, but its link with
clinical significance of AF spatio-temporal complexity needs to be more deeply explored.
Further attention should also be paid to the implementation modalities of the WPCA
weight matrix W. Roughly speaking, even though this approach proves to be robust
and appropriate for the application of interest, alternative computational strategies could
be conceived for a deeper comprehension of AF electrophysiology. Despite these short-
comings, the methodology illustrated is able not only to effectively quantify STV of AF
pattern by exploiting the multivariate character of standard ECG, but also to exploit such
diversity as a tool for predicting CA outcome in persistent AF in the long-term follow-up.
Compared with conventional PCA, WPCA is able to better capture the spatial variabil-
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ity typical of multilead recordings by automatically enhancing the most bearing-content
ECG leads from an appropriate subset of standard ECG while reducing the influence of
not significant or highly dispersive contributions, thus remarkably improving prediction
accuracy.
5.5 Multilead STV measures on standard ECG in
the nonnegative matrix factorization frame-
work
In the applications described until present, STV information has been extracted from
standard ECG and quantified in terms on NMSE between the original AA signal and
its rank-1 approximation determined by means of a suitable multivariate decomposition
strategy. Temporal variability of AF components is explored by dividing the input AA
signal in a fixed number of segments. ECG leads’ contributions are adequately combined in
a unique score acting as a predictor of procedural AF termination. Such contributions are
represented by the single-lead intersegment mean NMSE value µ`,n and the intersegment
variance σ2`,n, rendering an outlook of global accuracy of AA signal estimation.
In this section we explore further strategies to represent NMSE indices and characterize
STV content. In particular, we provide an alternative form of arrangement of NMSE data
and compute their low-rank approximation by a nonnegative matrix factorization (NMF).
NMF application implies non-negativity constraints of processed data and has extensively
been used in areas as diverse as text processing, data mining and image processing, among
other application domains [84]. To our knowledge, this technique is applied for the first
time to ECG signal processing. Our aim is for predicting short-term AF termination by
CA. After an overview of the NMF technique, its application to real ECG data for acute
CA outcome prediction is presented, and an extension to long-term assessment is also put
forward. These results were first producted in [107].
5.5.1 NMF decomposition of the NMSE matrix and feature extraction
Under these assumptions, we attempt an alternative characterization of the NMSE val-
ues computed on the AA signal. Most of the theoretical contributions to NMF definition
take the study led in [12] as a reference. Indeed, as they are computed on multiple ECG
leads, we expect that they share some common underlying factors that may be estimated
by suitable signal decomposition techniques. Furthermore, in keeping with its definition
in Eq. (5.3), the NMSE index can never have negative values. Therefore, by exploiting this
property as a decomposition constraint, we can process NMSE data adequately arranged
by means of the NMF technique and then compute the reconstruction error between the
original NMSE data and their reconstruction as a STV measure of the AA signal across
the standard ECG. More specifically, the NMSE values can be arranged so as to form a
nonnegative matrix A with size
(
L× β
)
, where β = S(S − 1). Indeed, for each reference
segment r , r = 1, . . . , S, we can estimate all the remaining (S − 1) time intervals. Each
element NMSE(s,r)`,n is assigned to entry [A]`,(r−1)(S−1)+(s−1) if r < s, otherwise in entry
[A]`,(r−1)S+(s−1), for r, s = 1, 2, . . . , S, s < r. Therefore, matrix A contains the NMSE
for all leads for all the possible pairs of reference-estimated segments (r, s). Once set this
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input matrix, we can apply NMF, which yields the approximate rank-R factorization:
A ≈WH (5.8)
where W and H with size (L × R) and
(
R × β
)
, respectively, are the nonnegative fac-
tors, i.e., matrices with nonnegative entries, computed as the minimizers of the objective
function:
Ψ(W,H) =‖A−WH‖2F (5.9)
where ‖·‖F stands for the Frobenius norm. This formulation may allow for a more attentive
examination of the spatial distribution of the reconstruction error in each segment.
Several algorithms can be run to obtain NMF factors. Concerning our application, we
employ an alternating least squares (ALS) minimization algorithm. Accordingly, given one
of the 2 factors, the other one can be found with a simple LS computation. As reported in
the Appendix A.3, nonnegativity is insured by the projection step, which sets all negative
elements output from the least squares computation to 0. Not only this strategy is quite
fast, but it also enhances sparsity and allows for some additional flexibility, which helps
to avoid attraction basins of suboptimal spurious solutions.
Criterion (5.9) is also a measure of approximation quality. Thus, we can express
the root mean square residual (RMSR) between A and its reduced-rank representation
defined in (5.8) as:
RMSR =
√
Ψ(WH)
Lβ
(5.10)
can naturally be exploited as a multilead AA STV measure as reflected on the NMSE
array.
5.5.2 Setting the NMF approximation rank
One of the main critical points related to NMF performance is represented by the
choice on the approximation rank R, which is generally application-specific. Accordingly,
since we can regard the product WH as a compressed form of A, we decided to process
NMSE matrix my means of a rank-2 (R = 2) NMF approximation, since only this setting
highlighted statistically significant differences between the categories of interest among
all values ranging from 1 to (L− 1).
5.5.3 NMF Initialization
Another issue that must be taken into account is the iterative nature of the NMF
algorithm, which is therefore sensitive to initialization of factors W and H. Nearly all
NMF algorithms use random initializations that are simple to be implemented but often
provide unsatisfactory performance. A good initialization can improve decomposition
speed and accuracy, as it can sidestep some of the problems coming from convergence to
spurious local minima [84].
In our research we examined two initialization methods returning the matrices W0
and H0 as outputs. The first algorithm searches for the 2 leads (i.e., rows of the NMSE
matrix) presenting the maximum mean square value (MSV) of the NMSE index in A, in
line with the maximum-variance formulation of PCA. Just as PCA achieves the best rank-
R subspace approximation by maximizing the components’ variance, one could expect
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that the rows of A with maximal MSV may lie not too far from the NMF components
in H minimizing the objective (5.9). As a consequence, rows fulfilling these criteria form
H0. Concerning the other NMF factor, the initial value W0 is determined by the ALS
algorithm under the positivity constraint as:
W0 = AHT0 (H0HT0 )
−1 (5.11)
and then setting all its nonnegative elements to 0.
The second initialization strategy stems from the “concept vector” notion proposed
in [43]. This approach basically aims at partitioning input data into clusters, whose cen-
troids will form the unknown matrices. This strategy can be quite time-consuming when
processing high-dimensional data, which has led to several clustering variants looking
for a trade-off between compression and data content preservation. In line with [83], the
SVD output can be used to form cheap centroid basis vectors. Accordingly, we exploit the
singular value decomposition (SVD) ofA, given byA = USVT, to form the R-component
centroid basis vectors. These clusters can thus obtained by taking into account the low
dimension VT. Accordingly,
1) A clustering algorithm is run on the first β = S(S − 1) orthogonal right-singular
vectors in V and we identify R clusters through the Euclidean k-means method, as
in [83]. We remind that the input matrix A has size L× β.
2) We locate columns of A corresponding to clusters of V.
3) We compute the centroids of such clusters, so as to form the columns of W0.
4) Matrix H0 is finally given by the ALS update:
H0 = (WT0W0)
−1WT0A. (5.12)
The choice of the input matrix for the clustering algorithm notably helps reducing ini-
tialization computational load, as a lower dimensional matrix is processed and successive
operations are computationally less complex. Thanks to this grouping action, a sort of
temporal quantization of AF information carried by every segment is fulfilled, unlike the
first initialization proposed above, in which a spatial selection of ECG leads is rather
accomplished.
5.5.4 NMF application to prediction of acute AF termination by CA
In [107] it has been demonstrated that NMF feature extraction can be successfully
applied to prediction of acute AF termination by CA. This evidence has been corroborated
by results obtained on an ECG dataset acquired in relation with 21 CA procedures. In
this experimental session we aim at investigating whether this result can be extended to
a larger database, consisting of 31 ECG signals, already introduced in Sec. 3.5.5. The
goal is predicting acute AF termination by CA in line with the criteria explained in the
same section. According to this short-term criterion, 26 CA procedures were successfully
accomplished.
In keeping with remarks made in previous sections, NMSE indices assess estimation
quality of the PCA approximation of rank n = 1 of the AA signal split into S = 4
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Table 5.5: Short-term CA outcome assessment: interclass statistical analysis.
AF Non AF
p valuetermination termination
RMSRSVD8,1 (mV) 10.79± 9.62 15.24± 7.80 1.71 · 10−1
RMSRMSV8,1 (mV) 10.79± 9.62 15.24± 7.80 1.71 · 10−1
RMSRSVD8,2 (mV) 5.97± 6.22 5.60± 3.24 4.05 · 10−1
RMSRMSV8,2 (mV) 6.09± 6.21 6.00± 3.24 4.68 · 10−1
RMSRPCA8,1 (mV) 0.006± 0.001 0.007± 0.001 2.49 · 10−1
RMSRPCA8,2 (mV) 0.005± 0.001 0.006± 0.001 1.70 · 10−1
µ˜PCA [n.u.] 44.22± 26.40 65.50± 37.47 1.7 · 10−1
(NMSE)V1 [n.u.] 22.54± 17.25 24.00± 20.68 8.51 · 10−1
D˜8 (mV) 0.038± 0.019 0.015± 0.007 9.56 · 10−4
D(V1) (mV) 0.068± 0.022 0.054± 0.017 1.85 · 10−1
segments. As in previous experimental sessions, once verified the type of data distribution,
differences between the groups examined (“AF termination” and “Non AF termination”
by CA) are assessed by an unpaired test under a confidence level α = 0.05 (see Table 5.5).
Classification performance ROC curve parameters, namely, the AUC index and the
optimal cutoff, as well as the related values of sensitivity and specificity, are reported in
Table 5.6. Once set the NMF approximation rank R, evaluation indices are computed
Table 5.6: ROC analysis of the NMF decomposition for short-term CA outcome predic-
tion. All the parameters are expressed in normalized units [n.u.], except of D˜8 and D(V1)
(mV).
AUC Sensitivity Specificity Best cutoff
RMSRSVD8,1 [n.u.] 0.70 0.54 0.85 8.34
RMSRMSV8,1 [n.u.] 0.70 0.54 0.85 8.34
RMSRSVD8,2 [n.u.] 0.50 0.46 0.85 4.35
RMSRMSV8,2 [n.u.] 0.50 0.46 0.85 4.02
RMSRPCA8,1 (mV) 0.66 0.73 0.60 0.008
RMSRPCA8,2 (mV) 0.68 0.62 0.80 0.005
µ˜PCA [n.u.] 0.71 0.62 0.80 65.62
(NMSE)V1 (mV) 0.54 0.46 0.80 16.09
D˜8 (mV) 0.98 0.92 0.80 0.023
D(V1) 0.68 (mV) 0.50 0.80 0.06
for both NMF initialization methods described in Sec. 5.5.3 on a subset of L ECG leads,
yielding RMSRMSVL,R and RMSRSVDL,R, respectively. Subscripts MSV and SVD refer
to the NMF initialization methods proposed. For sake of comparison with investigation
results presented in [107], we set R = 2. In the unpaired statistical analysis we also
take into account minimum-rank NMF approximation of the NMSE data, i.e., R = 1.
Dependence of CA outcome prediction performance on the NMF approximation rank R
has been investigated by means of the ROC analysis. Accordingly, the AUC index has
been determined as a function of the rank R (Fig. 5.12), ranging between 1 and S = 4 (the
minimum dimension of input data A). Our analysis is performed on the 8-lead subset
previously presented, thus L = 8. The RMSR criterion is also computed by replacing
NMF processing of the input matrix with the PCA decomposition, and the same rank
values R have been adopted as well. Special attention is also paid to the multilead STV
descriptor µ˜PCA defined in Sec. 5.3, averaging single-lead contributions of AF organization,
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Figure 5.12: Evolution of the AUC index describing prediction performance of the RMSR
criterion. CA outcome is observed at two follow-up moments (short-term and long-term
prediction, and both NMF initialization methods are examined).
weighted by their temporal variance in a unique index [101, 105]. Moving to the single-
lead perspective, the AF complexity descriptor based on the mean NMSE and presented
in Sec. 5.3 has also been computed in V1. This parameter, denoted (NMSE)V1 , has been
averaged over S = 4 segments; for the sake of comparison with the other predictors, we set
PCA rank R = 2. Moreover, the f-wave amplitude, originally proposed as a CA-outcome
predicting feature but obtained manually in [121], is herein automatically computed. The
single-lead parameter D(V1) and the multilead index D˜8 are determined in V1 and in
multiple leads (L = 8), respectively, as in Sec. 4.3.
5.5.5 Discussion and conclusions
Even though the NMF-based RMSR measures seem to be able to accurately distin-
guish between effective and failing CA procedures in [107], from experimental evidence in
Table 5.5 we deduce the impossibility to confirm such significance on the ECG database
under examination. As a consequence, low RMSR values are not significantly associated
with acute AF termination by CA, and the index is not able to convey STV information
estimated by the multilead NMSE-based classifiers put forth in 5.3. Assessment of proce-
dural AF termination seems to be globally more accurate when lower rank values R are
selected prior to NMF performance, as we can see in Fig. 5.12.
Despite the lower reconstruction errors compared with NMF, neither PCA perfor-
mance can underline intergroup significant differences, regardless of the rank chosen.
Similar conclusions can be drawn for the weighted NMSE mean µ˜PCA, exhibiting low
predictive accuracy. These results seem to underline that STV content may not be the
most adequate ECG feature for depicting CA effects in the first followup, since probably
some postoperative factors (such as edemas, inflammations, cardioversion, etc.) do not
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allow for accurately capturing STV of AF content.
The single-lead analysis is neither able to effectively discriminate between successful
and failing CA procedures. Despite its ability to assess AF organization as demonstrated
in [18], the NMSE index assessed in V1 seems to be characterized by a weak predictive
power in CA outcome evaluation. As far as atrial amplitude measures are concerned,
it seems that the median descriptor D˜8 is characterized by the most accurate predic-
tion performance, and it significantly correlates higher amplitude values with procedural
success. By contrast, limitations of the single-lead perspective are confirmed by experi-
mental evidence related to D(V1), whose prediction performance is quite poor. Despite
the predictive role of f-wave amplitude, there is no evidence of its ability to characterize
STV properties of AF by exploiting f-waves properties. In addition, prediction could be
less reliable when dealing with very complex or irregular patterns, which can hamper
interpolation performance and atrial amplitude characterization accuracy.
To conclude, we can state that the reconstruction error of the low-rank NMF approxi-
mation can not effectively predict CA outcome before ablation, therefore the clinical value
of this STV measure as a therapy outcome predictor can not be assessed in the immediate
postoperative phase. Interesting open questions concern the rank selection for the NMF
decomposition and the links of the proposed predictor with recent indices exploiting the
ECG multilead character, as well as the application of the algorithm to other features
extracted from standard ECG (e.g., f-wave amplitude).
5.6 STV predictors of CA outcome: extension to
long-term CA outcome prediction and classi-
fication test on a larger ECG database
As done in Chapter 4, results discussed until present are obtained on a subset of our
persistent AF database, due to constraints imposed by the follow-up duration in each
subject. In this section we investigate whether it is possible to confirm the conclusions
about AF STV quantification drawn in previous sections by validating these findings on
the ECG database consisting of 36 patients, presented in Sec. 3.5.5. In particular, we
inspect the role of each of the features introduced as a predictor of AF termination by
CA in the long-term follow-up (mean duration: 8 ± 4 months). It is worth mentioning
once again that changes in the ECG database alter not only its size, but can also concern
CA clinical outcome, thus modifying data labels employed in our classification session.
This factor represents one of the main difficulties encountered in this doctoral thesis, as
it makes harder to generalize the methods proposed to different follow-up lengths.
In the light of these considerations, we examine the inverse-variance weighted mean
NMSE indices obtained subsequently to PCA and WPCA approximation, µ˜PCAL and
µ˜WPCAL , which have been respectively introduced in Sec. 5.3 and Sec. 5.4. Moreover,
NMF estimation error defined in Sec. 5.5 is evaluated. Both types of decomposition
initializations are tested, for 2 rank values (R = 1, 2), thus yielding RMSRSVDL,R and
RMSRMSVL,R as output. All parameters are computed both on the proposed reduced
8-lead ensemble and the whole standard ECG (L = 8 and L = 12). In order to verify
whether of the aforementioned STV measures are able to predict long-term freedom from
AF recurrence. Results of the statistical analysis and the ROC indices assessment are
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Table 5.7: Interpatient statistical analysis and CA outcome prediction performance as-
sessment on the 36-patient database in the long-term follow-up.
AF termination Non AF termination p value AUC Sensitivity Specificity Best cutoff
µ˜PCA8 [n.u.] 41.74± 30.41 34.66± 29.66 5.82 · 10−1 0.57 0.24 0.86 30.85
µ˜PCA12 [n.u.] 46.85± 32.18 49.40± 29.44 8.50 · 10−1 0.53 0.76 0.29 74.33
µ˜WPCA8 [n.u.] 50.16± 27.73 66.47± 26.01 1.67 · 10−1 0.66 0.72 0.43 69.60
µ˜WPCA12 [n.u.] 56.11± 23.94 76.92± 13.77 3.48 · 10−2 0.76 0.69 0.71 70.52
RMSRSVD8,1 (mV) 7.86± 5.98 15.32± 9.70 1.33 · 10−2 0.76 0.72 0.57 8.70
RMSRSVD12,1 (mV) 9.21± 7.59 17.95± 10.18 1.51 · 10−2 0.79 0.62 0.71 10.01
RMSRMSV8,1 (mV) 7.86± 5.98 15.32± 9.70 1.33 · 10−2 0.76 0.72 0.57 8.70
RMSRMSV12,1 (mV) 9.21± 7.59 17.95± 10.18 1.51 · 10−2 0.79 0.62 0.71 10.01
RMSRSVD8,2 (mV) 3.86± 3.00 7.37± 4.32 1.55 · 10−2 0.78 0.76 0.71 5.27
RMSRSVD12,2 (mV) 4.39± 3.30 7.34± 4.24 5.21 · 10−2 0.75 0.76 0.57 5.98
RMSRMSV8,2 (mV) 4.21± 3.44 7.76± 4.15 2.44 · 10−2 0.79 0.72 0.86 4.89
RMSRMSV12,2 (mV) 4.64± 3.55 7.34± 4.23 9.07 · 10−2 0.74 0.76 0.71 6.00
reported in Table. 5.7.
We can remark that STV descriptors determined by PCA are not able to point out
significant differences between the groups of patients, regardless of the ECG leads consid-
ered. The p values are high, and prediction quality assessed by the AUC criterion seems
poor. Similar conclusions can be drawn for the WPCA parameter µ˜WPCA8 described in
Section 5.4. Conversely, concerning the index µ˜WPCA12 , even though the unpaired test
yields significant results and prediction is quite satisfactory, it seems that successful CA
procedures are predicted by low values of this parameter, which apparently contradicts
our deductions about STV content assessed by NMSE. By contrast, parameters assessing
NMF observation reconstruction accuracy seem to improve results obtained on smaller
datasets. AUC values are generally satisfactory and categories of interest are well dis-
tinguished, as confirmed by the low p values. We can interestingly note that predictive
information about CA outcome can be extracted by a reduced number of ECG leads
(L = 8), and both RMSRSVD8,2 and RMSRMSV8,2 outperform their 12-lead counterparts
RMSRSVD12,2 and RMSRMSV12,2, whole corresponding p values slightly exceed the sig-
nificance level α = 0.05. Prediction accuracy of this index seems to be globally more
accurate when low approximation rank values R are chosen, as confirmed by Fig. 5.12.
Consequently, such evidence corroborates the descriptive power of observation reduced-
rank approximations, and their ability to emphasize the AA components which are more
discriminant and relevant to CA outcome prediction.
5.7 Summary and conclusions
This chapter has investigated STV properties characterizing AF on surface ECG.
Taking a step from classical parameters describing AF complexity, AF STV content is
characterized in a multilead framework by applying suitable multivariate decomposition
techniques underlining the most descriptive AA signal components. Regardless of the
decomposition applied, we showed that reduced-rank approximations to AA signal effec-
tively enhance significant contributions to CA outcome prediction. Contributions coming
from each ECG lead are selectively emphasized by exploiting AA signal intersegment
temporal variability, providing a measure of dispersion and statistical uncertainty at the
same time. AA observation reconstruction error proves to be a reliable index able to
discriminate between successful and failing CA procedures at several followup lengths.
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Correlation with AF complexity according to classical medical criteria [78, 161] has still
to be demonstrated, due to the lack of this clinical information in our AF database. In
the next chapter we attempt to merge ECG features illustrated until present and we
investigate whether AF characterization can benefit from such a combined approach in a
multivariate framework.
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6 Combination of multiple features assessed on
standard ECG
6.1 Introduction
In previous chapters we have introduced some ECG features and we have characterized
their descriptive role in CA outcome evaluation in a multivariate context. In Chapter 4 we
have looked at f-wave amplitude spatial diversity as measured on surface ECG recordings;
in Chapter 5 AF variability has been explored both in time (in terms of AA signal com-
ponent repetitiveness) and space (in terms of complexity distribution over ECG leads).
In this chapter we investigate whether it is possible to combine such heterogeneous ECG
properties and which technique can help merging our multilead features so as to improve
AF therapy outcome assessment. As it will be explained in the next section, the solution
to this problem comes from the logistic regression (LR) analysis, which will prove to
be a suitable tool for processing contributions from all electrodes at the same time and
selectively enhance the most content-bearing ECG leads according to a leveraging scheme.
In Sec. 6.2 we first illustrate the theoretical background of the LR analysis. In Sec. 6.3 this
model is applied to multivariate f-wave amplitude characterization and some application
to CA outcome prediction are illustrated. In Sec. 6.4 LR analysis of AF STV content is
accomplished for the same kind of application. In Sec. 6.5 we finally merge such features
and we characterize their predictive content through the LR model. General comments
and remarks about this topic are summarized in Sec. 6.6.
6.2 Definition of the logistic regression model
The goal in any data analysis is to extract from raw observations the accurate esti-
mation of the information of interest. One of the most important and common question
concerning if there is statistical relationship between a response variable and explanatory
variables z of a certain phenomenon [6]. More specifically, we would like to investigate
whether the probability of getting a particular value of the nominal variable is associated
with the measurement variable. The second goal is to predict the probability of obtaining
a particular value of the nominal variable, given the measurement variable [100].
One possible solution to model such relationship is to employ regression analysis.
There are various types of regression analysis, depending on the type of distribution of
the nominal variable.
The LR model assesses the impact of multiple independent variables presented simul-
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taneously to predict membership to one of the two categories of the dependent or response
variable, with mutually exclusive membership probabilities θ and (1− θ) [87]. LR model
is generally defined as:
LR = log θ1− θ = b
Tz (6.1)
where (·)T denotes transposition. The LR score is defined as the ratio of the probability
of occurrence of an event θ to that of non-occurrence with level (1 − θ), i.e. the odds of
that event. In our problem, θ represents the probability of procedural AF termination.
LR forms a best fitting equation using maximum likelihood (ML), which finds the values
of the parameters most likely to have produced the observed results. Indeed, it aims
at maximizing the probability of assigning observations z to the correct category given
the fitted regression coefficients b = [b1, b2, . . . , bL]T . Unlike linear regression, there is
no closed-form expression for the estimates of model coefficients, but they need to be
computed by means of an iterative algorithm.
6.3 LR modeling of multivariate f-wave amplitude
In our application, zA = d = [d1, d2, . . . , dL], whose entries d` are the single-lead atrial
amplitude features from Eq. (4.2), determined in each lead of the PCA-approximated
AA signal defined in Eq. (4.19). Such coefficients quantify the contribution of each in-
dependent variable (i.e., ECG leads ` = 1, . . . , L regarded as linearly independent as
aforesaid in Sec. 2.4.4) to the response variable (i.e., CA outcome). It is worth to note
that interlead independence is not strictly true in the LR context, but it seems to be a
good approximation for the subset of ECG leads considered. It turns out that the higher
the score (6.1), the more likely AF freedom in the long-term follow-up. Given these
considerations, the score output by the LR linear combination of zA components acts as
a classifier which has to discriminate between successful and failing CA procedures:
LRA = bTAzA. (6.2)
6.3.1 Statistical analysis and prediction performance assessment
Groups of patients under examination are referred to as “Non AF recurrence” and
“AF recurrence”, and LR scores related to each class are expressed as mean ± standard
deviation. The level of separability of the two groups and statistical significance are
quantified by the p value output by the unpaired test under a confidence level α = 0.05.
Statistical analysis results are reported in Table 6.1.
Prediction accuracy is quantified by the AUC criterion. The optimal cutoff value
guaranteeing the maximum discrimination level between the two classes is reported as
well. In addition, the related maximum rates of positive and negative detections, namely,
sensitivity and specificity, are indicated. Classification results are then validated by the
LOOCV technique as in Sec. 4.4.2 and displayed in Table 6.2.
6.3.2 Results
ROC assessment and statistical analysis are led according to the modalities explained
in Sec. 4.4.2. Advantages of multilead analysis are demonstrated in Fig. 6.1. More specif-
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Table 6.1: Statistical analysis of the LR modeling of f-wave amplitude in long-term CA
outcome prediction.
AF Non AF
p-valuetermination termination
LRA 0.90± 0.11 0.42± 0.41 1.95 · 10−6
LRD(V1) 0.81± 0.04 0.79± 0.07 1.45 · 10−1
D8 0.035± 0.022 0.048± 0.026 1.9 · 10−1
RMS(V1) 0.036± 0.011 0.507± 0.024 1.11 · 10−1
R˜MS8 0.030± 0.012 0.041± 0.011 3.92 · 10−2
R˜MS12 0.027± 0.010 0.042± 0.012 2.20 · 10−3
RMS8 0.032± 0.020 0.054± 0.027 2.19 · 10−2
RMS12 0.030± 0.016 0.049± 0.022 1.39 · 10−2
SampEn(Ls, r(1)s ) 0.310± 0.057 0.255± 0.773 3.88 · 10−2
SampEn(Ls, r(2)s ) 0.148± 0.028 0.126± 0.041 9.30 · 10−2
1 2 3 4 5 6 7 8
0.4
0.5
0.6
0.7
0.8
0.9
1
L
A
U
C
AA
PCA
Figure 6.1: Analysis of the LR score prediction performance: AUC index as a function
of the size L of the subset of the 8 independent ECG leads. Mean values are highlighted
with markers; the vertical bars represent the range of AUC values between the minimum
and the maximum obtained for each L. AA: direct computation of the LR score on the
observed AA signal. PCA: LR score computation on the truncated AA signal in Eq.(4.19)
with R = 1.
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Table 6.2: ROC analysis of the LR modeling of f-wave amplitude in long-term CA outcome
prediction.
AUC Sensitivity Specificity Best cut-off
LRA 0.88 0.93 0.71 0.69
LRD(V1) 0.56 0.52 0.71 0.82
D8 0.63 0.21 0.86 0.045
RMS(V1) 0.65 0.72 0.71 0.040
R˜MS8 0.80 0.55 0.86 0.035
R˜MS12 0.88 0.66 0.86 0.031
RMS8 0.86 0.62 0.86 0.036
RMS12 0.84 0.59 0.86 0.030
SampEn(Ls, r(1)s ) 0.82 0.48 0.86 0.291
SampEn(Ls, r(2)s ) 0.79 0.45 0.86 0.138
ically, the AUC index is determined for each value of lead-subset size L ranging from 1
up to 8 and validated by the LOOCV technique as in Sec. 4.4.2 as well. The minimum,
maximum, and mean AUC values over all L-lead subset combinations have been obtained
as a function of the subset dimension L. Furthermore, the subsets of ECG leads providing
the most relevant contributions to CA outcome prediction are indicated in Table 6.3. The
Table 6.3: ECG lead subsets with optimal prediction performance based on the LR score
LRA
Number of leads (L) Leads
1 I
2 I, V6
3 I,II, V5
4
[I, II, V2, V5]
[I, II, V3, V5]
[I, II, V2, V5]
[I, II, V3, V6]
[I, II, V4, V6]
5 [I, II, V2, V4, V6][I, II, V2, V5, V6]
6 [I, II, V1, V4, V5, V6][I, II, V3, V4, V5, V6]
7 [I, II, V1, V2, V4, V5, V6]
LR descriptor of f-wave amplitude is then compared with some conventional predictors
of CA outcome. The same parameters examined in Sec. 4.4.3 are herein applied to long-
term CA outcome prediction. It is worth noting that the feature D8 is a particular case of
LR, i.e. uniform weighting of all contributions from ECG leads (bA = 1). All numerical
results are reported in Table 6.2. For the sake of completeness, f-wave amplitude in V1
is also processed through the LR model, thus yielding the index LRD(V1), even though
numerical results are equal to those obtained in absence of LR processing (the single-
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lead LR predictor is just scaled by a multiplicative constant). The RMS-based measures
of atrial amplitude introduced in Sec. 4.4.3 have also been taken into account in this
experimental section. Finally, a further comparison is drawn with the non-linear sample
entropy index, which has been already presented in the same section. Some comments
about LR generalization over the short-term prediction of CA outcome are also made in
the final part of the experimental session.
6.3.3 Discussion and conclusions
The results obtained demonstrate that prediction of CA outcome in persistent AF
benefits from multivariate LR of f-wave amplitude content. In particular, in Fig. 6.1
we can remark that the mean AUC value increases as the size of the set of ECG leads
does, thus confirming the relevance of information coming from multiple leads. This plot
also points out that PCA considerably improves classification performance relative to the
raw multilead ECG. In particular, mean AUC index for a fixed subset size L is higher
when PCA is applied to AA signal. Moreover, starting from L = 5, AUC ranges become
narrower when PCA is performed. This proves the filtering effect of this decomposition,
which underlines the most descriptive components of AA signal, which help discriminat-
ing between effective and failing CA procedures. Analysis of lead subsets in Table 6.3
highlights that prediction accuracy is due to contributions coming from multiple planes
at different orientations. Indeed, when L > 1, we always find a combination of limb
and precordial leads, thus supporting our assumptions about the role of ECG spatial
variability. Furthermore, we can interestingly find some combinations of leads already
presented in Table 4.3 for predicting acute AF termination by CA (for instance, I, II, V2,
V5 for L = 4; I, II, V2, V4, V6 for L = 5; I, II, V1, V2, V4, V5, V6 for L = 7), thus they can
effectively contribute to CA outcome prediction at different moments in the follow-up.
Experimental evidence shows the superiority of LR-based scores over conventional
AF descriptors in CA outcome prediction. Such a multilead strategy provides a more
accurate prediction than classical single-lead parameters, for instance, f-wave mean am-
plitude D(V1), whose prediction performance is quite poor and no significant differences
between the groups of interest can be remarked. By contrast, prediction performance of
the sample entropy index is quite satisfactory. Setting rs = r(1)s points out statistically
significant interpatient differences (just below p = 0.04), whereas rs = r(2)s does not. This
evidence makes us realize how sensitive to tuning parameter values this feature is, thus
highlighting the difficulty in searching for the most suitable setting. What is more, regard-
less of setting parameter values, results obtained do not match basic assumptions made
in previous studies [5], namely, correlation between low entropy values and CA success
due to a higher degree of AF organization, as failing procedures are predicted by lower
entropy values. Concerning the mean value of the PCA-descriptor of f-wave amplitude
D8, note that attributing the same weight to all ECG leads by simply averaging their
contributions does not improve prediction, as no significant differences can be observed
between the groups examined. It turns out that CA outcome prediction takes benefit
from multivariate data processing and classification, provided that independent variables
(i.e., ECG leads) are properly combined, as when LR is applied. Similar conclusions can
be drawn for D˜8 and the 12-lead counterparts D12 and D˜12. By contrast, it seems that
central tendency measures of the RMS of f-wave amplitude effectively predict procedural
AF termination, as proved by the high AUC values and by the significant statistical
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tests. However, all the RMS-descriptors are affected by quite low sensitivity rates, thus
increasing the risk of not treating AF patients who could actually benefit from CA. In
addition, our investigation points out that procedural success is predicted by low values of
RMS-based parameters, which is in contradiction with the clinical evidence about f-wave
amplitude, which is directly correlated with CA outcome.
It seems that some ensembles of electrodes are able to perfectly distinguish between
the categories of interest, in particular for L = 4 and L = 5, as proved by the unity
AUC values. Indeed, LR distinguishes the groups of interest, to the extent that they are
perfectly separated by a threshold value. This is a common issue with logistic models.
In certain cases, it can be due to the low number of observations with respect to the
number of parameters to be estimated. Another possible explanation can be also found
in the high degree of correlation between the variables examined, which can lead to
inaccurate inferences about the model parameters. Accordingly, input data require an
a priori analysis in order to assess the feasibility of the LR application to AA signal.
6.3.4 Some comments about f-wave amplitude LR analysis for prediction
of acute AF termination by CA
We aim now at investigating whether LR analysis can also effectively contribute acute
AF termination immediately after CA, thus generalizing prediction outcomes observed
at different follow-up periods. Therefore, we employed the LR coefficients determined in
Sec. 6.3 to compute the new scores on the 31-procedure database presented in Sec. 3.5.5,
and then we assessed results significance. Empirical evidence shows the impossibility to
validate amplitude LR measures on shorter follow-ups, due to the lack of significance
of the results obtained (successful CA: 1.34 ± 2.60; unsuccessful CA: 1.18 ± 1.81; p
value= 9.0 · 10−1). Weak prediction performance is also confirmed by the ROC analysis
and the extremely low values of the performance indices (AUC= 0.53, sensitivity= 0.58,
specificity= 0.60, best cutoff= 0.86). Similar results are obtained even when LR coeffi-
cients are computed again and optimized on the 31-procedure database, as no significant
differences between the categories of interest are highlighted by the LR amplitude de-
scriptor (successful CA: 0.84 ± 0.01; unsuccessful CA: 0.84 ± 0.01; p value= 9.2 · 10−1)
and its predictive power seems to be considerably low (AUC= 0.53, sensitivity= 0.81,
specificity= 0.40, best cutoff= 0.84).
6.4 LR modeling of AF STV multilead measures
In line with previous section, we apply the LR technique so as to weight contributions
provided by each ECG lead to spatio-temporal variability (STV) characterization in the
presence of AF and enhance those which are most relevant to CA outcome prediction.
Accordingly, the mean NMSE value over AA segments µ`, ` = 1, . . . , L as defined in Sec-
tion 5.3 is computed in each of the 8 ECG leads examined, so as to form the L-component
vector µ = [µ1, µ2, . . . , µL]T , rendering the estimation error of PCA approximation to the
AA signal in each ECG lead. Therefore, LR modeling of AF STV data zSTV = µ results
in:
LRSTV = bTSTVzSTV. (6.3)
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STV content examination is carried out on the 36-subject database described in Sec. 3.5.5.
However, unlike LR measures of f-wave amplitude, it seems that this model overfits input
NMSE data, thus yielding the score LRSTV, whose elements are equal either to 0 or 1.
This results in a perfect clustering of patients’ categories, and so AUC= 1.
In order to verify the correct assessment of this STV measure, we move to an unsuper-
vised classification framework. More precisely, LOOCV technique is applied by splitting
the original 36-patient ECG database into 2 parts, i.e., a training ensemble, including
35 ECGs, for learning classifier’s features, and one sample test set for validation. Test
feature is computed as a function of the LR coefficients estimated on the training set.
This procedure is repeated 36 times by discarding one sample at each iteration. The
AUC criterion quantifies the classification performance of the LR predictor. Such a vali-
dation method highlights the ability of the proposed STV measure to effectively predict
long-term AF termination by CA, as corroborated by the ROC analysis (AUC= 0.89,
sensitivity= 0.83, specificity= 0.86, best cutoff= 106.65). It turns out that higher LR
score values are significantly associated with AF termination by CA (AF termination:
315.30± 238.30; non AF termination: −33.91± 208.47; p value= 1.1 · 10−3).
For the sake of completeness, we also cite classification results related to the short-
term CA outcome prediction. In this case, the LR method does not seem to underline any
significant results (AF termination: 0.84±0.01, Non AF termination: 0.84±0.01, p value:
9.3 ·10−1, AUC: 0.55, Sensitivity: 0.81, Specificity: 0.40, Best cutoff: 0.84). This could be
due to postoperative events (for instance, inflammations, edemas, cardioversion therapies)
which may hide some information about AF organization. A possible explanation can also
come from the phenomena of reorganization of heart electrical activity subsequently to
ablation-induced modifications, which may need a certain amount of time before definitive
stabilization.
6.5 LR modeling of combined measures of f-wave
amplitude and STV content
Previous sections have underlined the versatility of the LR model and its ability to
properly weight contributions coming from each ECG lead in a multivariate perspective.
The flexibility of this technique derives from the possibility of not only examining mul-
tiple indices at the same time, but also combining heterogeneous ECG features, due to
the definition of the LR score as a ratio of probabilities in Eq. (6.1). Consequently, in
this session we attempt to analyze f-wave amplitude STV measures simultaneously and
characterize their content by means of the LR model.
6.5.1 Assessment of CA outcome based on the LR analysis of combined
ECG features at several follow-ups
In this section we investigate whether LR combination of AF STV measures can yield
predictive information about CA procedural outcome. Accordingly, we first examine
the 31-procedure dataset used for assessing acute AF termination by CA and previously
presented in Sec. 3.5.5. Subsequently, we switch to the long-term follow-up and we look
at the procedural outcome on the 36-patient database introduced in the same section.
Clinical endpoints evaluated on each dataset are explained in the same section.
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As in Sec. 6.4, the ROC analysis yields AUC= 1, regardless of the temporal window
examined, thus the categories of interest are perfectly separated, probably due to data
overfitting phenomena of the LR model. Accordingly, we tested the prediction perfor-
mance of the bi-feature LR score in a supervised classification framework, in line with the
methodology presented in the same section.
Similarly to the STV-based LR score defined in Sec. 6.3, the LR score output by
ECG feature combination does not seem to effectively discriminate between successful
and failing CA procedures in the short-term postoperative period, and acute effectiveness
of ablation can not be accurately estimated (Successful CA: 0.85 ± 0.37. Failing CA:
0.56 ± 0.52. p value: 1.42 · 10−1. AUC: 0.68. Sensitivity: 0.73. Specificity: 0.60. Best
cutoff: 0.76).
By contrast, therapy outcome analysis in longer follow-ups seems to benefit from the
LR modeling of the combined ECG features, and higher LR scores effectively predict
durable freedom from AF recurrence (AF termination: 0.83± 0.38. Non AF termination:
0.43 ± 0.53. p value: 3.86 · 10−2. AUC: 0.70. Sensitivity: 0.85. Specificity 0.60. Best
cutoff: 2.22 · 10−16).
In keeping with remark made in Sec. 5.6, this section highlights once again that gen-
eralizing the predictive power of a certain ECG measure over different kinds of analysis is
not a trivial task, since multiple factors have to be taken into account in our investigation
model when switching to a different dataset, e.g., the therapy evaluation criteria and
patient’s clinical history.
6.5.2 Selection of candidates for CEE based on the LR analysis of com-
bined ECG features
We move now to another clinical application, related to the selection of candidates
for CEE after ablation. We demonstrate that merging the ECG measures previously
introduced enhance the prediction of procedural acute AF termination by identifying
patients who need to be treated by CEE immediately after CA, which can be regarded as
a criterion of procedural failure according to certain medical protocols.
All therapies for AF treatment generally aim at either SR restoration or AF trans-
formation into an intermediate arrhythmia, for instance, AFL. In this framework, AF
termination is sometimes not exclusively obtained by CA. Different theories about therapy
combination have been proposed. One of the most adopted curative strategies to restore
SR and stabilize CA effects is performing CEE immediately after CA. In this context, we
developed a method for individuating candidates to CEE after CA, i.e., those for whom
CA did not terminate AF during the procedure. This tool combines information about
f-wave amplitude and AF STV content extracted from the rank-1 approximation to the
multilead AA signal and subsequently processed by LR. The proposed method enables a
more efficient prediction of acute CA success, as well as a more detailed design of patient’s
treatment protocol.
6.5.3 LR of multivariate ECG descriptors
In this experimental section we examine the database consisting of 54 signals described
in Sec. 3.5.5. As disclosed in Sec. 6.1, the main objective of this chapter is to verify whether
combining heterogeneous features, i.e., f-wave amplitude and STV content as measured on
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surface ECG, can improve AF therapy outcome evaluation. As a consequence, we examine
the 8 linearly independent ECG leads defined in Sec. 2.4.4 and we determine the f-wave
peak-to-peak amplitude feature vector defined in Sec. 6.3 zA = d = [d1, d2, . . . , dL]T , and
the intersegment mean NMSE value per lead zSTV = µ = [µ1, µ2, . . . , µL]T introduced in
Sec. 6.4. LR analysis has been previously applied on each multilead feature separately.
Simultaneous processing of these AF descriptors is achieved by concatenating them in a
unique variable z(A;STV) = [zTA; zTSTV]T , giving the score LR(A;STV) as output. Accordingly,
the LR score will be represented by a 2L-component vector.
LR(A;STV) = bT(A;STV)z(A;STV). (6.4)
6.5.4 Unpaired statistical analysis and prediction accuracy assessment
The categories of interest are referred to as “CEE” and “No CEE”, and LR scores re-
lated to each class are expressed as mean ± standard deviation. The unpaired Student’s t-
test assesses interclass statistical differences under a confidence level α = 0.05. Prediction
quality is evaluated according to the AUC criterion, accompanied by the optimal cutoff
separating the 2 categories and the related rates of sensitivity and specificity. These results
are validated by the LOOCV technique described in Sec. 4.4.2. All the aforementioned
values are reported in Table 6.4; values corresponding to the best prediction performance
are shown in bold. Finally, advantages of multilead analysis are demonstrated in Fig. 6.2
and quantified by the AUC index over all possible L-sized lead combinations as explained
in previous experimental sections. The minimum, maximum, and mean AUC values over
all L-lead subset combinations have been obtained as a function of the subset dimension
L. Such analysis is performed on all scores LRA, LRSTV and LR(A;STV).
6.5.5 Results
The combined LR measure LR(A;STV) is first compared with LR scores of f-wave am-
plitude and STV features analyzed separately, LRA and LRSTV, respectively. Some com-
parisons with some classical AF descriptors are drawn as well. In particular, we mention
mean peak-to-peak amplitude on lead V1 D(V1) is taken into account, as several studies
demonstrated that it is predictive of CA outcome [121]. In addition, sample entropy
SampEn(Ls, rs), widely regarded as a predictor of AF termination by CEE [5], is consid-
ered. Tuning parameters are set as in the previous experimental sections. A normalized
version of the sample entropy, i.e., the squared sample entropy (QSE), recently proposed
in [79], is also tested here under the same conditions. The computational load of each
algorithm is also reported in terms of execution time TC in Table 6.4.
The proposed method required on average no more than 3.4 seconds for processing
the whole ECG database on 2 leads through an Intel R© CoreTM 2 Quad 2.66 GHz Proces-
sor running MATLAB2012a (The MathWorks Inc.) when combining ECG features. Its
execution on the whole 8-lead ensemble provides a satisfactory trade-off between com-
putational load and classification accuracy compared with other methods. Influence of
weighting coefficients over prediction has been investigated as well. Accordingly, for each
procedure, f-wave amplitude computed on ŶAA has been averaged over the ECG leads
examined, thus giving D8 as output, already defined in Sed. 4.3. The same procedure has
been repeated for STV indices obtained on each ECG lead, whose mean value is repre-
sented by µ8. This is equal to attributing the same importance to all leads, according to
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Figure 6.2: Evolution of the AUC index of the proposed LR scores LRA, LRSTV and
LR(A;STV) as function of the number of ECG leads L.
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Figure 6.3: LR regression coefficients of ECG multivariate features, both in separate and
combined analysis. Left: multivariate f-wave amplitude (bA and first 8 coefficients of
b(A;STV)). Right: multivariate AF STV (bSTV and last 8 coefficients of b(A;STV)).
a uniform weighting scheme (b = 1). Furthermore, the regression coefficients’ weighting
action has been investigated. More precisely, values of LR coefficients bA computed on
f-wave amplitude data only are compared with the corresponding atrial amplitude kept
in the first L entries of vector b(A;STV), obtained when amplitude and AF complexity are
processed together. The same analysis is repeated for coefficients bSTV and the last L
entries of b(A;STV), referring to STV content so as to verify how such information provided
by every ECG lead influences prediction scores in both cases. Results of our examination
are plotted in Fig. 6.3, providing spatial distribution of regression coefficients over ECG
leads.
6.5.6 Discussion and conclusions
Our results show that amplitude and STV features seem to enhance prediction per-
formance when contributions computed on each lead are combined into the LR linear
combination and properly weighted by LR coefficients. This approach remarkably im-
proves acute CA outcome prediction and helps assessing procedural success, which is
associated with CEE performance right after the procedure.
Table 6.4 shows the advantages brought by LR measures to CA outcome prediction,
as proved by the high AUC values and the presence of significant differences between
the classes examined. Feature combination further enhances the degree of clustering of
such groups, therefore notably improving prediction. Such a multilead strategy provides a
more accurate prediction than classical single-lead parameters, for instance, f-wave mean
amplitude D(V1), which is not able to underline significant interclass differences. Similar
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remarks can be made for the sample entropy and the QSE index, as its discriminative
power is considerably weak. What is more, results obtained do not match basic assump-
tions made in previous studies [5], namely, correlation between low entropy values and
CEE success due to a higher degree of AF organization, independently from the setting
adopted.
Concerning mean values of f-wave amplitude and NMSE, (D8 and µ8, respectively),
note that attributing the same weight to all ECG leads by simply averaging their contri-
butions does not improve prediction, as no significant differences can be observed between
the groups of interest. It turns out that CA outcome prediction benefits from multivari-
ate data processing and classification, provided that input variables (i.e., ECG leads) are
properly combined, as when LR is applied.
Fig. 6.3 highlights that LR coefficient dispersion is considerably lower when analyz-
ing each set of features separately, as quantified by standard deviation (σbA = 68.00
vs. σb(A;STV)1...8 = 159.51, and σbSTV = 0.05 vs. σb(A;STV)9...16 = 0.15). It could depict a lower
degree of variability, which hides significant information coming from certain electrodes.
However, it is important to keep in mind that such variability could also be due to model
estimation errors, which tend to increase with the problem’s dimensionality for a given
sample size. Benefits from feature combination are confirmed by Fig. 6.2 as well. First,
it shows that CA outcome prediction is improved by multilead processing, as the higher
the number of leads L examined, the higher the AUC, in keeping with results shown in
Sec. 4.4.4. Secondly, regardless of the number of electrodes L exploited, examining such
ECG properties together probably provides a more complete overview of AF activity,
which enhances classification quality. On one hand, f-wave amplitude is predictive of CA
outcome and it is strictly correlated with AA signal energy; on the other hand, STV
quantifies the degree of regularity and temporal repetitiveness of AF patterns, besides
their spatial distribution over ECG leads. These characteristics are quite complementary
with each other. Indeed, f-wave amplitude can effectively depict very regular signals; con-
versely, sharp patterns can hamper signal interpolation and do not render AF temporal
evolution. In contrast, STV indices are more suitable for capturing signal diversity and
characterizing its temporal dynamics. However, their descriptive power is reduced when
dealing with very regular waveforms, where it is harder to extract information about their
variability; hence the advantage of merging knowledge about these two aspects, so as to
enrich AF characterization and overcome their respective limitations. The tool proposed
can be effectively exploited for selecting positive responders to CEE after ablation, thus
helping short-term CA outcome assessment in persistent AF.
6.6 Summary and conclusions
In this chapter we shed some light about the LR model ability to properly combine am-
plitude and STV measures derived from different ECG leads. Simultaneous examination
of heterogeneous ECG features enrich AF characterization, thus making the prediction
of procedural AF termination more accurate. This technique highlights ECG leads ex-
hibiting components which are more relevant to CA outcome prediction, while reducing
the influence of the remaining ones. Further investigation should be performed on LR
coefficients and their interpretation. In addition, the algorithm should be tested on other
features determined on standard ECG (e.g., frequency domain parameters). Despite these
115 Combination of multiple features assessed on standard ECG
shortcomings, the present multiple-feature framework notably improves CA outcome pre-
diction and helps AF characterization.
In the next chapter we define a further strategy for assessing AF content over surface
ECG, exploring the degree of spatial correlation and the amount of information shared
between ECG leads by means of approaches derived from information theory
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Table 6.4: LR analysis of combined ECG features for selection of CEE candidates: inter-
class statistical difference assessment and ROC analysis. ([n.u.]: normalized units).
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7Contributions from information theory to CA
outcome prediction
7.1 Introduction
As stated in Chapter 5, the concept of AF organization is not uniquely defined and it
can be interpreted from multiple perspectives. In Chapter 5 we studied how AF content
explains its variability over ECG leads (thus in terms of interlead spatial distribution)
and how its components recur along the ECG recording (therefore characterizing signal
repetitiveness). In the next sections we deal with a further strategy to assess AF regu-
larity from a different perspective, aiming at quantifying the degree of mutual correlation
between 2 or more ECG leads. Accordingly, we neglect signal temporal evolution, thus
exclusively focusing on interlead spatial correlation assessed on the whole ECG record-
ing. This approach is inspired by information theory (IT), the so-called “mathematical
theory of communication” founded by Claude E. Shannon in 1948 [136]. The techniques
presented in this chapter have been so far usually applied to telecommunication systems
so as to quantify the amount of information exchanged by two systems and carrying
out several signal processing operations (for instance, compressing data), as well as re-
liably storing and communicating data. Subsequently, such methods have been widely
employed in other fields, for instance, statistical inference, natural language processing
and neurobiology [164].
We organize this chapter in two main sections. The first part briefly sketches the key
ideas of IT in Sec. 7.2 and provides an overview of the mathematical background at the
basis of its development. These concepts then find a clinical application in the second
part, which outlines the main experimental results obtained in a single ECG lead in CA
outcome prediction and AF characterization in Sec. 7.3. Our analysis is then extended to
multiple electrodes in Sec. 7.4. Final conclusions are summarized in Sec. 7.5.
7.1.1 Overview of IT
In a communication system, the main goal is conveying information from one point to
another. This task arises from this question: what is the maximum amount of meaningful
information which can be conveyed between two systems [164]? As explained in [136],
the term “information” deals with a measurable quantity, assessing the ability of the
receiving system to interpret data flows coming from the transmitter, namely, decoding
the sequence of symbols it consists of. This explains the use of logarithmic measures
(as explained in the next sections) typical of IT, since every kind of data is codified into
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bits, the minimal units of information [136]. This assertion implies an idea of uncertainty
around information conveyed, which is expressed as the minimal number of bits required
for transferring data. These assumptions lead us to regard its sources as random variables,
and probability theory is therefore employed to model the efficacy of this information
transfer.
7.1.2 Some clinical applications of information theory tools
In [135] IT has been applied to molecular biology for understanding how proteins
interact with DNA at specific sequences called binding sites. In [146] a clustering method
based on mutual information (MI) enables co-expressing gene classification. Some ap-
plications to EEG analysis have also been put forward to investigate ischemic episode
effects on human brain [13]. In addition, a spectral analysis through IT measures has
been performed for analyzing EEG seizures on EEG [13]. The study led in [1] puts
forward a classification system for myocardial information based on the maximization
of entropy criteria on ECG. In [134] a method based on MI has been implemented for
selecting electrodes for the noninvasive extraction of fetal cardiac signals from maternal
abdominal recordings. Cardiac arrhythmia detection has been also envisaged in [88] by
computing MI on the heartbeat interval series. To our knowledge, no correlation between
IT background and AF therapy has been established until present. Accordingly, in the
sequel we attempt at quantifying AF regularity in the IT framework and investigate its
predictive power for CA characterization.
7.2 Basic theoretic definitions
7.2.1 Shannon’s information measures: the 2-variable case
Before illustrating some clinical applications to persistent AF analysis, we first provide
some definitions of the main concepts at the basis of IT mathematical background [37].
Accordingly, let us define a generic continuous random variable (r.v.) X that can take
on any value from a domain X and that is characterized by a probability mass function
p(x) = Pr{X = x}, x ∈ X . However, every function defined in the sequel can be applied
also to continuous variables, provided that sums are replaced by integrals.
We first introduce the marginal entropy H(X), which quantifies the degree of uncer-
tainty of the r.v. X:
H(X) = −E{log p(x)} = −
∫
x∈X
p(x) log p(x) (7.1)
Entropy is always a positive quantity (0 ≤ H(X) ≤ 1), so that log p(x) ≤ 0. The higher
its value, the higher the degree of uncertainty of the variable considered. Entropy and all
the IT measures are conventionally expressed in bits, thus logarithm function is computed
in base 2. Moreover, note that H(X) is a functional of the distribution p(x), therefore it
does not depend on the actual values taken by X, but only on their probabilities.
Just as with probabilities, we can compute joint and conditional entropies. Therefore,
let us extend entropy definition to two r.v., and explore their mutual dependency. To
this end, we introduce another r.v. Y taking values in Y with probability density p(y)
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Figure 7.1: Graphical representation of the relationships between the IT parameters de-
fined in Sec. 7.2.
and we attempt to quantify the degree of coupling with X, assuming p(x, y) as their joint
probability distribution. Accordingly, we present the joint entropy (JE):
JE = H(X;Y ) = −EX{EY {log p(x, y)}} = −
∫
x∈X
∫
y∈Y
p(x, y) log p(x, y) (7.2)
This index quantifies the degree of randomness shared between the pair of variables ex-
amined, thus we expect high values if the r.v. are independent. We also mention the
conditional entropy H(Y |X), which expresses the degree of uncertainty of Y conditioned
to the value of X:
H(Y |X) = −EX{EY {log p(y|x)}} = −
∫
x∈X
∫
y∈Y
p(x, y) log p(y|x) (7.3)
This definition allows for enunciating the chain rule, which puts the aforementioned pa-
rameters in functional relation with each other:
H(X, Y ) = H(X) +H(Y |X) (7.4)
Proof of Eq. (7.4) is provided in Appendix A.4.
Another feature already mentioned in Sec. 7.1.2, i.e., the MI index I(X;Y ), measures
the amount of information that one r.v. X contains about another one Y , thus expressing
the level of interdependence.
MI = I(X, Y ) = −
∫
x∈X
∫
y∈Y
p(x, y) log p(x, y)
p(x)p(y) (7.5)
Note that if X and Y are independent p(x, y) can be factorized into the product p(x, y) =
p(x)p(y), ∀x ∈ X , ∀† ∈ Y , thereby I(X, Y ) = 0. As a consequence, JE defined in Eq.(7.2)
will be equal to the sum of the marginal entropies of each variable according to the
expression in Eq. (7.1). MI relation with entropy can be expressed as:
I(X, Y ) = H(X)−H(X|Y ) = H(X)+H(Y )−H(X, Y ) = H(X, Y )−H(Y |X)−H(X|Y ),
(7.6)
which is also graphically explained in Fig. 7.1. MI is nonnegative (I(X;Y ) ≥ 0) and sym-
metric (I(X;Y ) = I(Y ;X)). Additionally, it is characterized by the property I(X;X) =
H(X).
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7.2.2 IT extension to multiple variables: the chain rule
Definitions of entropy functions provided in Sec. 7.2.1 can be extended so as to evaluate
interactions between L variables X1, X2, . . . , XL, whose probability density is denoted as
p(x1, x2, . . . , xL). Generalization of the 2-variable chain rule results in:
H(X1, X2, . . . , XL) =
L∑
i=1
H(Xi|Xi−1, . . . , X1) (7.7)
Proof of Eq. (7.7) is detailed in Appendix A.4. This rule can be also applied to MI,
also referred to as multivariate mutual information (MMI), thus yielding:
I(X1, X2, . . . , X`) = I(X1;X2; . . . ;X`−1)− I(X1;X2; . . . X`−1|X`) (7.8)
with ` = 1, . . . , L. It can be interpreted as the gain (or loss) in the information transmitted
between a set of variables due additional knowledge of an extra variable [144]. According
to the formulation proposed by [64], Eq. (7.8) can be also expressed in terms of entropies
:
I(X1, X2, . . . , X`) =
L∑
i=1
H(Xi)−H(X1, . . . , X`−1|X`) =
= −
`−1∑
i=1
(−1)iH(Xi) +
`−1∑
i=1
(−1)iH(X1, . . . , Xi−1|Xi)
(7.9)
with ` = 1, . . . , L. According to this definition, the MMI index can be expressed as a
function of L variables, depending on the `th conditional variable selected. In contrast
with bivariate MI, it is worth noting that MMI can also take nonnegative values, owing
to variations (either positive or negative) of dependence between variables when holding
one of them, therefore interpretation of its value is not always straightforward. Note that
the MMI measure is quantitatively different from the joint entropy computed on 2 leads,
as suggested by the definition in Eq. (7.9).
After this overview of the IT theoretical background, we illustrate in next sections
some applications to ECG analysis and CA outcome prediction for persistent AF charac-
terization.
7.3 Single-lead assessment of AF regularity on
surface ECG for CA analysis
7.3.1 Methods and results
As aforementioned in Sec. 7.2.1, the marginal entropy of a r.v. X as defined in Eq. (7.1)
expresses the degree of uncertainty about a certain event to occur. In our application,
as we deal with AA signal probability distribution functions (PDFs), entropy quantifies
the amount of information about atrial amplitude values, which occur with a certain
probability. The higher the uncertainty, the larger the amount of information conveyed
by AA signal on average.
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Figure 7.2: Box-and-whisker plot of the single-lead entropy H(X) in the long-term CA
outcome prediction. Outliers are marked with the symbol ×.
In the light of these considerations, we first computed this index for each patient
of the 36-subject database presented in Sec. 3.5.5. Marginal entropy values have been
determined in each of the 8 ECG leads of the subset introduced in Sec. 2.4.4. Entropy
index requires computation of the AA signal PDF. Accordingly, for a given T -sample AA
signal y`, `, ` = 1, . . . , L, L = 8, its histogram has been computed in the range of values
[XMIN − δ2 , XMAX + δ2 ], where δ = (T )
1
2 is the bin width of the histogram. Interclass
statistical differences are graphically represented by a box-and-whisker plot in Fig 7.2.
Moreover, ROC analysis has been carried out, and the AUC index determined on each
ECG lead has been plotted in Fig. 7.3. Dependence on signal amplitude has been
finally verified by computing marginal entropy of the AA signal after normalization by
its variance. This measures is then compared with that assessed on the non-normalized
signal by means of an index named negentropy [37] and defined as:
Neg(X) = H(G)−H(X) (7.10)
where H(G) is the marginal entropy of a Gaussian distribution having the same mean
and variance as the PDF of the r.v. X. The lower this index, the more input data
PDF resembles a normal distribution. We hypothesize that if negentropy does not vary
significantly from one electrode to another when AA signal variance is normalized to 1, it
means that the entropy measures depends on input signal amplitude. In Fig. 7.4 we plot
the spatial distribution of negentropy of the AA signal before and after normalization of
variance to 1, and they are denoted Neg(X) and Neg(X)NORM respectively. Values of this
parameter are averaged over the whole AF-database in each ECG lead and normalized
between 0 and 1.
In this section we do not include results concerning prediction of acute termination
by CA since we observed that entropy measures do not significantly contribute to this
clinical task, as confirmed by the poor prediction performance (AUC< 0.65 in each ECG
lead).
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Figure 7.3: AUC index related to H(X) long-term CA outcome prediction quality on each
ECG lead.
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Figure 7.4: Spatial distribution of the negentropy index determined on each ECG lead of
the AA signal before and after variance normalization.
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7.3.2 Results and discussion
The marginal entropy measure seems to be quite sensitive the ECG lead chosen, as
confirmed by Fig. 7.2. Significant interclass differences are obtained only in lead I (p
value: 4.0 · 10−4), II (p-value:7.4 · 10−3) and V2 (p value: 1.8 · 10−2), whereas the groups
examined can not be significantly distinguished in the other leads. The ROC analysis
corroborates the accurate prediction performance in the aforementioned leads in Fig. 7.3.
Note the high degree of variability of the AUC index over the ECG leads. However,
regardless of the electrode examined, we can generally remark that higher entropy values
are always associated with procedural AF termination and freedom from the arrhythmia in
the long-term follow-up. These results do not merely depend on signal PDF, but rather
on its amplitude. Indeed, Fig. 7.4 shows that not only the negentropy measure varies
when AA signal is normalized by its variance, but also that its values do not significantly
change when switching from one lead to another. In fact, negentropy standard deviation
σ computed on all leads is lower when AA signal is normalized (σ(Neg(XNORM)) =
0.02; σ(Neg(X)) = 0.16). This experimental evidence confirm the relationship between
marginal entropy and atrial amplitude, which is correlated with AF therapy outcome, as
demonstrated in Sec. 4.4.4. In keeping with those results, the higher H(X), the more
likely AF termination by CA. In the next sections our investigation will focus on the
assessment of the IT measures in a multivariate framework by taking into account more
than one ECG lead.
7.4 Multilead assessment of AF regularity on sur-
face ECG for CA analysis
7.4.1 Extension of IT measures to 2 ECG leads
The high degree of variability affecting CA outcome prediction performance in the
single-lead perspective of entropy measures lead us to explore further strategies for as-
sessing procedural AF termination in a more robust framework. This objective motivates
the exploitation of ECG spatial diversity and the investigation of IT indices defined on
more than one ECG lead.
CA outcome prediction based on IT indices has been carried out by taking into account
two distinct follow-up windows, since we aim at predict both acute procedural success and
long-term AF termination by CA. More precisely, short-term prediction performance of
the IT parameters has been first evaluated on the 31-procedure dataset introduced in
Sec. 3.5.5, whereas long-term procedural outcome has been assessed on the 36- patients’
database mentioned in the same section. Our analysis aims at investigating whether any
particular AF properties can be enhanced by this feature with respect to CA procedural
success, and how relevant to AF investigation the choice of couple of electrodes is. The
same histogram setting as that presented in Sec. 7.3.1 has been applied to both variables
involved into JE computation. Accordingly, the JE index defined in Eq. (7.2) is computed
for all the possible L!2!(L−2!) = 28 combinations of the 8-lead subset under examination
(L = 8), and CA outcome prediction performance is then assessed by the AUC index,
whose values are reported for each combination of leads in Table 7.1 and Table 7.2 for
the short-term and the long-term therapeutic outcome assessment, respectively. Entropy
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Table 7.1: ROC analysis of the short-term CA outcome for each pair of ECG leads by
means of the JE index directly computed on the AA signal (without PCA preprocessing).
ECG leads examined are underline by the symbol ×.
Leads AUC I II V1 V2 V3 V4 V5 V6
[V2 V3] 0.68 X X
[V1 V5] 0.65 X X
[V1 V3] 0.65 X X
[V2 V4] 0.61 X X
[V3 V6] 0.61 X X
[V4 V6] 0.60 X X
[V3 V5] 0.60 X X
[II V1] 0.60 X X
[V1 V6] 0.59 X X
[I V2] 0.57 X X
[V1 V4] 0.57 X X
[V3 V4] 0.56 X X
[II V5] 0.56 X X
[II V3] 0.56 X X
[V5 V6] 0.56 X X
[V4 V5] 0.56 X X
[II V6] 0.54 X X
[I V6] 0.53 X X
[V2 V5] 0.53 X X
[I V1] 0.52 X X
[II V2] 0.52 X X
[I V5] 0.52 X X
[I V4] 0.52 X X
[I V3] 0.52 X X
[I II] 0.51 X X
[V2 V3] 0.50 X X
[V1 V2] 0.50 X X
[V2 V6] 0.46 X X
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Table 7.2: ROC analysis of the long-term CA outcome for each pair of ECG leads by
means of the JE index directly computed on the AA signal (without PCA preprocessing).
ECG leads examined are underline by the symbol ×.
Leads AUC I II V1 V2 V3 V4 V5 V6
[I V3] 0.95 X X
[I V4] 0.94 X X
[I V2] 0.93 X X
[II V4] 0.93 X X
[II V3] 0.91 X X
[I V5] 0.91 X X
[II V6] 0.89 X X
[I V6] 0.89 X X
[I V1] 0.89 X X
[II V2] 0.89 X X
[II V5] 0.89 X X
[V3 V4] 0.79 X X
[V2 V6] 0.79 X X
[V4 V6] 0.78 X X
[II V1] 0.76 X X
[V2 V4] 0.76 X X
[V4 V5] 0.74 X X
[V3 V6] 0.74 X X
[V2 V3] 0.74 X X
[V3 V5] 0.72 X X
[V1 V3] 0.72 X X
[V2 V5] 0.72 X X
[I II] 0.71 X X
[V1 V4] 0.71 X X
[V1 V2] 0.70 X X
[V5 V6] 0.70 X X
[V1 V6] 0.70 X X
[V1 V5] 0.63 X X
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Table 7.3: AUC criterion assessment of long-term AF termination prediction performance
of the MMI index directly computed on the AA signal for a fixed conditioned variable Yc.
In the 8-lead subset, the symbol − means that the lead has not been considered in the
analysis.
Yc I II III aVR aVL aVF V1 V2 V3 V4 V5 V6
MMI8 0.79 0.64 − − − − 0.66 0.58 0.66 0.56 0.66 0.62
MMI12 0.76 0.61 0.55 0.73 0.80 0.70 0.66 0.58 0.56 0.64 0.71 0.74
value independence from atrial amplitude has also been investigated as in Sec. 7.3, and the
dispersion of negentropy values over the 28 pairs of ECG leads (X, Y ) has been quantified;
it is denoted σ(Neg(X, Y )) and σ(Neg(X, Y )NORM) for non-normalized and normalized
AA data, respectively. Also in this case negentropy has been averaged over the whole
database and normalized between 0 and 1.
7.4.2 Extension of IT measures to L ECG leads
Subsequently, we have investigated whether bivariate IT analysis can be generalized
over a higher number of ECG leads so as to underline further properties of AF electro-
physiology. Accordingly, we have attempted to combine ECG spatial variability and IT
regularity measures by looking at a higher number of ECG leads. To this goal, MMI
is computed as in Eq. 7.8 on the 8 linearly independent leads of the AA signal. In
keeping with the MMI definition given in Eq. 7.8, a conditional variable has to be fixed
for computing the conditional entropy term as defined in (7.3), and MMI value depends
on the variable chosen. Accordingly, MMI has been computed for each of the L possible
combinations by fixing an electrode Yc at a time, and prediction quality has been then
assessed by the AUC criterion, both for L = 8 and L = 12, as indicated in Table 7.3.
7.4.3 Discussion
Our investigation underlines that direct extraction of the JE feature from the AA signal
does not significantly provide to CA outcome prediction performance right after ablation
performance, as confirmed by the poor ROC analysis results in Table 7.1. Moving to the
long-term perspective, one of the main results put forward by the JE index computation
is the different relevance of ECG leads in characterizing AF with respect to therapy
outcome. In particular, we can remark that the most discriminative signal components
are properly emphasized when information about AF components is provided by different
planes and orientations of heart electrical vector. Indeed, as shown in Table 7.2, the most
accurate prediction performance is guaranteed by the combination of a frontal lead with
a limb lead, as proved by the related high AUC values. By contrast, contributions coming
from the same planes are not equally meaningful, or they poorly cluster the groups of
interest. A similar result has been demonstrated by the LR analysis of f-wave amplitude
in Sec. 6.4, in which CA outcome prediction performance of atrial amplitude descriptors
determined on small ECG subsets proves to be more accurate when leads belonging to
different heart planes are taken into account. On the other hand, we can remark that
such method does not benefit from PCA preprocessing of raw AA data. Joint analysis of
entropy on subsets of ECG leads confirms its robustness and efficacy in characterizing AF
at a higher degree of accuracy than single-lead methods, due to their strong prediction
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performance dependence on electrode selection, as confirmed by Fig. 7.3 The higher JE,
the more likely procedural AF termination, e.g., in leads I and V3, AUC= 0.95, AF
termination: 7.17 ± 0.82, Non AF termination: 5.43 ± 1.69, p value: 3.45 · 10−5. As
in Sec. 7.3, negentropy analysis reveals a relation between bivariate IT measures and
AA signal amplitude. Indeed, standard deviation of negentropy values computed on the
AA signal normalized by its variance is globally lower (σ(Neg(X, Y )NORM) = 3.2 · 10−4)
than that determined on data in absence of normalization (σ(Neg(X, Y )) = 0.10). As a
consequence, also in this case the higher JE values denote a more organized AF activity,
which is reflected by higher atrial amplitude values, ans are significantly correlated with
procedural AF termination by CA.
As far as the MMI multilead perspective is concerned, MMI does not seem to be able
to effectively predict freedom from AF recurrence in the long-term follow-up. One of
the main drawbacks is represented by the choice of the conditional variable prior to its
computation, which is not guided by any quantitative criteria. In Table 7.3 we can note
how variable and irregular classification performance is with respect to the electrodes
examined, and how the MMI discriminative power can remarkably decrease if the condi-
tional variable is not adequately selected. No significant differences between the groups of
interest when increasing the number of variables and examining the whole standard ECG,
thus confirming the redundancy exhibited by the electrodes removed by the reduced 8-
lead subset under examination. Prediction of candidates to CEE after CA has been
investigated as well. However, no significant results have been reported, thus they are
not included in this dissertation, and we exclusively focus on clinical tasks in which IT
measures demonstrate to provide relevant contribution. We did not report experimental
details concerning prediction of acute AF termination by CA, since the discriminative
power of the MMI index proves to be quite low in this context.
In the light of these considerations, given the relationship between IT measures and f-
wave amplitude demonstrated in Sec. 7.4.3, we now investigate whether this property can
be properly enhanced by PCA reduced-rank approximations of the AA signal, in keeping
with Sec. 4.3, so as to improve AF characterization and therapy outcome assessment.
7.4.4 What happens if we apply PCA?
In order to explore the potential PCA combination with IT feature extraction, features
defined in the IT scenario are computed on the rank-1 truncation of AA signal introduced
in Eq. (4.19).
In the bivariate framework, the same type of analysis explained in Sec. 7.4.1 is repeated
by computing IT features on the AA signal approximated by CA, and results are shown
in Table 7.4 and Table 7.5.
Acute AF termination by CA seems to be considerably improved by PCA-based AA
signal reduced-rank approximation in certain pairs of ECG leads, in particular those
including lead V5, as displayed in Table 7.5. This lead is located close to the left anterior
axillary line, yet our analysis is limited by the lack of a relevant clinical interpretation of
its role in AF characterization. In most of the ECG leads’ combinations examined, higher
values of this bivariate index significantly predict AF termination by CA in the long-term
follow-up, whereas recurrence of this arrhythmia seems to be depicted by lower JE values,
in line with remarks made about links between marginal entropy and atrial amplitude in
Sec. 7.3.2.
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Table 7.4: ROC analysis of the long-term CA outcome for each pair of ECG leads by
means of the JE index after PCA preprocessing of the AA signal. ECG leads examined
are underline by the symbol ×.
Leads AUC I II V1 V2 V3 V4 V5 V6
[V2 V3] 0.95 X X
[V2 V4] 0.92 X X
[I V2] 0.88 X X
[I V3] 0.87 X X
[V3 V4] 0.84 X X
[V1 V3] 0.84 X X
[V1 V2] 0.82 X X
[II V2] 0.82 X X
[V1 V4] 0.81 X X
[I V4] 0.74 X X
[V2 V5] 0.73 X X
[II V3] 0.73 X X
[I V1] 0.71 X X
[V2 V6] 0.71 X X
[II V1] 0.67 X X
[I II] 0.64 X X
[II V4] 0.62 X X
[II V6] 0.62 X X
[V3 V5] 0.61 X X
[V3 V6] 0.61 X X
[V5 V6] 0.59 X X
[II V5] 0.56 X X
[V4 V6] 0.54 X X
[I V5] 0.51 X X
[V4 V5] 0.51 X X
[I V6] 0.50 X X
[V1 V6] 0.50 X X
[V1 V5] 0.47 X X
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Table 7.5: ROC analysis of the short-term CA outcome for each pair of ECG leads by
means of the JE index after PCA preprocessing of the AA signal. ECG leads examined
are underline by the symbol ×.
Leads AUC I II V1 V2 V3 V4 V5 V6
[V4 V5] 0.92 X X
[V3 V5] 0.90 X X
[V5 V6] 0.89 X X
[V4 V6] 0.86 X X
[II V5] 0.85 X X
[V2 V5] 0.78 X X
[I V5] 0.78 X X
[V1 V2] 0.78 X X
[II V6] 0.76 X X
[V3 V6] 0.76 X X
[V3 V4] 0.70 X X
[II V4] 0.69 X X
[V1 V5] 0.69 X X
[I V1] 0.68 X X
[II V1] 0.68 X X
[I V2] 0.67 X X
[I V6] 0.65 X X
[II V3] 0.61 X X
[V2 V6] 0.60 X X
[I V4] 0.58 X X
[V1 V3] 0.57 X X
[V2 V4] 0.56 X X
[II V2] 0.56 X X
[I V3] 0.54 X X
[I II] 0.53 X X
[V1 V6] 0.52 X X
[V1 V4] 0.52 X X
[V2 V3] 0.43 X X
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Table 7.6: Unpaired statistical analysis and long-term CA outcome prediction perfor-
mance of MMI measures.
AF termination Non AF termination p-value AUC Sensitivity Specificity Best cut-off
MMI8 2.52± 0.54 1.55± 0.33 7.2 · 10−4 0.93 0.93 0.86 1.56
MMI12 2.53± 0.54 1.63± 0.36 1.8 · 10−3 0.93 0.93 0.86 1.75
H(V1) 1.99± 0.29 1.86± 0.34 3.0 · 10−1 0.58 0.69 0.43 1.87
On the other hand, when looking at longer follow-up periods, even though CA predic-
tion performance is extremely accurate on most of the ECG lead pairs examined and com-
parable with that reported on AA data, we can remark that physiological interpretation
about the descriptive power of orthogonal planes in AF electrical activity characterization
is partially lost. Also the role played by the most recurrent leads in the most discrimi-
native pairs, i.e., V2 and V3 (see Table 7.4), needs to be further elucidated. Generally
speaking, PCA preprocessing does not seem to significantly improve IT feature extraction
when processing pairs of ECG leads, since variables determined on PCA reduced-rank
approximations are all the same up to scale.
PCA preprocessing of the AA signal has also been combined with MMI computation
in a multilead framework. Accordingly, this index has been computed on the ensemble
of 8 linearly independent ECG leads and expressed as mean ± standard deviation. Fur-
thermore, its descriptive power is compared with that of the same index determined on
the full 12-lead ECG. In this experimental section we have interestingly remarked that
PCA decomposition of AA data makes the MMI parameter independent of the conditional
variable selected, and its value remains unvaried. Accordingly, after PCA performance,
we can consider only one MMI value instead of the 8 possible combinations obtained on
raw data. This method is also compared with a single-lead descriptor of entropy in V1,
denoted H(V1). The ability to discriminate between the categories of interest (“AF termi-
nation” vs “Non AF termination”) is quantified by the p value of the unpaired test, and
AUC analysis is carried out as well. All results are reported in Table 7.6. Independence
from the conditional variable chosen prior to MMI computation may be explained by
the fact that single-lead signals are all equal between each other up to a scale factor
after PCA rank-1 approximation. However, unlike JE, this phenomenon considerably
increases MMI index reliability, as it makes its computation independent from ECG lead
selection. It can be probably explained by the definition of the rank-1 approximation in
Eq. (4.19), underlining that in the AA signal truncation the dominant PC is influenced
by the dominant spatial topography m1 exclusively in each lead, and such modulation
may not be captured by the ROC analysis. MMI feature extraction after running PCA
notably improves prediction results, as demonstrated by the AUC analysis in Table 7.6,
on both groups of leads considered in this section. Indeed, after PCA preprocessing, both
parameters MMI8 and MMI12 are able to highlight significant differences between the
categories examined. AF termination by CA is predicted by higher values of such de-
scriptors, thus corroborating the hypothesis of a more organized and regular AF pattern,
which is easier to be predicted and treated by ablation therapy.
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7.5 Summary and conclusions
This chapter gives an overview of the basic concepts in the IT framework and their
main applications, with particular interest to clinical tasks. After providing some math-
ematical tools and definitions, our investigation demonstrates the ability of such indices
to emphasize AA signal predictive features, as well as underlining several aspects of ECG
spatial variability. Higher values of the IT indices significantly correlate with successful
CA procedures in the long-term follow-up. Moreover, they enhance AF content at or-
thogonal angles and orientations of the heart electrical activity, thus enriching disease
characterization. A more detailed analysis of some theoretical properties of IT indices
should be carried out, in particular when the dimension of the problem is higher than 2.
Moreover, physiological interpretation of multivariate measures needs to be more deeply
investigated. Finally, further attention should be paid to some algorithm parameters, in
particular those related to AA signal histogram computation. Results concerning this
part of the our study are still preliminary and deserve further investigation. However,
they corroborate the role of interlead spatial correlation as a descriptor of AF content
on multilead ECG, without accounting for signal temporal characterization. In the next
chapter, our research demonstrates that a further characterization of AF content can be
provided by features describing the distribution of RR intervals (RRIs) in a parametric
probabilistic approach.
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8Ventricular response characterization during
AF in a point process framework
8.1 Introduction
It is widely known that the irregular electrical dynamics typical of AF strongly influ-
ence the ventricular activity. Indeed, several studies demonstrated that the electrophysi-
ological properties of the AV junction are profoundly altered in presence of AF [20, 82].
More precisely, the irregular pattern of ventricular responses during AF are determined
by effects of concealed conduction and modifications of the physiological refractory period
of the AV junction, whose length is related to the duration of the preceding RR intervals
(RRIs). The study led in [34] also showed that alterations in AV node function and its
refractoriness during AF are reflected on RRI distribution irregularity on ECG. Indeed,
in subjects affected by AF the AV node transmits the random, fibrillatory atrial pattern
to the ventricles at a scaled-down rate, thus converting the rapid firing input into a slower
ventricular response [76]. Given these considerations, if such mutual relationships are to
determine the RRI behavior in AF, at least some correlation between the duration of a
RRI and that of its successors can be expected. AF effects on ventricular responses make
heart rate control one of the main strategies in its treatment [170] and ventricular response
analysis. In addition, estimation of the effects of several pharmacological therapies has
been performed [141]. Further clinical applications also concern ECG-based AF detec-
tion, which can help rapidly diagnosing ventricular arrhythmias [113]. The study in [33]
demonstrates that populations of predominant RRIs, i.e., the most probable intervals,
are multiple of the AV node refractory period, which are in turn related to AF cycle
length. Research led in [32] established that ventricular response during AF is affected
not only by AV node properties, but also by fibrillatory process irregularity. Similar
remarks in [76] confirm that ventricular rhythm is profoundly altered by AF complexity.
In [160] the presence of multiple electrical pathways in AV nodal tissue during AF has
been correlated to the number of peaks of the RRI histogram. An attempt to characterize
ventricular variability in the presence of AF has been made in [151], which assessed vagal
tone control by means of heart rate variability (HRV) features. The predictive power
of such features has also been employed in [158] to verify AF recurrence after electrical
cardioversion. However, in most of the previous studies RRI distributions are visually
inspected, and quantitative assessment of their features is not accomplished. An attempt
in modeling probabilistic properties of RR length time series is then made in [65]. Never-
theless, such an approach provides significant results only if applied to stationary signals,
and it is also highly dependent on histogram setting parameters (in particular the bin
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width), thus making it hard to generalize analysis results. In [35] the refractory periods
of the AV node dual pathways and other properties of electrical pattern propagation are
determined by performing maximum likelihood (ML) estimation of the RRI series. In [36]
some properties are also characterized on the Poincaré plot of the RRIs. Nevertheless,
all these methods prove their efficacy on long ECG recordings (at least 10 minutes up to
24-hour Holter recordings), which are not always available in daily clinical practice.
In this doctoral thesis we assume that AF properties are reflected on ECG signals and
are linked with therapy outcome. Indeed, electrical wavefronts spreading through the AV
node are altered by AF, since their firing rate is higher and their propagation more chaotic
and irregular. This induces a higher degree of refractoriness in the AV node, which delays
atrial impulses, or even blocks some of them, thus leading to concealed conduction effects.
All these events cause an irregular ventricular rhythm, and we hypothesize that they can
be investigated on surface ECG. To this end, assessing RRI variability can help shed some
light on alteration of ventricular response in presence of AF and that such complexity and
unpredictability can somehow influence AF therapy outcome. In this chapter we illustrate
a novel parametric method for characterizing the probability distribution of heartbeat
interval series, regarded as a history-dependent inverse Gaussian (HDIG) point process,
as opposed to standard non-parametric methods [11]. To our knowledge, this method
has been applied for the first time to AF analysis. Point process theoretical framework is
introduced in Sec. 8.2. The parameters involved in AF content characterization enable the
computation of features on RRI distribution which have been first employed as predictors
of CA outcome in Sec. 8.3. Then, we also describe an application to AF pattern recognition
in Sec. 8.4, in which these indices can significantly distinguish patients affected by the
disease from healthy SR subjects. Finally, the main conclusions about this methodology
are summarized in Sec. 8.5. Most of the theoretical concepts presented in this chapter
takes a step from the study in [11, 23].
8.2 Point process modeling of RRI distribution
8.2.1 Point process model assessment
Our model definition takes a step from the physiological process of R wave generation.
Indeed, R wave occurrences can be represented as a sequence of discrete events in con-
tinuous time, namely, as a point process [11]. Every R wave event is correlated with the
depolarization phenomenon starting in the SA node in the RA and then propagating to the
LA and the ventricles. After each depolarization process, the transmembrane potentials
of the conduction system cells return to their resting values, so that the spontaneous rise
toward depolarization threshold can start again. The beginning of this rise also marks
the beginning of the waiting time until the next ventricular contraction (i.e., the next
R wave). Previous studies demonstrated that the time between 2 consecutive threshold
crossings, i.e., the RRI length, is more accurately modeled by the inverse Gaussian (IG)
distribution [145]. This length is not fixed, but it varies according to the sympathetic and
parasympathetic dynamic inputs from the autonomic nervous system to the SA node,
whose effects can persist on the following heartbeat for several seconds [11]. More specif-
ically, an increase in the sympathetic input reduces RRI length, whereas an increase in
parasympathetic action leads to the opposite effect. It turns out that RRIs cannot be
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regarded as mutually independent, but it is reasonable to hypothesize their dependence
on the previous history of these time-varying inputs. In addition, as previously stated,
further contributions mechanisms contribute to modulate R wave temporization during
AF because of the alterations in AV node conduction and the irregular propagation of the
electrical wavefronts in the atria [36].
Let us consider an ECG interval (0, T ], where K consecutive R waves 0 < u1 < u2 <
, . . . , < uk <, . . . , < uK ≤ T at time {uk}k = 1K occur. We assume that the proba-
bility density of RRIs over the ECG recording can be modeled by a HDIG distribution
f(t,Huk ,θ) for each instant t > uk. Each interval wk = uk − uk−1 is considered as
dependent on its previous history Huk = (uk, wk, wk−1, . . . , wk−q+1), i,e., q the most recent
RRIs. The probability density function (PDF) fRR(t,Huk ,θ) of the waiting time before
the next R wave event is defined as:
fRR(t,Huk ,θ) =
(
θq+1
2pi(t− uk)3 )
) 1
2
exp{−12
θq+1[t− uk − µ(Huk ,θ)]2
µ(Huk ,θ)2(t− uk)
} (8.1)
where θ = θ(t) = [θ0, θ1, . . . θq] is a vector of model parameters and θq+1 is the distribution
shape factor. The PDF mean value µ(Huk ,θ) = µRR can be mathematically expressed a
linear combination of the most recent q intervals:
µRR = µ(Huk ,θ) = θ0 +
q∑
j=1
θjwk−j+1 (8.2)
thus summarizing the effects of the recent sympathetic and parasympathetic dynamic
inputs to the SA node on the RRI duration, namely, we take into account the influence
of RRI previous history on the successive R-wave occurrences.
In Fig. 8.1 we plot the HDIG distribution for some fixed values of the mean µRR and
the scale factor θq+1. The former represents the barycenter of the PDF; the latter yields
a measure of the shape of the distribution: the higher its value, the less peaked the PDF,
the slower the decaying of the right tail, the more the model resembles a Gaussian PDF
with the same mean value. We set q = 0 in these graphical examples, thus assuming RRI
history independence, so as to give an idea of the shape of this kind of distribution.
The HDIG PDF defined in Eq. (8.1) depicts the stochastic properties of the RRIs, thus
it can be employed to describe RRI variability by means of suitable statistical features.
Since heart rate (HR) is generally defined as the reciprocal of the RRIs, for any t > uk,
for any RRI t− uk, we can also introduce the HR random variable r = c(t− uk)−1, where
c = 60 s/min is the factor of conversion from seconds to beats per minute (bpm) [11].
This is a one-to-one transformation, which allows for deriving the HR PDF from the RRI
distribution in Eq. (8.1) by means of the transformation:
fHR(r|Huk ,θ) =
∣∣∣∣∣ dtdr
∣∣∣∣∣ fRR(t|Huk ,θ) (8.3)
thus rendering HR stochastic properties. This parametric modeling enables the assessment
of HR and RR variability, whose dynamics can be tracked instant by instant with no need
for interpolation between consecutive heartbeat intervals.
Several approaches for modeling RRI series PDF are examined in this section.
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Figure 8.1: Some representative examples of HDIG PDF.
1) Non-parametric analysis of RRI time series: RRIs wk are considered indepen-
dent of each other. HR and HRV descriptors are computed under no assumptions
on heartbeat interval PDF; their mathematical expresions are provided in Sec. 8.2.2.
2) Point process analysis of a stationary RRI time series: we assume that RRI
series is a point process with time-invariant statistics and that its PDF obeys a
HDIG law. We test two distinct hypotheses. To a first approximation, the first
moment of the distribution is considered equal to the mean RRI length RR. In
further analysis, all the parameters of interest are computed as a function of the
actual HDIG mean value, which thus depends on the first q intervals of the series, as
in Eq. (8.2). This comparison assesses the reliability of the RRI regression model,
whose output values are supposed to be similar in those actually computed on the
raw series.
3) Point process analysis of a non stationary RRI time series: RRI series is
regarded as a non stationary point process. The HDIG model can be applied in
this case as well, but its statistics are time-varying. Indeed, the series is split in
multiple subintervals, and distribution parameters are determined by local ML of
the IG distribution. Accordingly, each RRI wk can be regarded as a linear function
of the q previous ones wk−j, j = 1, . . . , q, and the first moment is defined at each
time instant as in Eq. (8.2). The output value of distribution statistics equals the
temporal average of their instantaneous estimates.
Going in more detail in the point process approach, under RRI series stationarity
assumptions, ML estimation of PDF characteristic parameters, namely, µRR and θq+1,
is globally performed on the whole length of the RRI series by taking into account the
first q R-wave events, thus each of them takes only one value along the series itself.
However, unless the series pattern is very regular and stable, it can be necessary to take
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into account a higher level of variability in time, especially in subjects affected by AF.
Accordingly, when series is assumed non stationary, ML estimation of instantaneous HR
and HRV is locally carried out on observation time intervals with length L∗ [11]. At
each time instant t, we define an interval (t − L∗, t] in which we observe n R waves
t− L∗ < u1 < u2 < · · · < unt ≤ t where distribution parameter θ can be instantaneously
defined as θt. The parameter ∆ is also set to indicate how much each interval must be
shifted so as to compute the next parameter update. ML estimation performance requires
the definition of the local joint PDF of the R waves (u1, . . . , unt), where each occurrence
is conditioned on the previous q events according to the law:
log fRR((u1, . . . , unt)|θt) =
nt∑
i=2
W (t− ui) log fRR(ui − ui−1|Hui−1 ,θt)
+W (t− unt) log
∞∫
t−unt
fRR(ν|Hunt ,θt)dν
(8.4)
whereW (t−u) = exp{−α(t−u)} is a weighting function, characterized by a time constant
α assessing the degree of influence of the previous observation u on the local likelihood
at time t. Once the estimation θ̂t is determined, we move from interval (t − L∗, t] to
(t− l+ ∆, t+ ∆], and local ML estimation is performed again. Prior to ML performance,
we also need to set a time resolution parameter tu for updating statistics. The procedure
is continued until the end of the RRI time series.
8.2.2 Heart rate and RRI variability feature extraction
Extraction of HRV measures and analysis of RRI probability distribution is motivated
by some empirical considerations. More precisely, we computed the RRI histogram in
one of the AF patients of our database, so as to compare it with one determined in a SR
healthy subject (see Fig. 8.2 ).
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Figure 8.2: RRI histogram: Left: AF, subject 7; Right: SR, subject 8.
Their visual inspection in Fig. 8.2 highlights a certain level of asymmetry around
the distribution mean in the histogram, which is rather tailing toward long RRIs, in
contrast with the PDF in case of SR. Indeed, as stated above, during AF rapid atrial
activations irregularly propagate throughout the AV node, leading to a correspondingly
irregular ventricular activation, as reflected on RRIs on the ECG. These effects can be
also observed in the RRI length time series plot in Fig. 8.3. During SR, not only RRIs
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Figure 8.3: RRI time series as a function of R wave time instants: Left. AF, subject 7;
Right. SR, subject 8.
are more evenly spaced, but their duration seems to be characterized by a low degree of
variability. By contrast, during AF, repetition rate of RRIs seems considerably higher, and
their length values are more irregularly distributed. These remarks lead us to investigate
whether more elaborate descriptors of RRI variability can quantify such characteristics on
the heartbeat interval series and overcome the limitations of traditional histogram-based
methods.
We determined the following descriptors of RRI variability each heartbeat interval
model proposed in Sec. 8.2.1.
• Skewness: it assesses the level of asymmetry of the RRI PDF, and it is defined as:
Skewness = E{(wk − RR)
3}
E{(wk −RR)2} 32
. (8.5)
Positive skewness values are typical of distributions with a longer right tail (as for
RRI histogram in the presence of AF); a negative skewness means a longer left tail.
If the distribution is symmetric about its mean, its skewness is equal to zero. In the
HDIG model, one of the main advantages is that skewness and all the HRV indices
can be expressed exclusively as a function of the distribution parameters, i.e., the
mean µRR and the factor shape θq+1, thus enabling results’ generalization. As a
consequence, Eq. (8.5) can be rewritten as:
Skew = 3
√
µRR
θq+1
. (8.6)
Such differences in symmetry between AF and SR subjects can be visually detected.
However, no studies have so far quantitatively assessed such a dissimilarity, hence
the interest in evaluating this feature in our ECG database.
• RRI standard deviation: RRI length irregularity typical of AF can be also
detected by visual inspection and intuitively estimated by second-order statistics
SDNN = E{(wk−RR)2} quantifying the degree of scattering of data distribution.
In the point process framework, it can be identified with the second moment of the
HDIG distribution:
σRR =
√√√√µ3RR
θq+1
. (8.7)
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• Mean RRI: it is computed as the average value of all RR lengths (RR) in the
non-parametric description. It is also an accurate approximation of the HDIG first
moment as demonstrated in the experimental section. The point process charac-
terization of this parameter underlines the dependence of RRI length on previous
history according to the definition in Eq. (8.2).
• HR mean value: it is conventionally assumed as the reciprocal mean RRI (HR).
For the HDIG model, it can be expressed as a function of µRR:
µHR = c(µ−1RR + θ−1q+1). (8.8)
• HR standard deviation: defined as the standard deviation of the reciprocal RRIs
SDHR, adequately scaled by the conversion factor c. In the HDIG density function,
it is expressed as:
σHR =
c
θq+1
√
2 + θq+1
µRR
(8.9)
In the following sections we illustrate some clinical applications in AF treatment and
investigation based on the point process characterization of these HRV features.
8.3 Point process analysis of heart rate and heart
rate variability in CA outcome prediction
8.3.1 Methods
The first task concern CA outcome prediction, and we attempt to discriminate between
effective and failing CA procedures at different follow-up lengths. Accordingly, RRI time
series have been extracted on each of the standard ECGs acquired in 36 patients before
CA performance prior to evaluation of the long-term CA outcome. This database has
been already introduced in Sec. 3.5.5.
Selection of the point process regression order
The choice of the optimal order q of the HDIG model is guided by the Akaike infor-
mation criterion (AIC), defined as:
AIC = 2q + 1
NRR
+ 2 logE (8.10)
where E stands for the final prediction error of the estimated q-order model of the RRI se-
ries with length NRR computed by means of the Yule-Walker (or autocorrelation) method.
In an autoregressive (AR) model of order q, the current output is linearly dependent on
the past q outputs plus a white noise input. The AIC criterion measures the trade-
off between the fitting quality of a model and the number of model parameters needed
to achieve such level of accuracy. This method assumes that the system examined is
driven by white noise and attempts to fit a q-th order AR model to the actual series, by
minimizing the forward prediction error in the LS sense. This formulation leads to the
Yule-Walker equations, which are solved by the Levinson-Durbin recursion [112]. In the
light of these considerations, we compute the prediction error E once set AR regression
order q, ranging from 1 up to 10, and for each subject we choose the order q minimizing
the aforementioned criterion.
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8.3.2 Goodness-of-fit evaluation
Once chosen the most appropriate regression order, we actually verified whether
the HDIG model proposed effectively describes original data PDF. Evaluating model
goodness-of-fit when attempting to fit spike train series data is not a straightforward
extension of the continuous-valued process theory. As a consequence, standard measures
of discrepancies between estimated model and raw data PDF (e.g., the NMSE index)
cannot be directly used for the point processes [23]. Accordingly, several methods have
been put forward in order to convert discrete processes to continuous-valued processes and
perform this comparison by means of classical measures. In the point process framework,
a widely accepted theory is represented by the general time-rescaling theorem [108]. It
states that any point process may be rescaled into a Poisson process with a unit rate,
provided that it has an integrable rate function λ = λ(t,Huk ,θ), defined as:
λ = fRR(t,Huk ,θ)
1−
t∫
0
fRR(ν,Hν ,θ)dν
(8.11)
The rescaled heartbeat intervals can be generated by this model through the relation:
τk =
u−k∫
uk−1
λ(ν,Hν)dν (8.12)
for k = 1 . . . , K consecutive R waves. The output variables are independent exponential
variables with unity mean. Accordingly, if we apply the transformation:
zk = 1− exp {τk} (8.13)
the new variables zk are independent and uniform in the interval [0, 1]. Since the trans-
formations in Eq. (8.12)- (8.13) are one-to-one, every comparison between the variables
zk and a uniform distribution directly refers to the relation between the model and the
actual data.
In this framework, the Kolmogorov-Smirnov (KS) test allows us to quantify the degree
of fitting precision in terms of distance between the point process model and the input
RRI data. The lower the distance, the closer the model to the real RRI series. Construct-
ing this test requires arranging zk values in increasing order, thus yielding the sequence
z∗k. Subsequently, the cumulative distribution function (CDF) of the uniform density is
computed as bk = k−0.5K , k = 1, . . . , K, and it is plot against the z
∗
k values. If the model
is correct and fitting is accurate, the points of this plot should lie on the 45◦-degree line.
Confidence bounds are determined by the KS statistic, and they are expressed as bk± 1.36√K .
Some examples of KS plot are provided in Fig. 8.4.
In agreement with the time-rescaling theorem, the rescaled intervals τk must be in-
dependent, regardless of the level of independence of the actual RRIs, thus the model
proposed is consistent with the input series. As independence is not easily quantifiable
in a time series, we can simplify our analysis and assume that, if rescaled RRIs are at
least uncorrelated, they are more likely to be independent as well. Accordingly, a further
strategy to verify whether model properties are respected is computing the autocorrelation
function of the rescaled τk values. For each patient we have taken into account 10 lags: the
lower their values, the higher the degree of uncorrelation. Some examples are displayed
in Fig. 8.5.
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Figure 8.4: Representative examples of KS plots for testing HDIG model goodness-of-fit.
Top: an example of accurate fit (patient 2). Bottom: an example of poor fit (patient 22).
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Figure 8.5: Representative examples of autocorrelation function of the rescaled RRIs and
their related bounds of confidence. Top: good agreement with uncorrelation hypothesis
(patient 5). Bottom: an example of low consistency with uncorrelation hypothesis (patient
31).
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8.3.3 Unpaired statistical analysis
Algorithm parameters’ setting is followed by the computation of the models explained
in Sec. 8.2.1 and HRV indices defined in Sec. 8.2.2. The predictive power of each HRV
measure in assessed by the ROC analysis, and statistical interclass differences are quanti-
fied by the p value on an unpaired test (t test in the presence of normal data distributions,
Mann-Whitney U test otherwise) under the confidence level α = 0.05.
In order to compute HRV indices and improve their accuracy, as far as the non-
stationary RRI model in concerned, the window length ∆ for local ML estimation is taken
as large as possible, thus reducing the number of values involved in the final average of
model statistics. In addition, employing shorter windows in certain subjects sometimes
can give rises to isolated, spurious negative µRR values, which are not consistent with basic
hypotheses about HDIG PDF definition. Therefore, for a RRI series with NRR samples,
the length of such window is assumed equal to ∆ = NRR − 1, by keeping a resolution
tu = 5 ms.
The order of the HDIG model q has been chosen so as to minimize the AIC criterion as
defined in (8.10), in a set of values ranging from 1 to 10. The overall number of subjects
ns for whom each order value q is optimal is reported in Table 8.1, as well as the rate of
occurrences per category (“AF termination” vs “Non AF termination”). The analysis of
these results led us to set q = 1 prior to estimation of each model.
Table 8.1: Number of subjects ns for whom regression order q is optimal according to the
AIC criterion.
HHHHHHns
q 1 2 3 4 5 6 7 8 9 10
All patients 11 5 3 2 3 2 3 2 1 4
Goodness-of-fit of each model has been assessed by the KS test. Local ML estimation
is performed on several intervals, whose width is equal to the 60% of the whole series
length,so as to account for a sufficient number of samples for accuracy assessment, in
agreement with series total length at the same time. The analysis of the KS plot in each
subject allowed us to verify any possible deviations form the reference uniform distribution
(represented by the 45◦-degree line in the plot). Two representative examples are displayed
in Fig. 8.4. The maximum KS distance provides us such a measure of model goodness-of-
fit. The percentage of points in the KS plotNKS exceeding the confidence bounds has been
computed in each subject as well and averaged over the whole database. Such results are
indicated for the two patients’ groups of interest in Table 8.6. Further confirmation about
model representation ability is also provided by the examination of the autocorrelation
function of the rescaled RRIs; two examples are shown in Table 8.5.
After verifying HDIG model accuracy, CA outcome prediction performance has been
assessed on the HRV features for each of the models aforementioned. Findings of the
statistical analysis are summarized in Table 8.2- 8.5, besides the results of the ROC
analysis, i.e., the AUC index and the related cutoff, and the rates of sensitivity and
specificity.
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Table 8.2: Long-term CA outcome prediction: HR and RRI variability parameters under
the RRI independence assumption (non-parametric approach); n.u.: normalized units;
bpm: beats per minute.
AF termination Non AF termination p value AUC Optimal cutoff Sensitivity Specificity
Skewness [n.u.] 0.50± 1.15 0.75± 0.79 5.8 · 10−1 0.61 0.86 0.69 0.71
SDNN [s] 0.16± 0.08 0.14± 0.04 6.9 · 10−1 0.52 0.14 0.45 0.57
RR [s] 0.74± 0.18 0.76± 0.11 8.0 · 10−1 0.56 0.69 0.45 0.71
HR [bpm] 90.79± 22.15 83.52± 12.12 4.1 · 10−1 0.57 89.79 0.62 0.43
SDHR [bpm] 28.41± 61.43 15.33± 4.34 5.8 · 10−1 0.63 13.89 0.41 0.86
Table 8.3: Long-term CA outcome prediction: HR and RRI variability parameters; RRI
time series is considered stationary and obeys a HDIG model. Approximation of the first
moment to mean RRI (µRR = RR); n.u.: normalized units; bpm: beats per minute.
AF termination Non AF termination p value AUC Optimal cutoff Sensitivity Specificity
Skew 0.64± 0.33 0.55± 0.12 4.0 · 10−1 0.61 0.55 0.72 0.43
σRR 0.16± 0.11 0.14± 0.04 5.4 · 10−1 0.53 0.14 0.52 0.57
RR [s] 0.74± 0.18 0.76± 0.11 8.0 · 10−1 0.56 0.69 0.45 0.71
µHR 90.72± 22.12 83.45± 12.04 4.1 · 10−1 0.57 89.86 0.62 0.43
σHR 19.17± 11.29 15.26± 4.02 3.4 · 10−1 0.62 14.56 0.66 0.57
8.3.4 Results
In 1 patient out of 7 experiencing an ineffective CA procedure some points fall outside
the confidence band of the KS plot. Similar remarks can be made for 4 patients out 29
among those who underwent a successful CA procedure. Nevertheless, the number of
outliers is negligible with respect to the amount of KS plot points, as it can be inferred
from Table 8.6. Accordingly, no patients have been discarded from our investigation.
Examination of the autocorrelation function of the rescaled RRIs also underlines the
agreement of the HDIG model with the uncorrelation hypothesis. Indeed, even though
autocorrelation function values fall within the confidence interval in 31 patients out of
36, we can remark that only one outlier point can be detected outside the band for these
subjects and that its deviation from confidence band is very limited. Therefore, the point
process model is effectively capable of depicting RR series in AF patients and render its
variability properties.
Despite modeling effectiveness, extraction of HRV features in patients affected by AF
does not seem to highlight any potential predictive features from which CA outcome
assessment can benefit from. Indeed, regardless of the methodology proposed, no HRV
parameter is able to predict procedural AF termination, as results in Tables 8.2- 8.5 con-
Table 8.4: Long-term CA outcome prediction: HR and RRI variability parameters; RRI
time series is considered stationary and obeys a HDIG model. The actual mean µRR of
the distribution is herein employed for statistics’ computation; n.u.: normalized units;
bpm: beats per minute.
AF termination Non AF termination p value AUC Optimal cutoff Sensitivity Specificity
Skew 0.64± 0.32 0.55± 0.12 4.5 · 10−1 0.60 0.56 0.56 0.71
σRR 0.16± 0.10 0.14± 0.04 9.7 · 10−1 0.51 0.13 0.56 0.57
µRR 0.74± 0.18 0.77± 0.10 5.2 · 10−1 0.58 0.68 0.59 0.57
µHR 91.34± 23.05 82.26± 11.15 3.2 · 10−1 0.60 97.11 0.62 0.57
σHR 19.28± 11.52 15.16± 4.03 3.0 · 10−1 0.63 14.10 0.45 0.71
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Table 8.5: Long-term CA outcome prediction: HR and RRI variability parameters; RRI
time series is assumed non-stationary and obeys a HDIG model. The temporal average
of features’ instantaneous values is examined in the statistical analysis; n.u.: normalized
units; bpm: beats per minute.
AF termination Non AF termination p-value AUC Optimal cutoff Sensitivity Specificity
Skew 0.67± 0.47 0.55± 0.11 3.8 · 10−1 0.61 0.56 0.66 0.57
σRR 0.17± 0.14 0.14± 0.03 6.6 · 10−1 0.56 0.13 0.45 0.86
µRR 0.74± 0.18 0.75± 0.10 9.0 · 10−1 0.55 0.68 0.41 0.86
µHR 91.49± 23.69 84.05± 10.83 4.3 · 10−1 0.57 91.48 0.62 0.43
σHR 20.87± 20.67 15.36± 3.78 3.4 · 10−1 0.62 14.00 0.62 0.43
Table 8.6: Evaluation of the goodness-of-fit of the HDIG model in CA outcome prediction:
maximum KS distance and percentage of points inside the confidence bounds.
AF termination Non AF termination
KS distance 0.11± 0.03 0.14± 0.06
NKS[%] 98.55± 5.06 96.31± 9.76
firm. Indeed, no statistically significant differences between the categories examined are
emphasized by such indices, and prediction accuracy as quantified by the ROC analysis
seems to be rather poor as well. Even though we are not able to provide any clinical
explanation of this phenomenon, we can hypothesize that the exclusive characterization
of the ventricular response only does not prove sufficient to describe the complexity and
the randomness of the AF pattern. Indeed, ventricular activity irregularity is a reflection
of AA in the presence of AF, whose effects are not easily quantifiable. We should also to
mention that not all patients are treated by exactly the same CA steps, thus making it
harder to compare the groups of interest. Despite the agreement of a procedural protocol,
consisting of a fixed number of specific steps, patient’s conditions and physical reactions
at the moment of the procedure profoundly influence some decisions, such as the number
and the type of lesions actually performed, thus increasing the degree of variability and the
complexity of ablation, which could be harder to be described by the ventricular response
only. Finally, CA always implies modifications on one or more sites (for instance, PVs,
LA, CS, etc.), whose contribution to AF dynamics is generally at least comparable to that
coming from the SA, whose activity risks to be hidden. In the light of these considera-
tions, we can deduce the inability of our analysis to shed some light about the effective
potential of the point process modeling to predict AF termination by CA, which can be
probably helped by adding some complementary features for patients’ characterization
and/or improving the HDIG model adopted (e.g., with AF non-linearities integration).
8.4 Point process application to AF pattern recog-
nition
8.4.1 Introduction
Despite the weak predictive performance of the point process modeling in CA out-
come assessment, we demonstrate next that this approach can actually emphasize some
properties of RRI series which are typical of AF and help its diagnosis and character-
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ization. In clinical centers, AF is often visually investigated, either by detecting the
absence/presence of the P wave (replaced by irregular fibrillatory waves) or alterations
in the heartbeat distribution variability, more irregular in subjects affected by AF. RRIs
analysis presents some advantages, such as the easier detection of the R peaks on the ECG
and their robustness to artifacts and signal noise, which can alter waveform pattern, in
particular the shape of the P wave. Furthermore, it is practically unaltered by the choice
of a specific electrode on multilead ECG recordings, whereas most of the classical ECG
characterization methods (especially those performed on a single lead) require an accurate
ECG inspection prior to lead selection.
Particular attention has been paid to RRI histogram analysis, and we actually show
that some characteristics of RRI PDF are exclusively encountered in AF patients, and not
in healthy subjects. This assumption derives from investigation about RRI histograms
acquired in AF patients, and then compared with those computed in SR control subjects.
We include one example for each group of subjects in Fig. 8.2 for the sake of clarity. Visual
inspection of RRIs histograms reveals a higher degree of asymmetry around PDF mean
value in AF patients, tailing toward long RRIs. Concentration around short RRIs may
reflect rapid ventricular contractions due to uncoordinated AA evolution. It is also worth
noting the higher PDF dispersion around the mean, whereas in SR subjects probability
distribution is narrower. Such differences can be also observed in the RRI length time
series plot is Fig. 8.3. During AF, RRI repetition rate seems considerably higher than
in SR subjects. By contrast, in healthy subjects, not only RRIs are more evenly spaced,
but duration values seem also to be characterized by a lower degree of variability com-
pared with the irregular RRI length distribution typical of AF patients. Our preliminary
examination led us to investigate whether RRI histograms characteristics encountered in
AF patients could be properly quantified by HRV measures presented in Sec. 8.2.2, with
particular attention to skewness and dispersion indices of HR and RRI variability, in the
point process framework, thus reintroducing the concept of RRI history-dependence.
8.4.2 ECG database
One-minute standard ECG was acquired in 47 male patients, aged 50 to 70, affected
by persistent AF, at a sampling rate of FS = 977 Hz. Seventy-one healthy subjects are
assigned to the SR control group (FS = 128 Hz) [56], 35 men (aged 26 to 76 years) and 37
women (aged 20 to 73). Long-term ECG recordings of 18 subjects from the Arrhythmia
Laboratory at Boston’s Beth Israel Hospital (now the Beth Israel Deaconess Medical
Center) are added to the control group. Healthy subjects are not at rest conditions.
Information about the remaining healthy subjects comes from the Normal Sinus Rhythm
RR Interval Database [15], which includes beat annotation files obtained by automated
analysis with manual review and correction.
8.4.3 Methods
Most of the methodological steps presented in Sec. 8.3 are herein applied again. More
precisely, after assessing the optimal regression order q through the Akaike criterion, each
of the models introduced in Sec. 8.2.1 is determined in each subject. Accordingly, KS test
is carried out to verify whether the HDIG model fits the actual RRI series. Examination
of the autocorrelation function of the rescaled RRIs is also accomplished so as to check
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agreement with their mutual uncorrelation hypothesis. Subjects can be discarded from
the analysis if their related RRI series do not fulfill these hypotheses.
Correctness of the HDIG model hypothesis is further validated by comparing this
probability distribution with a history-dependent Gaussian (HGG) PDF. Discrepancies
of the estimated models from actual RRI data are quantified by the maximum distances
computed by the KS test.
We also examined a classical non-parametric method, the so-called kernel density
estimation (KDE), and compared it with the point process method. According to this
approach, PDF is estimated by applying a smooth kernel function (for instance, the
normal function) K(·) to each data point x(i) of a generic series x of n samples (in our
application, heartbeat interval series samples). Therefore, PDF estimate is defined as:
f̂(x) = 1
n
n∑
i=1
K
(x− xi
h
)
(8.14)
where h is the kernel bandwidth, the most critical setting parameter in KDE application.
Accordingly, we first chose the number of points NKDE (related to the histogram bin
width) in which PDF estimation is performed. Model fitting of each KDE distribution is
evaluated by means of the KS test in Table 8.7. Effects of the tuning parameters’ selection
on HRV assessment are shown in Table 8.8 for the skewness index.
Table 8.7: Mean KS distance of transformed RRIs modeled by the KDE method for each
value of NKDE: comparison with the point process approach.
NKDE = 50 NKDE = 100 NKDE = 300 NKDE = 1000 HDG (q = 5) HDIG (q = 5)
AF 0.6583± 0.0703 0.6688± 0.0392 0.6925± 0.0158 0.2847± 0.0962 0.7023± 0.0049 0.1193± 0.0581
SR 0.6789± 0.0470 0.6833± 0.0454 0.6989± 0.0209 0.7035± 0.0086 0.2040± 0.0889 0.1225± 0.0492
Table 8.8: Analysis of the skewness index computed on RRI data modeled by the KDE
method.
AF SR p-value
NKDE = 50 0.4740± 0.8067 0.8566± 3.3065 9.0 · 10−3
NKDE = 100 0.4822± 0.8107 0.3455± 3.9585 9.2 · 10−3
NKDE = 300 0.4877± 0.8133 2.4503± 9.9187 4.9 · 10−2
NKDE = 1000 0.4905± 0.8143 1.0760± 2.8033 4.7 · 10−2
Once the model fitting accuracy has been verified, HR and RRI variability descriptors
are computed and statistical analysis is accomplished as described in Sec. 8.3.1. Its out-
come is quantified by the test p value. HRV indices underlining statistically significant
differences between the two groups examined (“AF” vs “SR”) are subsequently exploited
for supervised classification of all subjects. More precisely, classification accuracy of sta-
tistically significant HR and HRV features in the non-stationary point process framework
is tested. Therefore, linear discriminant analysis (LDA) is performed to classify each test
sample into the correct category based on information provided by the training group.
Each classifier (C1 =Skewness, C2 = RRI standard deviation and C3 =HR standard devi-
ation) is either tested separately or in combination with the other ones, thus yielding 2D
(C12 = (C1, C2), C13 = (C1, C3), C23 = (C1, C3)) or 3D features (C123 = (C1, C2, C3)). In
this section, feature combination is not accomplished according to the logistic regression
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(LR) analysis introduced in Sec. 6.2, since data risk to be overfitted due to the very low
number of features (ranging from 1 to 3). By contrast, LDA seems a more suitable tool,
since the database accounts a high number of samples (117 subjects). Indeed, classification
can benefit from a supervised framework, in which predicting features can be properly
learned by a sufficiently large training set and then applied to ascribe the new test samples
to the correct category. LOOCV technique is applied for results’ validation. Classification
accuracy of each classifier Acc is the quantified by the ratio between the number of correct
detections and the overall number of subjects. Let us consider AF patients as positive
cases, and SR subjects as the negative ones. Under these assumptions, the number of
correct detections per category (true positive TP and true negative TN) and the number
of misclassifications is also computed (false positive FP and false negative FP ). Classifi-
cation performance of the point process approach is also compared with that of the same
classifiers obtained with the non-parametric approach.
Influence of the model order q on the autoregressive structure of the RRI series has
also been investigated. Accordingly, autocorrelation function has been computed for each
subject by setting 2 different q values, the default q = 5 (explanations about this setting
are provided is Sec. 8.4.4) and a lower one, q = 2. Differences in model representation
accuracy as estimated by the autocorrelation function are shown in Fig.8.7. Structure
of the autoregressive model has also been investigated by assessing the mean maximum
log-likelihood MLL for each category.
Assuming dependence of each heartbeat interval on its previous history implies HDIG
point process model agreement with the principle of causality. We verified this assumption
by reversing the order of the RRI sequence and computing HRV statistics on the new
series. If our hypothesis is correct, HRV parameters should take different values on the
reversed series. For sake of example, in Fig. 8.6 we report results obtained on the reversed
RRI series examined in the point process framework, under the hypothesis of series non-
stationarity.
We finally focused on the influence of ECG sampling frequency FS on RRI series
modeling and feature extraction. As a matter of fact, as this parameter changes according
to the group of subjects, we set the same value FS = 128 Hz for all subjects (thus
downsampling AF ECG signals), we computed HRV descriptors and performed statistical
analysis again so as to verify whether interclass differences are exclusively due to RRI
series properties and are not influenced by the sampling rate.
8.4.4 Results
The same tuning parameters adopted in Sec. 8.3.4 are set for this application as well,
except for the regression order q, which is equal to 5, as demonstrated by Table 8.9,
showing the number of occurrences of RRI database subjects for each q value. Also in
this experimental session, we have taken into account the compromise between an accurate
modeling of RRI series and their limited length (around one minute). More specifically, we
set this order value so as to accurately describe RRI series in control subjects, exhibiting a
more correlated structure. Concerning AF patients, even though q is generally quite low,
we can note that increasing its value does not alter time series characterization accuracy,
since higher order regression terms can be considered negligible. Hence, a satisfactory
trade-off between such objectives is accomplished by setting q = 5.
The ability to fit the actual RRI series is expressed in terms of maximum KS distance
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Table 8.9: Number of subjects ns with optimal regression order q according to the AIC
criterion. AF: number of subjects in AF group. SR: number of subjects in SR group.
q 1 2 3 4 5 6 7 8 9 10
ns(AF )/47 15 6 3 2 3 2 6 5 1 4
ns(SR)/71 8 10 7 9 11 4 4 6 6 6
(mean ± standard deviation) for each category (AF vs SR) and each model (HDIG, HDG
and KDE for several values of NKDE) in Table 8.7. As far as AF patients are concerned,
model representation accuracy assessed by the KS test is globally quite high (more than
75% of KS plot points belong to the confidence band). Only in the healthy patient 62 the
model fails to fit real data, and estimation quality is quite poor. As a consequence, this
subject is discarded from the statistical analysis discussed in the following sections. RRI
series PDF in healthy subject is also well fitted by the point process model, except in one
subject, who has been removed from our analysis.
Statistical analysis outcome is reported in the box-and-whiskers plots in Fig. 8.6.
The non-parametric approach is denoted by HMAN. Notations HSTAT,APP and HSTAT
refers to the point process under RRI series stationarity hypothesis, with and without
approximation of the HDIG first moment to the mean RRI interval RR, respectively.
When RRI series is assumed non-stationary, notation HNONSTAT is employed. AF data
downsampling effects on HRV parameters make reference toHMAN,DS andHDS for the non-
parametric and the point process approaches, respectively. Finally, experiments about
RRI series time reversal are ascribed to HREV. For the sake of clarity, in Fig. 8.6 we report
statistical results obtained on downsampled AF data for the non-parametric approach
and the point process analysis of RRI series regarded as non-stationary only, since similar
results are obtained under the hypothesis of HRV statistics’ time-invariance.
Classification outcomes output by the point process modeling are reported in Ta-
ble 8.11 and they are compared with those displayed in Table 8.10, which are obtained
by features directly determined on RRI series in a non-parametric framework. The ratios
TP , TN , FP , FN and the classification rate Acc are indicated for each of the classifiers
previously defined, either separate or combined. The 47 AF patients included in the
classification task are regarded as positive cases, whereas the 71 SR control subjects form
the group of negative cases.
8.4.5 Discussion
This part of our study demonstrates the ability of the point process method to properly
enhance RRI series content in the presence of AF, applied to this arrhythmia for the first
time [11].
Point process setting parameters of the proposed method have been adequately chosen
by taking into account database characteristics as well as the type of features to be
extracted. Regression order analysis in Table 8.9 underlines that RRI series in most of
AF patients are better described by a lower number of terms for regression, whereas the
more correlated structure of RRI series in healthy subjects requires a higher number of
components in the linear combination. This is also corroborated by the inspection of
the MLL measure, which takes higher values in healthy subjects, thus rendering a more
correlated heartbeat interval series structure (AF: 66.43 ± 94.97, SR: 188.63 ± 94.17, p
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Figure 8.6: [
Box-and-whiskers plots of HR and RRI variability indices: non-parametric analysis vs
point process]Box-and-whisker plot of HR and RRI variability parameters. Left:
Non-parametric analysis. Right: Point process modeling according to different
assumptions about RRI time series. In each plot, for each method examined, AF group
is on the left (continuous line), SR group on the right (dotted line). Results concerning
effects of AF data downsampling and time-reversed RRI series are also reported.
Notations. HMAN: non-parametric approach. HSTAT,APP and HSTAT: point process under
RRI series stationarity hypothesis, with and without approximation of the HDIG first
moment to the mean RRI interval RR, respectively. HNONSTAT: point process under
RRI series non-stationarity hypothesis. HMAN,DS and HDS: AF data downsampling in
the non-parametric and the point process methods, respectively. HREV: RRI series time
reversal.
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Table 8.10: LDA classification outcomes of features determined in 47 positive cases (AF)
and 71 negative cases (SR) on the raw RRI series under no assumptions about their PDF
(single-feature classifiers C1 = Skewness, C2 = SDNN and C3 = SDHR, and their
multivariate combinations C12, C13, C23, C123).
TP TN FP FN Acc
C1 26 24 46 21 0.4274
C2 25 63 7 22 0.7521
C3 27 67 3 20 0.8034
C12 32 44 26 15 0.6496
C13 33 65 5 14 0.7607
C23 27 62 8 20 0.8376
C123 35 58 12 12 0.7949
Table 8.11: LDA classification outcomes of features determined in 47 positive cases (AF)
and 71 negative cases (SR) on the non-stationary RRI series estimated by the point
process HDIG model (single-feature classifiers C1 = Skew, C2 = σRR and C3 = σHR, and
their multivariate combinations C12, C13, C23, C123).
TP TN FP FN Acc
C1 43 62 8 4 0.8974
C2 34 62 8 13 0.8205
C3 37 62 8 10 0.0.8462
C12 35 62 8 12 0.8291
C13 38 62 8 9 0.88034
C23 41 62 8 6 0.8547
C123 42 62 8 5 0.8889
value: 4.35 · 10−10). This evidence hints a higher degree of irregularity in AF patients
compared with SR and a lack of structure of RR series, thus implying a higher level of
unpredictability, as we expect in AF patterns. This is also confirmed by the examination
of the AIC values corresponding with the optimal order q of each subject, which are by
average lower in SR control subjects (AF: −7.9341 ± 2.6794; SR: −13.8983 ± 4.8411; p
value= 2.3096 · 10−12).
Visual inspection of KS plots generally reveals a good agreement between model and
real data for most of subjects, as their values generally fall within the 95% confidence
bounds. A pair of examples is displayed in Fig. 8.8. Indeed, even when HDIG model
computation is not completely accurate, deviation from real data evolution is limited,
and global fitting precision is generally quite high (80% by average).
To the same end, autocorrelation function computation has been performed for two
different regression order values so as to inspect the correct assessment of the regressive
structure properties. A representative example in Fig. 8.7. We can see that increasing
the regression order notably improves model accuracy as series structure becomes more
robust when more terms are taken into account. This is confirmed by the reduction, and
in several cases the disappearance of autocorrelation function outliers.
Our investigation demonstrates the adequateness of the PDF chosen for fitting RRI
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Figure 8.7: Autocorrelation function of the rescaled RRIs computed in AF patient 8 for
2 distinct regression order values q. Left: q = 2. Right: q = 5.
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series probability distribution. Indeed, RRI series during AF are better fitted by the HDIG
model than the HDG one, as confirmed by the lower KS distance values in Table 8.7 for 34
patients out of 47. Mean global accuracy as quantified by the number of points NKS falling
within the confidence bounds is equal to 97.23±6.88. Even in patients whose KS plots of
estimated RR series are not entirely bounded by the confidence limits, our results show
that the HDIG model can better describe RR length distribution, as in subjects 7 and
30. The comparison with the HDG distribution also confirms the HDIG modeling is not
biased by distribution variance values. Consequently, higher values of certain statistics
observed in presence of AF (in particular, skewness and RRI standard deviation) are
exclusively due to disease effects and not to assumptions about RRI PDF. Concerning
the control group, lower KS distances can be by average found when we assume that RR
length series obeys a HDIG distribution law as well (NKS = 97.14± 7.96).
Similar remarks arise from the comparison with the KDE estimation approach, as
proved but the higher KS distances values in Table 8.7 obtained for each class, regardless
of the number of points used for PDF estimation. In addition, such an analysis also shows
how the method is dependent on setting parameters. Furthermore, in some subjects PDF
can not be correctly estimated if the number of points NKDE is too low, thus making it
hard to properly assess HRV statistics. Such a variability is reflected on the computation
of HRV features, as confirmed by the statistical analysis of the skewness index in Table 8.8,
even though the method always underlines statistically significant differences between the
categories of interest.
The point process modeling considerably enhances the descriptive power of RR length
distribution statistics, and it overcomes the non-parametric approach, as there is no need
for interpolating between consecutive heartbeat intervals for characterizing series dynam-
ics and HRV measures are independent from histogram settings. The method we put
forward is able to effectively discriminate between AF and SR conditions, despite the
high level of RR variability encountered in healthy subjects. Indeed, it must be noticed
once again that ECGs in control subjects are not acquired at rest conditions, whereas
AF signals are recorded right before ablation performance. This experimental condition
underscores the descriptive power of the point process methodology, which is able to
correctly distinguish the two groups despite such complexity. HRV statistical assessment
for the classical non-parametric modeling in Fig. 8.6 highlights that dispersion measures
of RRI and HR variability are significantly higher in AF patients. Statistical significance
of the index SDHR is not altered by the presence of an outlier (AF patient 15), which is
still valid even if it is removed from our analysis (AF: 16.70± 5.32, p value: 2.3 · 10−15).
Concerning PDF asymmetry quantification, we can remark that skewness does not seem
a reliable index when it is directly computed on raw data. Indeed, it underlines more
skewed distributions in healthy subject, which is in contradiction with conclusions drawn
about our visual inspection in Fig. 8.2. The fist moment of the HDIG PDF proves to
be a reliable estimation of the mean RRI directly computed on the input RRI series,
as confirmed by results in Fig. 8.6, which are quite similar to each other. Results can
also be generalized for non-stationary RRI series, as confirmed in the same figure, thus
demonstrating the ability of this model to capture series dynamics, which are even more
complex and variable.
Supervised classification outcome also corroborates the predictive power of HRV fea-
tures characterized in the point process framework, which overcomes the classical non-
parametric computation. In Table 8.10 we can clearly remark the low discriminative
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Figure 8.8: Two examples of KS plots for HRV characterization in AF patients and healthy
subjects. Left: High modeling accuracy (AF, subject 39). Right: Low modeling accuracy
(SR, subject 62).
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power of the skewness index, which is rather improved by the combination with disper-
sion measures, in particular with C3 = SDHR; multivariate features generally perform
better than features considered separately. By contrast, all parameters estimated in the
point process scenario can effectively distinguish between AF and SR, as confirmed by the
high accuracy scores, and the number of incorrect detections is considerably low for both
categories. The skewness index proves to be the most accurate classifier, even though
classification performance of other parameters is equally satisfactory. Multidimensional
predictors are also able to ascribe each sample to the correct category, as indicated in
Table 8.11. This evidence shows the advantages of point process assumptions, making
AF characterization more robust and reliable.
We also demonstrate the robustness of the point process method to the influence
of ECG acquisition factors, in particular to ECG sampling frequency (see Table 8.6.
Regardless of the approach considered, we can remark that features computed on the
modified RRI series in AF patients sometimes take values which are slightly higher than
those obtained at their typical sampling rate (FS = 977 Hz). However, interpretation of
statistical analysis results remains unchanged for most of the features considered, except
of the mean RRI value for all the approaches (RR and µRR). More precisely, HR and RR
dispersion indices are still significantly higher in AF patients than in healthy subjects,
thus correctly depicting the higher level of RRI irregularity reflecting AF uncoordinated
activity. Similarly, the higher values of skewness denote RRI PDF asymmetry in presence
of AF. In contrast with results previously commented, it seems that mean RRI can sig-
nificantly discriminate the groups, and it takes higher values in AF patients, regardless
of the method applied.
Finally, we verified the ability of the point process approach to underline the most
content-bearing components of the RRI series in presence of AF by modeling their tem-
poral evolution and underlining the relation of each heartbeat interval with the previous
ones, which is shown to be physiologically correlated with autonomous system activ-
ity [11]. The results of the statistical analysis in Fig. 8.6 demonstrate that altering such
dynamics by reversing the order of RRI sequences influences the properties of the HDIG
model computed and the numerical results of our statistical analysis. Accordingly, even
though variations are quite limited and significance levels do not change, also the values
HRV measures computed on the reversed series are affected by RRI sequence reversal,
thus confirming the dynamical structure emphasized by the point process. Point process
structural dependence on previous history provides a useful tool in terms of RRI series
predictability and evolution characterization at each time instant.
8.5 Summary and conclusions
This chapter has shed some light on the potential characterization of the ventricular
response in the presence of AF by means of HRV measures obtained in a parametric
probabilistic point process framework, which has been employed for the first time for
the characterization of this arrhythmia. RRI PDF is shown to obey a HDIG law, and
each heartbeat interval is modeled as a function of its previous history, thus rendering
the influence of the autonomic inputs as reflected on RRI length variations. Our study
represents the first application of the point process method to AF analysis and ventric-
ular response modeling in the presence of this arrhythmia. It overcomes limitations of
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traditional approaches, especially those related to dependence on histogram bin width
and strict hypotheses about RRI series, and it leads to a more refined, instantaneous
characterization of HRV features, even in short recordings. From the statistical model
proposed we can derive a novel formulation of HR and HRV indices instant by instant,
the capability of our model to describe real data and capture the dynamics of heartbeat
interval temporal evolution is confirmed by the KS test and correlation analysis. Despite
the inability to predict AF termination by CA, the method proposed here can on the
other hand highlight and quantify some properties of RRI distribution encountered in the
presence of AF. These results open new lines of investigation for enriching HDIG model
so as to better render AF properties, e.g., by including non-linearities. Future research
about other HR and RR features could be performed as well. The method could be
potentially applied to further clinical applications, for instance, arrhythmia classification
and prediction of AF episode onset.
Part III
Summary and conclusions
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9 Conclusions and future work
In this doctoral thesis we have put forward several techniques and tools aiming at an
improved, more robust noninvasive prediction of CA outcome in persistent AF. We illus-
trated the potential role of standard ECG for improving AF understanding and treatment.
Particular attention has been paid to CA, since prediction of its outcome is still an open
challenge in current medical practice. We have developed some mathematical tools aiming
at extracting the most descriptive components of ECG signal, which are relevant to CA
outcome prediction. In particular, we have exploited standard ECG spatial variability
to highlight such predictive features, by combining contributions coming from multiple
ECG leads and properly enhancing the most significant descriptive ones. In most of the
applications introduced in our dissertation, PCA has proved to be suitable for represent-
ing the most meaningful characteristics of AA signal, thanks to its ability to compress
its maximum-variance features into a few, representative components. In particular, we
demonstrated that rank-1 approximations to AA signal can effectively render most of
its structure without loss of significant information and represent a suitable basis for
subsequent feature extraction. The introduction of further constraints (e.g., component
non-negativity, ECG lead weighting schemes) has also allowed the application of other
multivariate decomposition techniques (NMF, WPCA), which are equally able to empha-
size the most discriminative components of the AA signal in CA outcome prediction. AA
signal properties such as f-wave amplitude, regularity and STV content have been charac-
terized in the presence of AF in a multivariate framework. The approaches developed thus
overcome the limitations of traditional methods, which are manual or exclusively focus
on only one ECG lead, thus neglecting the richness of multilead recordings and lacking of
robustness to lead selection. Investigation of RR variability has also been envisaged for
ventricular response characterization, and peculiarities of RRI distribution in AF patients
have been assessed in a probabilistic point process framework. We next summarize the
main contributions of this doctoral thesis
9.1 Summary and conclusions
9.1.1 Multivariate characterization of f-wave amplitude on standard
ECG
One of the main objectives achieved in this work is represented by the assessment
of f-wave amplitude in a multivariate framework. Moving from the empirical correlation
between f-wave amplitude and CA outcome, widely acknowledged in clinical practice,
we have developed an automatic method able to assess atrial peak-to-peak amplitude
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distribution over multiple ECG leads. Single-lead measures obtained on reduced-ranks
approximations to AA signal through PCA are properly combined in a unique parameter
which can predict AF termination by CA. This approach allows us to extract the most
significant components of f-wave amplitude by processing all the ECG leads at the same
time, thus overcoming the limited perspective of single-lead methods. Results obtained
are consistent with the clinical assumption that high values of f-wave amplitude predict
AF termination by CA. By adequately combining contributions from each ECG lead,
not only an extension to prediction in the long-term followup has been performed, but
variations of this parameter within CA procedure have also been quantified. Our research
corroborates the predictive value of atrial amplitude for CA outcome prediction and the
improvement in performance accuracy and robustness provided by multilead processing.
9.1.2 Assessment of multivariate ECG measures of AF STV
Spatial diversity of the 12-lead ECG has also proved to be exploitable for quantifying
the degree of STV of the AF pattern. Previous studies have noninvasively quantified
AF organization on surface recordings. The extension of these works to a multilead
framework has yielded novel measures of AF STV content, which quantify not only the
degree of temporal repetitiveness of AF pattern between consecutive AA signal segments,
but also its spatial distribution over ECG leads. PCA reduced-rank approximations to
AA signal effectively retain its most content-bearing components, while rejecting noisy
and/or redundant elements. Similar remarks can be made about WPCA application,
which decomposes the AA signal based on a priori knowledge about contributions from
each ECG lead in terms of temporal variance: the most stable and low-dispersion patterns
effectively contribute to AA content characterization, whereas the most variable ones are
automatically filtered out. The same rationale guides the choice of the multilead STV
descriptor, once again underlining the advantages of correctly recognizing and empha-
sizing the most descriptive ECG leads for CA outcome prediction, at different follow-up
lengths. An important line of research the application of the NMF technique to CA
outcome prediction, which is, to our knowledge, employed for the first time in ECG signal
processing in general, and in AF analysis in particular. Indeed, the NMF-compressed form
of the multivariate information about AF STV proves to be still predictive of CA outcome,
thus preserving its clinical meaning. Relation with AF organization according to classical
clinical criteria, such as Wells’ and Koning’s, represent a future line of investigation.
9.1.3 Combination of multiple ECG features in a multivariate framework
The ECG descriptors aforementioned show to be reliable predictors of AF termination
by CA and effectively render some properties which are visible on this type of heart
electrical activity recording and are typical of persistent AF. In this dissertation, we have
demonstrated that these measures of f-amplitude and AF STV can be properly examined
at the same time by means of the LR analysis. This model linearly combines these
multivariate measures extracted from PCA low-rank representations of the AA signal
and selectively highlights ECG leads exhibiting the most content-bearing contributions.
Components enhanced by this technique seem to be relevant to CA outcome prediction,
and effectively assess AF therapy success. AF characterization seems to be enriched
when these indices are simultaneously processed, thus opening promising perspectives for
161 Conclusions and future work
the multivariate analysis of other heterogeneous ECG-based parameters, which can be
potentially merged with further clinical data about the AF patient.
9.1.4 Multivariate processing of IT measures from CA outcome predic-
tion
In this thesis, the concept of spatial variability of standard ECG has been investigated
from multiple perspectives. A further way to explore such a diversity takes a step from
the examination of the degree of mutual correlation between pairs of ECG leads, which
has been subsequently extended to subsets of multiple electrodes. We demonstrated the
existence of a relation between the degree of interlead uncorrelation and AF pattern
regularity, assumed to be closely related to therapy outcome. This analysis provides a
more accurate characterization of AF pattern distribution over ECG leads, and better
enhances contributions coming from different orientations of the heart electrical axis. AF
regularity content also proves to be correlated with CA outcome, and we actually verified
the assumption that more uncorrelated and irregularly propagating patterns are linked
to a lower probability of a successful CA procedure. To our knowledge, IT mathematical
support has been employed for the first time not only for AF study on standard ECG in
a multivariate framework, but also for establishing a relation between AF uncorrelation
and CA clinical outcome.
9.1.5 Parametric approaches for RR variability characterization during
AF
For the sake of completeness, after characterizing information extracted for the AA
signal, we also investigated the ventricular response as quantified by RRI analysis. RRI
variability has been described in a probabilistic framework, by assuming that R wave
occurrences represent a point process model. Accordingly, their probability distribution
has been rendered through a HDIG model by taking into account the temporal variability
of RRI length as induced by the sympathetic and the parasympathetic inputs to the SA
node. This parametric description is free from tuning parameters of RRI histograms,
in particular bin width, as RRI distribution parameters are estimated at each time in-
stant, with no need for interpolation between consecutive R wave events. Moreover, the
adequateness of the model proposed to depict RRI distribution can be mathematically
assessed by means of the point process theory, relying on the time-rescaling theory and
the goodness-of-fit analysis. This formulation allows for the extraction of HRV features
which are exclusively function of HDIG distribution parameters estimated on the data
themselves, and do not depend on histogram computation modalities. Despite the weak
predictive power of the HRV measures in CA outcome assessment, such indices prove to
be able to highlight some characteristics of RRI histograms, enhancing the differences
between AF patients’ and healthy subjects’ RRI distribution, in particular concerning
asymmetry and dispersion of the RRI PDF. These preliminary results hint new potential
lines of research and clinical applications, in particular for instantaneous AF detection
and arrhythmia classification.
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9.2 Future work
9.2.1 Study challenges and limitations
The wide variety of AF aspects investigated in this work and the number of ECG
features inspected can give rise to several questions about the best method which should
be actually adopted to effectively predict CA outcome. The answer to such questions
cannot come from just one methodology, since all the properties explored contribute
to understand AF pathophysiology, whose complexity cannot be effectively rendered by
examining just one property.
Consequently, we should rather wonder how to adequately exploit all these features.
One potential strategy can come from proper combination of such ECG measures, in
which only the most significant contributions are enhanced. This strategy resembles the
approaches adopted throughout this dissertation for combining ECG leads’ contributions,
such as statistical measures of central tendency or LR analysis, but also multivariate
decompositions, e.g., PCA. More sophisticated solutions come from the machine learning
theory, which perform feature selection based on ranking criteria or distance measures.
Different methods for variable subset selection can be actually taken into account. For
instance, wrappers utilize the learning machine of interest as a black box to score subsets
of variable according to their predictive power. Filters extract subsets of variables as a
pre-processing step, independently of the chosen predictor. Finally, embedded methods
perform variable selection in the process of training and are usually specific to given
learning machines [59]. However, it must be mentioned that advanced approaches based
on feature leaning generally need a large number of samples (i.e., AF patients or CA
procedures in the applications of our interest), especially when a large set of variables
is under examination. Roughly speaking, a higher number of subjects undergoing CA
should be included in our study so as to confirm the predictive power of the ECG-based
parameters introduced in this thesis.
In the same line, generalization of the results reported in this work is hampered not
only by the variability of the ECG database size, but also by changes in criteria defining
CA outcome. In certain groups, procedural success is obtained only if SR is restored,
whereas other studies also admit conversion to intermediate, more organized arrhythmias
(e.g., AFL). These changes have been frequently encountered throughout the present
study, and make it harder to validate the ECG measures proposed. Furthermore, the
application of complementary cardioversion therapies and/or additional ablations can
also radically influence CA outcome evaluation in time, especially when switching to
longer followup periods. Indeed, CA procedures regarded as failing in the immediate
postoperative phase can turn into AF termination in the long-term followup because of one
of the aforementioned therapies. Similarly, acute CA success can change into a procedural
failure later in the follow-up because of clinical complications or atrial remodeling effects.
In this thesis, all the findings made on smaller groups of patients’ have been validated
on a bigger set, and links between acute procedural success and long-term AF termination
have been established when possible. In future works, including a higher number of
AF patients and applying machine learning techniques could help generalizing methods’
validity and overcome issues related to dependence on followup length, since the most
suitable features will be automatically determined and chosen by the algorithm.
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9.2.2 CA outcome prediction in persistent AF by tensor decompositions
The present doctoral thesis has explored in detail the potentialities of matricial repre-
sentations of the 12-lead ECG as directly obtained in clinical centers. More precisely, in
order to assess how AF pattern is distributed over leads and how it can be characterized
from different planes and angles, we assumed to analyze signal variability throughout
ECG leads at a fixed time instant. Therefore, ECG analysis has been performed both in
terms of space and time. However, despite the suitability of this matrix representation,
further potential information about AF content could be properly highlighted by this kind
of approach. Indeed, it could be useful to include in the analysis other signal properties
(for instance, frequency), or examine multivariate features on the same lead all at once,
without decomposing their matrix structure (as we did, for example, in Chapter 5 when
dealing with AF STV extraction and NMSE computation over AA segments). Hence,
moving to tensorial analysis could help overcoming these issues and better enhancing
AF properties. More precisely, the main purpose of this approach is the exploitation of
tensorial forms to extract suitable features which are based on projections on data linear
subspaces and are predictive of CA outcome in persistent AF.
A tensor is a multidimensional array. More formally, an N -way or Nth-order tensor
is an element of the outer product of N vector spaces, each characterized by its own co-
ordinate system [77]. As in the 2-D case, the core of our investigation is to which extent
it is possible to transfer properties of matrix decompositions to higher tensor orders, and,
when this transposition is not possible, which aspects and differences should be taken into
account from a mathematical point of view. In fact, as compared to matrix techniques,
tensor decompositions present some remarkable features such as essential uniqueness un-
der mild conditions and rank possibly exceeding the data dimensions, but some computa-
tional constraints should be also taken into account, dealing with greater time and space
complexity inherent in tensor algorithms. One of the main fields of application of tensor
decompositions has been so far represented by telecommunications [40]. In particular,
some techniques, such as the PARAFAC (Parallel factor analysis) decompositions, aim
at representing the tensor as a sum of rank-1 tensors, and have been successfully applied
to wireless communication [122, 140]. A higher order generalization of SVD , i.e. the
HOSVD, has also been presented in [86]. Another line of research has attempted to
perform an orthogonal decomposition of tensorial data in keeping with the bidimensional
case of PCA in the variance-extraction sense, thus yielding the contribution presented
by [149]. Some of its variants, i.e., the multinear PCA (MPCA) and the uncorrelated
MPCA (UMPCA) have been applied to image classification [90, 91] and EEG feature
selection [9]. A non-negative factorization (i.e., the tensorial counterpart of the equiva-
lent NMF in the 2-D case) has also been implemented, with particular concern for sparse
image coding [137].
In our application, one of the most crucial points is the correct identification of the
structure of input data. We actually wonder not only how many dimensions (the so-called
tensor modes) we can process by means of our algorithm (roughly speaking, the optimal
order of tensorial data), but also which feature should be taken into account for each
dimension. Intuitively, we could keep the spatial notion intrinsic to ECG leads’ spatial
distribution, besides the temporal evolution of signal samples. Choice of further ECG
properties to be analyzed is not a trivial task, and it must take into account which global
information we aim to extract. For instance, a possible experimental line could concern
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the introduction of frequency-based features determined on each ECG lead, provided
that ventricular activity is previously removed from the ECG recording. Another possible
solution could aim at exploring AF STV content and considering the AA segment as a
mode of the tensor, thus introducing the non-negativity constraint intrinsic to NMSE
definition. In addition, the proper tensorial decomposition must be selected so as to
extract potentially predictive features, whose interpretation must be consistent with AF
pathophysiology.
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Appendix
A.1 Derivation of the least squares estimates
The objective of the least squares (LS) method is computing the slope S and the
intercept I of the linear law y = Sx + I so that E =
n∑
i=1
d21 introduced in Sec. 4.6.3 is
minimized. We first introduce some definitions:
• x: sample mean of the predictor variables;
• y: sample mean of the response variables;
• σ2x: sum of squared deviations from x;
• σ2y: sum of squared deviations from y;
• σ2xy: sum of cross products of squared deviations.
For the generic sample i, we can write:
yi − Sxi − I = (yi − y)− S(xi − x) + (y − I − Sx). (1)
If we square both sides of Eq. (1) we obtain:
(yi − Sxi − I)2 =
= (yi − y)2 + S2(xi − x)2 + (y − I − Sx)2
− 2S(xi − x)(yi − y)− 2S(xi − x)(y − I − Sx) + 2(yi − y)(y − I − Sx).
(2)
By summing both sides of Eq. (2), it reduces to:
D = σ2y+S2σ2x+n(y−I−Sx)2−2Sσxy = n(y−I−Sx)2+(Sσx−
σxy
σx
)2+(σ2y−
σ2xy
σ2x
). (3)
Minimization of this expression yields the estimates:
S = σxy
σ2x
; I = y − Sx. (4)
The degree of linear correlation between the variables x and y can be quantified by
Pearson’s coefficient:
RP =
σxy
σxσy
. (5)
A.2 WPCA algorithm
WLSminimization is achieved by following the optimization algorithm proposed in [66]:
• Initialize Ŷ0 and compute h0 = h(Ŷ0|Y,W), where h(·) is the WLS cost function
given by Eq. (5.5).
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• for i = 1, 2, . . . until convergence
1. Compute Y˜i = Ŷi+βW∗W∗ (Y− Ŷi), where β = w−2M , wM is the maximum
weight of W. The update is based on a maximization-function approach.
2. Compute Ŷi+1 as the reduced-rank model fitting the data Y˜i:
Ŷi+1 = arg min
Ŷ
‖Y˜i − Ŷ‖2 (6)
subject to the orthogonality constraints on Ŷ. This is given by the best rank-r
approximation (determined, e.g., via the SVD) of the matrix Y˜i obtained at
the previous step.
3. Compute hi+1 = h(Ŷi+1|Y,W). Given a fixed, small tolerance , if C∗ < ,
where:
C∗ = (hi − hi+1)/hi (7)
the convergence is reached; otherwise set i = i + 1 and repeat the algorithm
from Step 1 until convergence.
end
More specifically, the criterion is monotonically minimized according to Eq. (6), know-
ing that Y˜ depends on the multivariate input signal Y, the weight matrix W and the
model Ŷ at the current iteration.
Different procedures for initializing Ŷ have been envisaged in earlier works. The
implementation used in Sec. 5.4 assumes to assign the OLS solution obtained by the
standard PCA, so that Ŷ0 equals the best rank-r approximation determined without
assigning loads to preferential leads.
A.3 NMF: ALS algorithm
The basic ALS algorithm for NNMF consists in an alternation of LS steps and non-
negativity (NN) constraint enforcing. Given the linear model A = WH, the main steps
are herein introduced:
1. W initialization (as explained in Sec. 5.5)
2. for i = 1, 2, . . . until convergence
1. LS: Solve for H in
WTWH = WTA (8)
2. NN: Set all negative elements in H to zero
3. LS: Solve for W in
HHTWT = HAT (9)
4. NN: Set all negative elements in W to zero
3. end
As far as the stopping criterion is concerned, a convergence tolerance ‖wk−wk−1‖‖wk‖ equal to
10−4 is set for our algorithm.
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A.4 Chain rule in information theory
The chain rule cited in Chapter 7 can be demonstrated by starting from the definition
of joint entropy. By applying Bayes’ theorem, we can rewrite it as:
H(X, Y ) = −∑
x∈X
∑
y∈Y
p(x, y) log (p(x, y)) = −∑
x∈X
∑
y∈Y
p(x, y) log (p(x)p(y|x)). (10)
According to the linearity property, we can rewrite Eq. 10 as:
−∑
x∈X
∑
y∈Y
(p(x, y) log (p(x))− p(x, y) log p(y|x)) = −∑
x∈X
p(x) log p(x)− p(x, y) log p(y|x).
(11)
By applying the definition of marginal and conditional entropy put forth in Chapter 7:
−∑
x∈X
p(x) log p(x)− p(x, y) log p(y|x) = H(X) +H(Y |X). (12)
A.5 IT entropy extension to multiple variables
By iteratively applying the 2-variable expansion rule for entropies, we can write:
H(X1;X2) = H(X1) +H(X2|X1). (13)
In case of 3 variables we have:
H(X1;X2;X3) = H(X1) +H(X3, X2|X1) = H(X1) +H(X2|X1) +H(X3|X2, X1). (14)
Generalization to m variables yields:
H(X1;X2; . . . ;Xm) = H(X1) +H(X2|X1) + · · ·+H(Xn|Xn−1, . . . , X1) =
=
m∑
i=1
H(Xi|Xi−1, . . . , X1). (15)
